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Beta-hemolytic, large-colony-forming (diameter greater than 0.5 mm) Lancefield 
group C and group G streptococci (GCGS) is a group within the Streptococcus genus 
which includes several species recognized as either colonizers or pathogens in humans 
and animals. Streptococcus dysgalactiae subsp. equisimilis (SDE), which can express 
any of these two Lancefield group antigens, is the GCGS species most commonly 
reported in human infection worldwide and may cause a number of potentially life-
threatening infections. SDE is increasingly regarded as an emerging global pathogen 
and is able to colonize and infect humans, while other GCGS species, such as 
Streptococcus canis, are mainly animal pathogens that occasionally infect the human 
host. The rising number of human infections reported to be caused by GCGS warrants a 
better study of their epidemiology, in order to establish the relevance of each species, 
and clarifying the clonal dynamics and the intra-specific factors influencing the 
virulence of the strains. 
This work aimed at determining the GCGS species responsible for human infection 
in Portugal and, by assessing the genetic diversity of the isolates recovered, to define the 
clonal structure of this population. Thus, a special emphasis on molecular typing 
techniques was given, including those more commonly used to type these streptococci: 
pulsed-field gel electrophoresis (PFGE), emm typing and multilocus sequence typing 
(MLST). The application of these techniques to characterize collections of SDE and S. 
canis isolates recovered from other geographic locations and, for the latter species, from 
animal hosts, allowed to elucidate their respective population structures and provided 
new insights into the biology and evolution of GCGS. 
Initially, the speciation and characterization of GCGS isolates recovered from human 
infections in Portugal identified the central role of SDE. Not only was there a weak 
correlation between emm typing and PFGE results, but the polyclonal origin of the SDE 
population in this region was revealed by each of the methods used that generated 
multiple partitions. Furthermore, a correlation between emm type and invasive disease 
potential was suggested. 
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A more global snapshot of the clonal architecture of this pathogen population was 
achieved by developing a MLST scheme which was applied to an expanded collection 
of SDE isolates recovered from distinct continents. An association of Lancefield groups 
with distinct MLST partitions was found and the high prevalence of a small number of 
widely distributed MLST sequence types (STs) suggested that a few genetic lineages 
dominate among SDE causing human infection worldwide. The occurrence of intra-
specific and inter-specific recombination with Streptococcus pyogenes (Lancefield 
group A streptococcus, [GAS]), involving the housekeeping genes used in MLST was 
detected. 
The poor correlation between emm typing and either PFGE or MLST defined groups 
was illustrated by lineages displaying distinct emm types and the presence of the same 
emm type in unrelated genetic backgrounds, as defined by both techniques. These 
observations suggested the existence of recombinational replacements involving the 
emm locus and question the value of emm typing to accurately ascertain the genetic 
relatedness of SDE strains. 
The characterization of the antimicrobial susceptibility patterns presented by SDE 
found a high proportion of levofloxacin-resistant isolates (12%) associated with 
multiple genetic lineages. Sequence analysis of the quinolone resistance-determining 
regions of the gyrA and parC genes of representative resistant and susceptible isolates 
showed that full resistance was associated with mutations in both GyrA and ParC. As 
observed for the housekeeping genes used in MLST, recombination with GAS DNA in 
some parC alleles was evident, though this phenomenon was not exclusively associated 
with resistance. 
The final part of the work in this thesis focused on S. canis, the second most frequent 
GCGS species isolated from human infections in Portugal. A collection of S. canis 
isolates recovered from infections in both humans and animals, collected in Portugal 
and abroad, were characterized by employing the same typing methods used for SDE. 
The S. canis population was polyclonal, and several genetic lineages were shown to 
possess the ability to infect the human host. The zoonotic nature of S. canis infection 
was demonstrated, as identical genetic lineages were found infecting house pets and 
humans, indicating that they constitute a single population. Phylogenetic analysis 
showed that S. canis was a divergent taxon of SDE and GAS and unveiled the 
acquisition of genetic material of SDE by S. canis. The presence of emm-like genes was 
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restricted to a few S. canis isolates and correlated with some MLST-based genetic 
lineages. 
Globally, this thesis contributes to the current knowledge of the molecular 
epidemiology and evolutionary relationships among members of the two GCGS species 
studied. The clonal relationships among strains were elucidated and MLST schemes for 
SDE and S. canis were established, providing useful tools for future studies of their 
population dynamics. The use of emm typing was shown to be complemented by 
applying other typing methods and the role of the M protein in SDE virulence was 
reinforced. The evidence found for recombinational replacements between SDE and 
GAS in several loci and, to a smaller extent, between SDE and S. canis, indicates that 
horizontal gene transfer events are important mechanisms driving genetic variability in 




Palavras-chave: S. dysgalactiae subsp. equisimilis, S. canis, população, 
recombinação. 
Os estreptococos beta-hemolíticos formadores de colónias grandes (diâmetro 
superior a 0.5 mm) dos grupos C e G de Lancefield (GCGS) formam um grupo dentro 
do género Streptococcus que inclui várias espécies reconhecidas como colonizadoras ou 
agentes patogénicos no Homem e em animais. Streptococcus dysgalactiae subsp. 
equisimilis (SDE), que pode integrar cada um destes dois grupos de Lancefield, é a 
espécie de GCGS mais vezes reportada em infecção humana a nível mundial e pode 
causar diversas infecções potencialmente fatais. SDE é cada vez mais visto como um 
agente patogénico emergente, com a capacidade de colonizar e infectar o Homem, 
enquanto as outras espécies de GCGS, tais como Streptococcus canis, são 
principalmente agentes patogénicos de animais que ocasionalmente infectam o 
hospedeiro humano. O número crescente de infecções humanas atribuídas aos GCGS 
exige um estudo reforçado da sua epidemiologia, de modo a estabelecer a relevância de 
cada espécie e permitindo que a dinâmica clonal e os factores intra-específicos que 
influenciam a virulência das estirpes sejam clarificados. 
Este trabalho teve como objectivo identificar as espécies de GCGS responsáveis por 
infecção humana em Portugal e, através da avaliação da diversidade genética das 
estirpes recolhidas, definir a estrutura clonal da população. Deste modo, foi dado 
especial ênfase às técnicas de tipagem molecular, incluindo aquelas que mais 
habitualmente são utilizadas para a tipagem destes estreptococos: a electroforese em 
campo pulsado (PFGE), a tipagem emm e “multilocus sequence typing” (MLST). A 
aplicação destas técnicas para caracterizar colecções de estirpes de SDE e S. canis 
isoladas noutras regiões geográficas e, no caso da última espécie, de hospedeiros 
animais, permitiu elucidar as respectivas estruturas populacionais e percepcionar novos 
aspectos da biologia e evolução dos GCGS. 
Inicialmente, a especiação e caracterização de estirpes de GCGS isoladas de 
infecções humanas em Portugal mostrou o papel central de SDE. Verificou-se uma fraca 
correlação entre os resultados obtidos pela tipagem emm e PFGE e a aplicação destas 
técnicas revelou a origem policlonal da população de SDE nesta região, dado que cada 
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um dos métodos utilizados gerou múltiplas divisões. Adicionalmente, os resultados 
sugeriram a existência de uma correlação entre o tipo emm e o potencial de doença 
invasiva. 
Uma imagem mais geral da estrutura apresentada pela população deste agente 
patogénico foi alcançada através do desenvolvimento de um esquema de MLST, 
aplicado a um conjunto alargado de estirpes de SDE isoladas em continentes distintos. 
Esta análise permitiu estabelecer uma associação entre grupos de Lancefield e divisões 
distintas de MLST. Foi possível observar uma elevada prevalência de um pequeno 
número de “sequence types” (STs) na população. A ampla distribuição geográfica 
destes STs sugeriu o predomínio de algumas linhagens genéticas entre as estirpes de 
SDE que causam infecção humana em todo o mundo. Foi detectada ainda a ocorrência 
de recombinação intra-específica e inter-específica com Streptococcus pyogenes 
(estreptococos do grupo A de Lancefield, [GAS]), envolvendo genes “housekeeping” 
utilizados no MLST. 
A fraca correlação entre tipos emm e os grupos definidos por PFGE ou por MLST foi 
ilustrada pela existência de linhagens com tipos emm distintos e pela presença do 
mesmo tipo emm em patrimónios genéticos não relacionados, tal como definido pelas 
duas técnicas de tipagem. Estas observações sugeriram a existência de substituições 
recombinacionais envolvendo este locus e questionam o valor da tipagem emm para 
determinar correctamente a relação genética de estirpes de SDE. 
A caracterização dos perfis de susceptibilidade aos antimicrobianos apresentados por 
SDE permitiu detectar uma elevada percentagem de estirpes resistentes à levofloxacina 
(12%), associada a múltiplas linhagens genéticas. A análise das sequências das regiões 
determinantes da resistência às quinolonas nos genes gyrA e parC de estirpes resistentes 
e susceptíveis representativas, mostrou que a aquisição de resistência se encontra 
associada a alterações dos aminoácidos das proteínas codificadas pelos dois genes. A 
existência de recombinação com ADN de GAS foi evidente em alguns alelos do gene 
parC, como observado para os genes “housekeeping” utilizados no MLST. No entanto, 
este acontecimento não foi associado exclusivamente com o desenvolvimento de 
resistência. 
A parte final do trabalho descrito nesta tese focou-se na segunda espécie de GCGS 
mais frequentemente isolada de infecções humanas em Portugal, S. canis. Uma colecção 
constituída por estirpes de S. canis isoladas de infecções em seres humanos e animais, 
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recolhidas em Portugal e no estrangeiro, foi caracterizada recorrendo aos mesmos 
métodos de tipagem utilizados para SDE. A policlonalidade da população de S. canis foi 
evidenciada e várias linhagens genéticas mostraram ter a capacidade de infectar o 
hospedeiro humano. A natureza zoonótica da infecção por S. canis foi demonstrada pois 
as mesmas linhagens genéticas foram encontradas a infectar animais domésticos e seres 
humanos, indicando a existência de uma única população. A análise filogenética 
mostrou que S. canis é um taxon divergente das espécies SDE e GAS e revelou a 
aquisição de material genético de SDE por S. canis. A presença de genes similares ao 
gene emm restringiu-se a uma pequena proporção das estirpes de S. canis e 
correlacionou-se com algumas das linhagens genéticas definidas por MLST. 
Globalmente, este trabalho contribuiu para o conhecimento actual da epidemiologia 
molecular e das relações evolutivas entre os membros das duas espécies de GCGS 
estudadas. As relações clonais entre as estirpes foram elucidadas e esquemas de MLST 
foram estabelecidos para SDE e S. canis, constituindo ferramentas úteis para futuros 
estudos sobre a dinâmica populacional destas espécies. Mostrou-se que a utilização da 
tipagem emm é complementada pela aplicação de outros métodos de tipagem e a 
importância da proteína M na virulência de SDE foi reforçada. As indicações 
encontradas da ocorrência de trocas recombinacionais entre SDE e GAS em vários loci 
e, em menor extensão, entre SDE e S. canis, indica que os eventos de transferência 
genética horizontal são mecanismos motrizes da variabilidade genética em populações 
de GCGS, podendo afectar aspectos fulcrais da biologia destas espécies, como a 




The main purpose of the current work was to provide insights into the molecular 
epidemiology of GCGS causing human infections. 
Chapter 1 is a general introduction describing the main aspects of GCGS biology. As 
the current thesis focuses on human infections by these bacteria, a special emphasis is 
given to SDE, the species most commonly found and the subject of most of the 
laboratory work described in this thesis. A few aspects regarding the biology of other 
GCGS species are also studied, especially those which have also been isolated from the 
human host. A more detailed description of the typing methodologies used is also found 
under this section. This chapter concludes by stating the aims of the current work. 
Chapter 2 describes the epidemiology of GCGS recovered from invasive and non-
invasive infections in Portugal, and involves the characterization of 116 isolates 
recovered from 1998 to 2004 in hospital associated laboratories across the country. It 
starts by identifying the species involved and, since only SDE is detected, it proceeds 
with a detailed characterization by emm typing and PFGE of the isolates of this species. 
Also, the association of specific emm types and PFGE defined clones with invasive 
disease potential is statistically evaluated. The epidemiologic characterization of SDE 
presented in this chapter is supplemented by the data described in chapters 3 and 4. 
Chapter 3 centers on the development of an MLST scheme for the characterization of 
SDE. In collaboration with groups from Australia and the United States, an 
epidemiological and genetically diverse collection of isolates was obtained, including 
36 isolates recovered in Portugal and representative of several emm types encountered 
in the work reported in chapter 2. The application of the MLST technique allowed a 
global view of the SDE population causing infections in humans and to estimate the 
occurrence of recombination involving the housekeeping genes used in the MLST 
scheme. 
Chapter 4 describes the antimicrobial resistance patterns observed among an 
expanded collection of SDE human isolates recovered in Portugal (n = 314, recovered 
from 1998 to 2005), with a special focus on levofloxacin resistance. Prompted by the 
high resistance rate found and by previous suggestions that members of the S. 
dysgalactiae taxon could mediate the appearance of resistance in GAS through 
horizontal gene transfer events, the molecular mechanisms of fluoroquinolone resistance 
xii 
in SDE were investigated and phylogenetic analyses were conducted with the sequence 
data generated from the resistance-determining regions of the relevant genes. 
Chapter 5 focuses on a distinct Lancefield group G species, S. canis, which was 
found as an infrequent agent of human infection in the last years of the study. This 
chapter reports the molecular characterization of 85 S. canis isolates employing the 
same typing techniques used for SDE, as described in the previous chapters. Special 
emphasis was given to the development of a universally applicable MLST scheme for S. 
canis. Given the low number of human infections caused by this species, the collection 
was expanded by adding isolates recovered from animal sources, mainly house pets, 
which allowed the characterization of the S. canis population and provided reinforced 
evidence of the zoonotic nature of human infection. 
Chapter 6 is a general discussion which aims to summarize and articulate the main 
findings of the thesis. The contribution of this work is contextualized in the current 
issues on GCGS biology and the working questions that can be pursued in the future are 
highlighted. 
Chapters 2 to 5 can be read independently and are reproductions of the publications 
listed in the next page. Only minor alterations were made relative to the published 
version, with the purpose of standardizing text with the other contents of the thesis. 
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AW – Adjusted Wallace coefficient 
CC – clonal complex1 
CDC – Centers for Disease Control and Prevention 
CI – confidence interval 
CLSI – Clinical and Laboratory Standards Institute 
DLV – double-locus-variant1 
FCT – fibronectin-binding, collagen-binding and T antigen 
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GAS – Lancefield group A streptococcus, Streptococcus pyogenes 
GBS – Lancefield group B streptococcus, Streptococcus agalactiae 
GCGS – beta-hemolytic, large-colony-forming (diameter, >0.5 mm) Lancefield group C 
and group G streptococci
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GCS – Lancefield group C streptococci 
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MLST – multilocus sequence typing 
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RDP – Recombination Detection Program 
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  These terms are always used in the context of the multilocus sequence typing technique. 
2
 The designation GCGS used in the current work refers exclusively to large-colony-forming species. 
Some authors use the GCGS acronym in a broader sense which also includes the small-colony-forming 
(diameter, <0.5 mm) species belonging to the “Streptococcus milleri” or “Streptococcus anginosus” 
group. Although some beta-hemolytic “S. milleri” isolates can be found in the same ecologic niches of 
GCGS and may bear the Lancefield group C and G antigens, they constitute a genetically distinct group, 
differing from GCGS in the spectrum of clinical manifestations caused, in their pathogenicity and 
affecting different patient populations. 
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Chapter 1 – General Introduction 
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INTRODUCTORY NOTE 
Beta-hemolytic, large-colony-forming (diameter greater than 0.5 mm) Lancefield 
group C and group G streptococci (GCGS) is a group within the Streptococcus genus 
including several bacterial species which colonize and/or infect humans and animals. 
Since the original description of streptococci bearing these Lancefield groups by 
Rebecca Lancefield in the 1930’s, who found them infecting animals (1) and colonizing 
the vagina of parturient women (2), GCGS were thought to be essentially animal 
pathogens showing low pathogenicity towards the human host, in which they were 
present as part of the commensal microbiota (3). Moreover, the low numbers of human 
infections reported for GCGS, particularly when compared to other beta-hemolytic 
pathogens, such as Streptococcus pyogenes (Lancefield group A streptococcus [GAS]) 
or Streptococcus agalactiae (Lancefield group B streptococcus [GBS]), further 
strengthened that view and contributed to the fact that GCGS infections in humans 
would be overlooked in subsequent years. 
A trend of increasing detection of GCGS in human infections has been noted from 
the late 1970’s and 80's onwards in various locations around the world (3). Many of the 
reports published since then have described invasive infections by GCGS (4–7) and 
these microorganisms were implicated in triggering some of the most severe clinical 
syndromes caused by beta-hemolytic streptococci (8, 9). Occasionally, increased 
incidence of GCGS infection has been reported (10–12) and a few studies showed that 
the disease burden attributable to these bacteria could be similar or even higher than that 
of GAS or GBS (11–13). The characterization of the genome of GCGS undertaken in 
the last five years (14–16) confirmed their genetic similarity to other beta-hemolytic 
streptococci and further showed that these bacteria have a wide array of genes encoding 
factors that could mediate their virulence. Taken together, these observations led to the 
recognition of the pathogenic potential of these microorganisms towards humans, and 
highlighted the need for a better characterization of the GCGS strains causing infection 
in the human host. 
The speciation of GCGS was frequently neglected over the years. Although it was 
long recognized that the term GCGS included several groups that could be potentially 
distinguished by their phenotypic traits and host distribution (3), many of the available 
studies in the literature did not report isolate characteristics other than the Lancefield 
group. Nowadays, it is recognized that the distinct taxonomic entities included in the 
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group differ in their significance as human pathogens. A single taxon, Streptococcus 
dysgalactiae subsp. equisimilis (SDE), is found established in the human host, being the 
only GCGS for which colonization is currently recognized and the most frequently 
detected in infection in many parts of the world (17–19). Therefore, many authors refer 
to GCGS isolated from human specimens as SDE (20). The spectrum of infections 
caused by SDE is similar to that caused by GAS and both bacteria share many proteins 
that were shown to be virulence factors (6, 15, 20). However, a few other GCGS species 
may also be found in human infections, as is the case of Streptococcus equi subsp. 
zooepidemicus (5) and Streptococcus canis (21). These are primarily found as animal 
pathogens and they have been isolated from human infections less frequently than SDE. 
The current work focuses on the importance of GCGS for human infections and the 
literature review carried out in this chapter highlights the aspects of the biology of 
GCGS relevant for the pathogenesis in the human host. Thus, emphasis is given to SDE 
and to studies which unambiguously identify the isolates included. The comparison 
between SDE and the other GCGS species is made whenever there are differences that 
justify it. Particular attention is also given to S. canis, as it was the second most frequent 
GCGS species isolated in Portugal and part of the work is dedicated to it (Chapter 5). 
Many studies have focused on the pathogenesis of GCGS in animals, mainly regarding 
members of the S. equi taxon. Such contributions are not discussed since they are 
beyond the scope of this thesis, but may be referred to in relevant points. 
A few issues should also be noted on the possible limitations of the available GCGS 
literature. In addition to the studies indicating solely the Lancefield group of the 
isolates, many authors characterize Lancefield group C and group G strains 
independently and studies that focus on either one or the other are available. In the 
context of the human host, it is now clear that most GCGS are SDE and, for this 
species, there is no evidence supporting a separation between strains bearing Lancefield 
group C and G antigens based on their clinical relevance. Thus, reports focusing solely 
on group C or group G SDE strains are included and no separate analysis is made. 
Finally, in a significant number of studies it is unclear whether the authors discriminate 
between GCGS and the small-colony-forming “Streptococcus milleri” strains, which 
can be relevant in particular ecologic niches where the two groups coexist (as is the case 
of the human oropharynx). The aspects mentioned above limit the value of some 
studies, since the relative importance of each GCGS species cannot be accurately 
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1. CLASSIFICATION OF GCGS 
1.1. Morphologic and general characteristics 
As members of the Streptococcus genus, GCGS are facultative anaerobic and 
catalase negative Gram-positive cocci, with spherical or ovoid cells less than 2 μm in 
diameter that display chains upon Gram staining (22). The guanine-cytosine content of 
GCGS species is within the range of 39 to 42%, as evaluated by the currently available 
genomes (http://www.ncbi.nlm.nih.gov/genome). GCGS are nutritionally fastidious 
bacteria and their growth in enriched media is enhanced by the addition of blood or 
serum (22). GCGS have been traditionally classified based on a set of phenotypic 
characteristics, including the morphology and size of the colonies, the type of hemolysis 
and the serologic specificity of the cell wall Lancefield group carbohydrate, which 
determines the classification of streptococcal isolates in this group. 
The use of the hemolytic activity to classify streptococci started in the beginning of 
the twentieth century and is credited to Schottmüller (23). Almost all GCGS strains are 
beta-hemolytic, i.e. the colonies formed after growth in solid medium containing blood 
are surrounded by a zone of complete erythrocyte lysis due to the action of an exotoxin 
(24)  (Fig. 1.1). Thus, GCGS are members of the beta-hemolytic or pyogenic group 
(23), which includes major human pathogens such as GAS and GBS to which GCGS 
are genetically related (25, 26). Some GCGS strains present variable hemolytic activity, 
since they can be alpha-hemolytic (partial hemolysis, due to reduction of the 
hemoglobin in erythrocytes which originates a green colored halo) or gamma-hemolytic 
(absence of hemolysis) (Fig. 1.1). Such features are described for members of the taxon 
Streptococcus dysgalactiae (27, 28) but are not exclusive of GCGS as occasional non-
hemolytic isolates from other beta-hemolytic streptococci have been reported (29). 
Most beta-hemolytic streptococci can be further classified serologically into distinct 
Lancefield groups, according to the precipitin reaction scheme proposed by Rebecca 
Lancefield in 1933 (1). Although Hitchcock was the first to describe the presence of a 
soluble specific substance on the cell wall of these streptococci (30), only after the work 
of Rebecca Lancefield was the polysaccharidic and group-specific nature of this 
substance unveiled, which was named carbohydrate C (1). The major constituents of 
carbohydrate C were identified as rhamnose and one amino sugar (31). Changes in 
content of this last component originate differences in the antigenic specificity between 
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FIGURE 1.1. Colony morphology and hemolytic reaction of  
Lancefield group C and G bearing strains 
Colonies formed after growth for 24 hours at 37ºC in tryptic soy agar supplemented with 5% (vol/vol) defibrinated 
sheep blood. (A) Large-colony-forming (>0.5mm) SDE isolate displaying beta-hemolysis; (B) Large-colony-forming 
gamma-hemolytic (no hemolysis) Streptococcus dysgalactiae subsp. dysgalactiae isolate; (C) Large-colony-forming 
alfa-hemolytic S. dysgalactiae subsp. dysgalactiae isolate; (D) Small-colony-forming (<0.5mm) “S. milleri” isolate 
displaying beta-hemolysis. 
The Lancefield grouping scheme was a critical contribution to the classification of 
beta-hemolytic streptococci and has been widely used over the years (23, 25). Although 
this technique has been particularly useful in identifying both GAS and GBS in the 
clinical microbiology laboratory, its utilization has some drawbacks which negatively 
influence the classification of GCGS. It is now recognized that GCGS strains related at 
the species or subspecies level may have different Lancefield antigens. The most 
notorious example is found in SDE for which isolates bearing Lancefield group G, C, L 
and A antigens are known (32, 33). Moreover, distinct species may bear the Lancefield 
group C or G antigens (25), including certain members of the unrelated “S. milleri” 
group, which are distinguishable from GCGS by the formation of minute colonies after 
growth on solid media for 24 hours at 35 to 37ºC (22) (Fig. 1.1). 
Contemporaneously with the Lancefield grouping scheme development, it was noted 




tests (23). The attempted sub-grouping of GCGS into individual species was 
subsequently based on their serological properties, biochemical testing results and host 
distribution (3). The GCGS classification obtained by combining these data changed 
over the years and distinct epithets were used to name the defined groups. More 
recently, the application of genotypic methods allowed the taxonomy of the group to be 
clarified (25). 
1.2. Species delineation and host distribution 
GCGS is a phenotypic and genotypically diverse group comprising several 
taxonomic entities which have evolved in different hosts. In some situations, this has 
lead to a niche separation which correlates with the taxonomic divisions accepted at the 
present time. Seven distinct taxa, including four species, are currently defined (Table 
1.1). Further division into subspecies resulted from the genotypic analysis which 
justified their inclusion under the same epithet (27, 34). GCGS speciation is important 
because the individual taxa differ in their pathogenic characteristics, may cause distinct 
infections in the same host, present different infection transmission routes and their 
prevalence in human infection differs markedly. 
Table 1.1 shows the current taxonomic status of GCGS and summarizes key aspects 
such as host distribution, ecologic behaviour and spectrum of infections caused by the 
individual taxa. While some GCGS behave as host restricted pathogens, others can be 
regarded as generalists having the ability to infect a wide range of distinct animal 
species, including humans. The occurrence in human infection is well established for 
SDE, S. equi subsp. zooepidemicus and S. canis (25), though their prevalence is quite 
different. These three taxa display a broad host range and can be found as either 
colonizers and/or pathogens of many domestic and wild animals (33–35). SDE is by far 
the most frequent in human infection (17–19) and the only one for which human 
colonization is recognized (25). Another contrasting feature of SDE is that isolates 
recovered from human and non-human sources can be distinguished by both phenotypic 
and genotypic tests (27, 33), a separation not observed for the other two species. S. equi 
subsp. zooepidemicus and S. canis are mainly animal pathogens but their occurrence in 
human infection is well documented (5, 36). For the other GCGS listed in Table 1.1, 
infection of the human host is negligible, as very few confirmed cases of human 
infection have been published (37–40),   the description of poorly characterized  isolates 
  
 

















S. dysgalactiae subsp. equisimilis A, C, G, L Human Both SSTI, bacteremia, pharyngitis, STSS 
  Animal (various) Both Pneumonia, septicemia, arthritis, uterine infections 
 
S. dysgalactiae subsp. dysgalactiae C Animal (cow, fish) Pathogen Bovine mastitis, fish septicemia 
 
S. canis G Animal (various) Both Dermatitis, otitis externa, pneumonia, infective 
endocarditis, bacteremia 
  Human Pathogen Bacteremia, SSTI 
 
S. equi subsp. zooepidemicus C Animal (various) Both Septicemia, pneumonia, arthritis, uterine infections 
  Human Pathogen Bacteremia, meningitis, nephritis, arthritis, STSS 
 
S. equi subsp. equi C Animal (horse) Pathogen Equine strangles 
 
S. equi subsp. ruminatorum C Animal (various) Pathogen Ovine/caprine mastitis, strangle-like disease in hyenas 
  Human Pathogen Bacteremia 
 
S. phocae C, F, G, none Animal (seals, fish) Pathogen Systemic infections 
a The taxon S. dysgalactiae subsp. dysgalactiae is not beta-hemolytic (presents gamma or alpha hemolysis). The inclusion in GCGS is justified by the genetic proximity with 
other species of the group.  
b Isolates from a given species are divided in lanes human/animal to differentiate their role in colonization and infection according to host. For species other than SDE, this 
separation does not imply that they actually represent distinct populations. 
c   Refers to the main role. Classification as “pathogen” indicates that role as colonizer or reservoir has not been clearly identified or is restricted to a specific ecological niche. 
d  SSTI – skin and soft tissue infections; STSS – streptococcal toxic shock syndrome. 
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questions their true identity or, as is the case of Streptococcus phocae, have not yet been 
reported. 
1.2.1. Streptococcus dysgalactiae subsp. equisimilis (SDE) 
The GCGS strains currently included in the S. dysgalactiae taxon were long divided 
into groups according to their host distribution and phenotypic characteristics (27, 33). 
At least five groups were recognized over the years, which have been reclassified under 
the S. dysgalactiae epithet following the genetic evidence for the inclusion in a single 
species of the non-hemolytic group C S. dysgalactiae strains of bovine origin and the 
beta-hemolytic strains of Lancefield groups C (S. equisimilis), G and L (34) (Table 1.2). 
TABLE 1.2. Subspecies division of S. dysgalactiae strains 
Former S. dysgalactiae groups
a
 




Vandamme et al.,  
1996 (27)  









S. dysgalactiae  
subsp. dysgalactiae 
Animal beta-hemolytic group L strains 
 
 
S. dysgalactiae  
subsp. equisimilis 
Animal beta-hemolytic group C (S. equisimilis) 
 
 
Human beta-hemolytic group C (S. equisimilis) 
 
S. dysgalactiae  
subsp. equisimilis  
 
Human beta-hemolytic group G     
a Both terms S. dysgalactiae and S. equisimilis were used in the past. Group L strains have been more frequently 
isolated from animals than from humans and cannot be distinguished from each other, thus being assigned as animal 
strains. 
b Dashed lines indicate the separation point according with the two distinct subspecies proposals. 
c The subspecies division proposed by Vieira et al. is the most commonly accepted and is the one adopted in this 
thesis. 
The two subspecies currently defined for S. dysgalactiae were initially established in 
1996 by Vandamme et al. (27). Based on whole-cell protein analysis and physiological 
tests, these authors proposed that all strains isolated from humans should constitute the 
subspecies equisimilis, while S. dysgalactiae subsp. dysgalactiae would accommodate 
all strains of animal origin, regardless of the hemolytic activity displayed. However, a 
study conducted two years later by Vieira et al. (33), based on DNA-DNA hybridization 
and multilocus enzyme electrophoresis data, showed that the alpha-hemolytic group C 
strains of bovine origin were a group distinct of all the others and restricted the S. 
dysgalactiae subsp. dysgalactiae taxon to these strains. Thus, these authors proposed 
SDE to include all the beta-hemolytic strains, from both humans and animals. This 
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segregation by hemolytic reaction but not by host became the most accepted (25). 
However, the disagreement in the two original studies on the taxonomic position of the 
animal beta-hemolytic strains and some inconsistencies observed in the 16S rRNA 
analysis of those strains (41), has led different authors to classify them in distinct 
manner and at the present time this classification is still a matter of debate (42). 
In view of the current taxonomic status, SDE still encompasses a phenotypically 
diverse set of strains, which may be differentiated by their Lancefield group 
carbohydrates, biochemical characteristics and by host specificity. Most SDE isolates 
recovered from human specimens present the Lancefield group G antigen, followed by 
group C, while Lancefield’s groups L and A are seldom found (17, 43). The occurrence 
of this last group carbohydrate in SDE strains is of particular significance given their 
potential erroneous identification as GAS. The first SDE strain bearing the Lancefield 
group A antigen was identified in 1997 (32), and group A SDE have been isolated and 
characterized in a few other studies (43, 44). A study from Japan pointed to the 
dissemination of a single clone in the country (44), a likely indication that this antigen 
may be restricted to a single or only a few SDE genetic lineages. 
SDE is also found as a colonizer and pathogen in a wide variety of animal hosts, 
including house pets (such as dogs and cats), domesticated cattle (pigs, sheep, cows, 
horses, chicken) and as an opportunistic pathogen in many other wild species (27, 41, 
45). SDE strains isolated from animals are predominantly of Lancefield groups C and L. 
While group C strains were shown to possess unique phenotypic and genotypic 
characteristics, allowing their separation from human SDE isolates expressing this 
Lancefield group, group L strains have been reported to be indistinguishable 
independently of the host they have been isolated from (33, 46). 
The other species of the S. dysgalactiae taxon, S. dysgalactiae subsp. dysgalactiae, is 
the only non-hemolytic species included among GCGS (25). This taxon now includes 
alpha- or gamma-hemolytic Lancefield group C strains commonly associated with 
bovine mastitis and also isolated from the vagina of cows (33), a similar description to 
the one made by Garvie et al. in 1983 for S. dysgalactiae (47). Over the years, the term 
S. dysgalactiae was occasionally used to designate Lancefield group C strains isolated 
from animals other than cows (47, 48) and some authors described cases of human 
infection by S. dysgalactiae subsp. dysgalactiae  (49, 50). However, such reports do not 
give an accurate description of the microbiological characteristics of the isolates which 
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could unambiguously identify them as S. dysgalactiae subsp. dysgalactiae, especially 
when the taxonomic issues described above are considered. At present there is no data 
that consistently supports a role for this species as an agent of infection in humans or 
other animals, and it is arguable that it might behave as a host restricted pathogen of 
cows. 
In recent years, non-hemolytic Lancefield group C S. dysgalactiae strains were 
identified infecting several species of cultured fish in Japan and other Asian countries 
(51, 52), and a case of a woman who developed cellulitis and bacteremia after being 
stung while cleaning raw fish has been reported from Singapure (38). As suggested by 
the absence of hemolytic activity and the analysis of the manganese-dependent 
superoxide dismutase (sodA) gene (53), these isolates seem to belong to the S. 
dysgalactiae subsp. dysgalactiae taxon. However, they present unique genotypic 
features that distinguish them from the S. dysgalactiae subsp. dysgalactiae type strain 
isolated from bovine mastitis and other S. dysgalactiae strains isolated from mammals 
(51). More recently, beta-hemolytic isolates were detected in farmed fish from Brazil 
(54), making the exact phylogenetic position of these strains still unclear at the moment. 
1.2.2. Streptococcus canis 
The term Streptococcus canis was used in veterinary clinical microbiology long 
before the formal establishment of the species by Devriese et al. in 1986 (35). 
According to these authors, S. canis should include the Lancefield group G strains 
found causing bovine mastitis and distinct infections in dogs which were biochemically 
distinguishable from human Lancefield group G streptococci (SDE) (35). S. canis is not 
only part of the microbiota of cats and dogs (55, 56) but also an important pathogen for 
these two species and other domestic and wild animals (35, 57). S. canis causes from 
relatively mild non-invasive infections, such as dermatitis and otitis externa, to severe 
invasive infections (58–60). S. canis may be transmitted between different animal 
species living in proximity, as shown by its involvement in outbreaks of clinical and 
subclinical mastitis with bacterial shedding in milk in cattle herds (61) and in pets living 
in shelters (59). 
The first confirmed report of human infection by S. canis was published in 1997 and 
described a case of septicemia in a 77-year-old man (62). An increasing number of 
reports has subsequently identified this species mainly from cases of bacteremia (17, 21, 
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63) and skin and soft tissue infections (36, 64). The presence of S. canis in human 
infection is thought to have a zoonotic origin, and in most of the reported cases direct 
contact with colonized or infected animals was proposed (62, 64). Many studies failed 
to detect S. canis among GCGS causing human infections (11, 12, 65–67), while others 
found it at low frequency (17, 68). A single study reported increased incidence of this 
pathogen among GCGS causing both invasive and non-invasive infections in a hospital 
in France (36), raising the possibility of increased importance of this pathogen in certain 
geographic regions. In contrast to SDE, little is known of the relationships between S. 
canis strains isolated from distinct hosts and of the characteristics of this population. 
The publication of the first S. canis whole-genome sequence showed the close 
evolutionary relationship to both SDE and GAS, bacteria which share with S. canis 
many of the genetic determinants that are thought to contribute to the colonization of 
distinct niches, invasion of specific tissues and evasion of the host immune system (14, 
26). 
1.2.3. Other GCGS species 
Lancefield group C strains found in human infection that do not belong to SDE are 
part of the Streptococcus equi taxon. The name S. equi was first used in the late 19
th
 
century (69), to refer to diplococci causing respiratory infection in horses. Currently, it 
includes three distinct subspecies which are found as animal pathogens: S. equi subsp. 
zooepidemicus (34), S. equi subsp. equi and the recently described S. equi subsp. 
ruminatorum (70). While S. equi subsp. equi is a strict horse pathogen the other two 
infect a broader range of hosts which also includes humans. 
S. equi subsp. zooepidemicus is a equine commensal which may opportunistically 
cause infections, mainly in the respiratory tract (71). Infections caused by this bacterial 
species in other animal species, both domestic and wild (72–74), are often severe and 
include meningitis (74) or hemorrhagic pneumonia (75). In the human host, S. equi 
subsp. zooepidemicus has been isolated from bacteremia and endocarditis (5, 76), 
meningitis (77), streptococcal toxic shock syndrome (STSS) (78, 79) and nephritis 
outbreaks (80, 81). This is the second GCGS species for which more cases of human 
infection have been reported (5, 77, 81). 
S. equi subsp. equi is long known to be the etiological agent of equine strangles, a 
highly contagious disease that affects the upper respiratory tract of horses and is 
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characterized by the formation of abscesses in the lymph nodes of the head and neck 
(82). Although some horses can become carriers of the bacteria in their guttural pouch 
after the acute phase of the disease, the colonization seems to be restricted to this 
anatomical region and it is not associated with infections other than strangles. Another 
contrasting feature to S. equi subsp. zooepidemicus is the host range since it has not 
been found in other animals. Thus, S. equi subsp. equi is regarded as a highly adapted 
pathogen of the equine respiratory tract and it is not considered an agent of human 
infection (25), from which it has been very rarely isolated (4, 37). Genetic analysis of S. 
equi subsp. equi isolates suggests that this bacterium is a clone which evolved from S. 
equi subsp. zooepidemicus to become a horse specific pathogen (83). 
The third subspecies of S. equi, S. equi subsp. ruminatorum, was only described in 
2004, from ovine and caprine mastitis in Spain (70), and subsequently recognized in 
hyenas, zebras and wild dogs in Africa (84, 85). Soon after its description, two 
independent cases of invasive human infection were published (39, 86). The reservoir 
for this bacterium is still unknown since the niches it may occupy as a colonizer were 
not identified. Although the literature is still scarce for S. equi subsp. ruminatorum, the 
apparent distribution by host species seems to indicate that this species may be more 
similar to S. equi subsp. zooepidemicus than to the restricted host tropism presented by 
S. equi subsp. equi. 
A very limited number of studies have focused on S. phocae, a bacterium first 
described by Skaar and colleagues in 1994, as an opportunistic pathogen of seals with a 
viral infection (87). S. phocae has been later detected infecting several marine mammals 
(88, 89) and aquaculture salmon in Chile (90). The original study identified strains 
bearing antigens of Lancefield groups C, F or non-groupable, but subsequent studies 
reported the occurrence of the Lancefield group G antigen in this species (89, 91). No 
case of human infection by S. phocae has been reported so far. From the currently 
available literature on S. phocae it should be noted that although S. phocae isolates 
present biochemical traits that should allow their distinction from other GCGS species 
(87), the absence of biochemical profiles specific for this species in databases of 
currently used identification systems hamper its correct identification. The application 
of 16S rRNA gene sequencing is the most frequently used method for this species 
identification (89–91). Thus, infection by this agent may pass unrecognized unless 
molecular characterization is used.  
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1.3. Laboratory identification 
The most commonly reported procedure for identification of a beta-hemolytic 
streptococcal isolate as belonging to the GCGS group involves Lancefield group 
determination, in laboratories performing this serological technique, or identification by 
means of biochemical testing. However, according to the available literature, in cases of 
beta-hemolytic pathogens other than GAS and GBS, additional characterization of 
GCGS isolates, including species level identification and antimicrobial susceptibility 
testing, may be relatively uncommon (17). The serological identification of these 
Lancefield groups will imply in first instance the confirmation of a large-colony-
forming phenotype. In addition to colony size, the Voges-Proskauer test (acetoin 
production) will allow the differentiation of GCGS from the small-colony-forming “S. 
milleri” strains bearing identical Lancefield groups (25), as only the members of the 
latter give a positive reaction in this test. 
Most of the GCGS taxa can be distinguished by biochemical testing, including the 
identification of the subspecies defined for S. dysgalactiae and S. equi (82). Among the 
carbohydrate fermentation tests allowing species identification, the fermentation of 
trehalose and sorbitol (22) identify Lancefield group C strains as SDE, S. equi subsp. 
zooepidemicus or S. equi subsp. equi (25). On the other hand, the isolation of Lancefield 
group G streptococci from a human specimen requires the distinction between SDE and 
S. canis, which can be achieved by the positive reactions of beta-glucoronidase activity 
and acid production from trehalose for the former, and alfa- and beta-galactosidase 
activity for the latter (21). SDE isolates which bear the Lancefield group A antigen can 
be distinguished from GAS by testing pyrrolidonyl arylamidase (or aminopeptidase) 
activity, since only GAS produces this enzyme (19, 21). Some commercial kits have 
also proved to be useful in identifying GCGS species, namely SDE (65). However, the 
phenotypic tests described above not always allow the accurate identification of all taxa 
currently included in the group. 
Other methods have also been applied, including matrix-assisted laser desorption 
ionization-time of flight mass spectrometry (MALDI-TOF MS), which is being 
increasedly used in the clinical microbiology laboratory as it provides fast, accurate and 
cost-effective bacterial identification (92). Few studies have evaluated the capacity of 
this technique, based on the protein composition of microbial cells, to specifically 
categorize individual GCGS species. Although one report applying this technique to 
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beta-hemolytic streptococci showed that species level identification of S. dysgalactiae 
may be accomplished (92), another one, which used 16S rRNA gene sequencing as the 
gold standard, reported the misidentification of a SDE isolate (93). Thus, genotypic 
methods may be the only way to warrant exact identification in many instances. 
 
FIGURE 1.2. Neighbor-joining tree of the 16S rRNA gene of GCGS  
and other beta-hemolytic species 
Branches clustering sequences with greater that 75% bootstrap support (1,000 replicates) are indicated. The tree is 
drawn to scale, with branch lengths corresponding to the number of base substitutions per site. The species name and 
strain identification are indicated. GenBank entries whose sequences were used to construct the tree are shown in 
brackets. Small-colony-forming “S. milleri” species which may also possess Lancefield group C or G antigens are 
also included. “T” denote type strain. 
Several molecular approaches have been employed for the differentiation of GCGS, 
but only a few were aimed at the routine laboratory identification, while others were 
directed towards veterinary microbiology (94). A few studies had a special focus on 
assays allowing the distinction between SDE and GAS (95, 96). Among the sequence 
based methods developed for streptococci and applied in GCGS speciation, several 
distinct genes were targeted (21, 41, 42, 53). Among these, sequence analysis of the 16S 
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taxonomic status of the genus (25) since it allows the distinction of all the currently 
defined GCGS species (Fig. 1.2), and it has been the most used method by workers in 
the field (65). 
Disagreements were frequently seen among phylogenies derived from distinct genes 
(41, 42, 97). For example, 16S rRNA gene analysis places S. canis as the closest relative 
of GAS (as observed in Fig. 1.2), while analysis based on other housekeeping genes 
shows a closer relationship between SDE and GAS (97). Multilocus analysis and full 
genome sequence data have confirmed a close relationship for the three taxa (26, 42), 




2. GCGS ECOLOGY AND EPIDEMIOLOGY IN THE HUMAN HOST 
The recognition of SDE as part of the human microbiota and the diversity of clinical 
conditions for which this species is believed to be responsible, makes SDE the most 
relevant GCGS species in the context of the human host. Although some older literature 
has limited information on GCGS species identification, more recent studies focusing 
on the clinical and epidemiologic features of SDE infections produced similar 
conclusions, confirming previous observations and supporting a major role of this 
species in the earlier studies. 
2.1. Ecological niches and origin of infection 
The occurrence of GCGS in human specimens is known since the original 
description of Lancefield groups C and G bearing strains by Rebecca Lancefield (2). 
Sites associated with colonization by these organisms include the nasopharynx, the skin, 
the gastrointestinal and the female genitourinary tracts (2, 98, 99). Although there is a 
limited number of reports on GCGS carriage in the human host and many did not 
identify the species, it is generally accepted that SDE is the only GCGS that can 
consistently colonize humans (100). 
Most of the available studies on human GCGS colonization have focused on the 
pharynx. SDE asymptomatic carriage rates of 2 to 3% have been reported in both 
children and young adults (98, 101–103). Throat colonization rates have been noted to 
change over time (101) and others have shown they may be much higher in certain 
human populations (104–106). A study with school children from India found a SDE 
colonization rate of almost 10% (106), and in the aboriginal communities of Northern 
Australia this value may go up to 20% (104, 105). 
The origin of the infection has been poorly studied in SDE. Taking into consideration 
the presence in the human microbiota and the potential separation of human and animal 
strains within this taxon (33), the most likely source of infection is endogenous. This 
idea is reinforced by the fact that SDE infections often occur in the skin and upper 
respiratory tract (19), suggesting that colonization of these areas may have a role in the 
origin of infection. For example, the presence of these bacteria in toe webs (107) or anal 
colonization (99) was suggested as reservoirs for erysipelas and cellulitis of the lower 
limbs. SDE is likely present in the intact skin before the onset of infection and 
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cutaneous infections, mainly those involving deeper layers of the skin (e.g. cellulitis), 
may allow SDE to access the bloodstream and cause invasive infections (7, 108). 
Indeed, studies characterizing SDE bacteremia have repeatedly implied the skin as the 
primary focus (following not only cellulitis, but also wounds, ulcerations and 
intravenous drug use) (4, 12, 17, 109). The origin of infection may also be localized to 
the upper respiratory tract (in neutropenic patients and those with pneumonia), and the 
genitourinary tract (in women during the peripartum period) (4, 68). 
A person-to-person route of transmission has also been demonstrated for SDE. In a 
case-control study conducted in Finland (67), SDE was more frequently isolated from 
household members of patients with cellulitis. Molecular typing identified the same 
SDE strain in the pharynx of patients and members of their household. References can 
also be found in older literature to healthcare-associated infections associated with both 
person-to-person transmission and transmission from contaminated environmental 
sources, with SDE being implicated in outbreaks of skin infections and puerperal sepsis 
(110) and in post-operative wound infections (111). Less frequently, food borne 
community outbreaks of pharyngitis attributable to SDE have been detected (110), 
although this route of transmission is more common for S. equi subsp. zooepidemicus 
(see below). 
The phenotypic and genotypic separation between SDE strains isolated from humans 
and animals (46) could be interpreted to suggest that zoonotic transmission is not 
frequent in this taxon. However, no separation between group L strains isolated from 
human and non-human sources is apparent (33) and a recent report identified the same 
SDE strain in a child and a dog (112). These observations show that cross-species 
transmission can occur and question whether animal SDE strains are transmitted to 
humans, as observed for other GCGS species. It should be noted that infections by such 
strains may pass essentially unrecognized as neither the genotypic characteristics of 
such isolates are firmly established, nor is the intra-specific characterization of SDE 
isolates that could allow such discrimination to be made usually performed. 
The other GCGS species are not recognized as agents of colonization in humans. 
Nevertheless, S. equi subsp. zooepidemicus has been identified in throat swabs of farm 
workers with no clinical signs of infection at farms experiencing outbreaks caused by 
this pathogen, and also in convalescent patients several months after the original 
infection (80). No such evidence have been found for any other of the GCGS species 
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that are present in animals, but one study detected an unusual high number of S. canis 
isolates in non-invasive human specimens suggested the occurrence of human 
colonization by this agent (36). Thus, it is conceivable that transient colonization by S. 
equi subsp. zooepidemicus and S. canis may occur in people contacting frequently with 
animals. 
Human infection by GCGS species other than SDE, as is the case of S. canis, S. equi 
subsp. zooepidemicus, and more recently, S. equi subsp. ruminatorum, is thought to 
originate from contact with animals or with their products. For these three species, cases 
of direct transmission through pre-existing skin lesions, such as patients’ wounds and 
ulcers, or direct inoculation by bites or scratches, were considered the most likely portal 
of entry (63, 113, 64, 114, 86). A couple of studies employed typing methods to 
definitively determine the zoonotic origin of the infection in these patients. One report 
identified the same S. canis strain in a dog and its owner’s blood cultures following a 
bite (63), and another one showed the transmission of a S. equi subsp. zooepidemicus 
strain from a dog to a handler (115). Only S. equi subsp. zooepidemicus infection has 
been associated with the consumption of unpasteurized milk products, resulting in 
outbreaks of bacteremia (116) and glomerulonephritis (81). The presence of this 
bacterium in milk is related to its role as an agent of mastitis in cows and other cattle 
(80, 117). Although other GCGS species may cause mastitis in animals with bacterial 
shedding in milk (47, 61, 70), such a route of infection has not been established.  
2.2. Infections 
GCGS have been associated with a multitude of infections in humans, ranging from 
mild to life-threatening conditions. Most commonly, infections occur in the skin and in 
the upper respiratory tract (3, 19) The spectrum of infections caused by this species 
closely resembles that caused by GAS, and includes numerous skin and soft tissue 
infections (67), pharyngitis (98), ocular infections (118), bacteremia (119), endocarditis 
(120), septic arthritis (121), pneumonia (122), meningitis (110), necrotizing fasciitis 
(123) and streptococcal toxic shock syndrome (STSS) (124). S. canis has been mostly 
isolated from skin and soft tissue infections and associated bacteremia (21, 36), while S. 
equi subsp. zooepidemicus infections are often severe, including septicemia (125), 
endocarditis (76), septic arthritis (126) and meningitis (77), sometimes with the 
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formation of brain abscesses (113). This bacterium has also been associated with STSS 
(78, 79) and with several outbreaks of acute glomerulonephritis (80, 81). 
Skin and soft tissue infections are usually the most common SDE clinical 
manifestation and may range from wound infections (111), impetigo (104), erysipelas 
(127), and cellulitis (67), to severe conditions such as necrotizing fasciitis (123). Milder 
forms of skin and soft tissue infections and cellulitis occur predominantly in the lower 
limbs (7), and disruption of the cutaneous barrier may serve as site of entry. Recurrence 
has been noted for cellulitis (67). 
SDE has been frequently identified from throat swabs (106, 128, 129), but its role as 
an etiological agent of pharyngitis has been questioned. Factors that may explain this 
include the fact that SDE may be present in a significant proportion in the throat of 
healthy people (98), identification issues related to the differentiation from “S. milleri” 
strains (130) and potential differences in importance in patients of distinct age groups 
(102). Studies conducted in young adults in the United States showed that patients from 
whom SDE was isolated in throat swabs had clinical features compatible with pyogenic 
infection (129) and a statistic association between SDE and the presence of symptoms 
compatible with pharyngitis in a similar population has been reported (131). However, 
other studies failed to detect such association in the pediatric population (102, 103, 
106). A study from Norway concluded that although patients with GAS tonsillitis are 
younger, patients with GCGS tonsillitis present the same clinical picture and that SDE 
should be considered as throat pathogen (132). Pharyngitis epidemics caused by SDE 
have long been recognized and to affect people of all age groups (110, 133). Outbreaks 
due to S. equi subsp. zooepidemicus after consumption of contaminated milk products 
have also been recognized (80). In the case of the latter species, these are normally 
followed by more severe clinical manifestations (5, 81). 
Most of the published literature on GCGS infections report invasive infections (4, 11, 
65, 108, 120, 124). In the last ten years, numerous studies described SDE bacteremia 
episodes, providing some form of epidemiologic characterization of the isolates and 
clinical features of the patients. The most common clinical manifestations associated 
with SDE bacteremia included primary bacteremia, septicemia, cellulitis, endocarditis, 
septic arthritis, osteomyelitis, pneumonia, meningitis, necrotizing fasciitis and STSS 
(12, 17, 68, 122). Disruption of the cutaneous barrier is common in patients with SDE 
bacteremia (11, 12) and bacteremia secondary to cellulitis is a common finding (7, 65, 
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108). Those studies also identified many underlying diseases among patients and noted 
a frequent recurrence of bacteremia (7, 32, 68, 119). S. equi subsp. zooepidemicus has 
also been identified from bacteremia (5) and endocarditis (76), while S. canis has been 
isolated mostly from sporadic bacteremic episodes (62, 63). 
The first description of STSS caused by a Lancefield group G strain was in 1996 (9), 
and since then, many other reports have confirmed SDE involvement in this severe 
syndrome (17, 78, 124, 134, 135), for which mortality rates of nearly 50% have been 
reported (136). As noted for SDE bacteremia, STSS patients commonly have underlying 
diseases (136). S. equi subsp. zooepidemicus has also been identified in cases of human 
STSS (78, 79). S. canis has not yet been associated with either necrotizing fasciitis or 
STSS in humans, although it does cause infections with similar features in house pets 
(58). 
GCGS have also been associated with the occurrence of non-suppurative syndromes 
typically associated with GAS. Definitive epidemiologic evidence for S. equi subsp. 
zooepidemicus in triggering glomerulonephritis has been obtained. Duca et al. (80) 
described the first outbreak of sore throat followed by acute glomerulonephritis caused 
by this species in Romania in 1969, due to the consumption of contaminated milk from 
cows with mastitis (80), and subsequent studies implied this organism in 
glomerulonephritis outbreaks, always associated with consumption of raw milk products 
(81). The hypothesis that Lancefield group G streptococci could also trigger this disease 
has been proposed almost thirty years ago (101), but very few cases have been reported 
(110). 
GCGS were also proposed to trigger acute rheumatic fever and rheumatic heart 
disease in certain human populations experiencing simultaneously high incidence of 
these diseases and high rates of GCGS pharyngeal carriage (105, 106). These diseases, 
believed to result from an autoimmune response subsequent to an upper respiratory tract 
infection by GAS (137), are very frequent in the Aboriginal population from northern 
Australia, even though GAS is rarely isolated from either carriage or symptomatic 
infection at the pharynx (105). Hadean et al. showed that GCGS could elicit a immune 
response leading to acute rheumatic fever, as antibodies against GCGS isolates showed 
cross-reactivity with human heart myosin, which has been identified as a major cardiac 
antigen recognized by heart cross-reactive autoantibodies against GAS (105). Although 
later studies confirmed important throat carriages of SDE in these communities (138), 
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and others explored the possible role of the SDE M-like protein in triggering this 
syndrome (139), no definitive evidence has been generated so far for the role of SDE or 
other GCGS species in triggering these diseases. 
2.3. Clinical and epidemiologic features of GCGS infections 
SDE is clearly the GCGS species responsible for most cases of both invasive and 
non-invasive infections in the human host reported worldwide (17, 140–142). SDE has 
been frequently the only species found among Lancefield group G isolates causing 
human infection (12, 65), while S. canis generally accounts for at most only a small 
proportion of the isolates (17, 68). Similarly, SDE is the most commonly isolated 
species among Lancefield group C isolates (17, 19, 120), although some studies also 
report the presence of S. equi subsp. zooepidemicus (4, 5). A study from Hong Kong 
showed that this species was the most prevalent among Lancefield group C isolates 
causing bacteremia (5). In a ten-year study in Finland (12), the only S. equi subsp. 
zooepidemicus isolated could be related to an outbreak associated with consumption of 
unpasteurized cheese (116), showing that increased detection of this species in some of 
these studies may be due to specific epidemiologic situations.  
The disease burden attributable to GCGS is usually inferior to that caused by GAS 
and GBS in most geographic locations (7, 143), but SDE appears as the most prevalent 
beta-hemolytic pathogen after those two species (17). However, it has been noted that 
colonization rates and the number of cases of both non-invasive and invasive infections 
may occasionally exceed that of GAS and/or GBS. Throat colonization rates (104–106) 
and isolation from patients with clinical signs of pharyngitis (106, 144) exceeding that 
of GAS, were reported from India, Australia and the United States. In Finland, SDE was 
shown to be the main beta-hemolytic species causing erysipelas and cellulitis in 
hospitalized adults (67) and bacteremia in adult patients (12). 
For invasive infections, population-based studies have shown GCGS annual 
incidence rates of 2.24 per 100 000 population in Canada (145), a similar value in 
United States (17), and up to 4.3 per 100 000 in Finland (12). Mortality rates ranging 
from 15% (17, 65, 109) to 25% (4) have been reported for GCGS invasive infection, 
although in patients with STSS this value may be higher. Most of the published series 
report community acquired infection (65, 108, 122), but up to one third of the 
bacteremias may be related to hospital care (109). The incidence of GCGS bacteremia 
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was identical to that of GAS but lower than that of GBS in the United States (120), and 
has occasionally been reported to exceed that of GAS in Israel (11) or that of GBS in 
adult patients from Denmark (109). In Japan, where numerous reports of invasive 
infection by SDE have originated, including STSS (6, 78, 136), invasive infections by 
this species have increased gradually (6, 136) and SDE is now responsible for a disease 
burden superior to that of other beta-hemolytic species (122). Among the studies 
showing relevant incidence of SDE bacteremia, several pointed to an increasing trend 
over time. Such patterns were noted over the 1990’s in one hospital from Israel (11) or 
over a 10-year period in the Finish study cited above (12), for example. 
Despite the similarity in the spectrum of infections caused by SDE and GAS, 
differences in severity and in the clinical characteristics of the patients have been noted 
by some authors. Patients with SDE invasive infections were reported to be older and to 
have more co-morbidities than GAS patients (109, 122). Most of the patients with SDE 
invasive infections have underlying diseases, including malignancy, diabetes mellitus, 
cardiovascular disease, peripheral vascular disease, immunosupression, substance 
abuse, chronic renal failure, chronic wounds and immobilization (4, 11, 17, 65, 68, 119, 
146). Given that most patients are elderly and often present with multiple underlying 
conditions (4), immunosenescence has been proposed as the major risk factor for SDE 
invasive infection (108). Although this view highlights the opportunistic nature of SDE 
infections, this species has been shown to have the ability to cause severe invasive 
disease in previously healthy adults (123). The multiple examples of increased isolation 
rates of GCGS described above could reflect improved detection methods or an 
increased virulence of the bacteria. Given the importance of underlying conditions for 
the infection by these microorganisms, an expanding population of compromised hosts, 
more susceptible to infections by these agents, should also not be disregarded as a cause 
for their increasing importance in human infection. 
2.4. Virulence factors 
The pathogenic role of GCGS for their respective hosts is highlighted by the 
multitude of factors now known to be encoded in their genomes. These allow GCGS to 
specifically bind or degrade host components, enabling them to adhere and spread 
through cellular tissues and to evade the host immune system. A large body of 
information on the virulence factors carried by SDE has been provided by studies trying 
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to identify such factors in GCGS isolated from human infections, while studies focusing 
on the pathogenic properties of GCGS species of veterinary relevance also 
accomplished a good characterization for members of the S. equi group (71). 
The ability of GCGS to exert lytic activity on human fibrin was recognized shortly 
after the identification of GCGS (23), and subsequent studies showed that these bacteria 
could bind many human components (147, 148). Cloning and sequencing of the genes 
encoding the proteins responsible for these properties led to the identification of several 
potential virulence factors, as was the case of protein G, a surface molecule with 
immunoglobulin-binding properties (149). Another common approach was to look for 
factors linked previously to virulence in GAS, given the recognized similarity between 
the two species. Several homologs of GAS genes were identified in SDE, including the 
gene coding for the M protein (150), one of the most important virulence factors in GAS 
(137). More recently, microarray and genome analysis confirmed that many of the 
virulence factors present in both species are shared (15, 151). Whereas the extensive 
study of the mechanism of action of these factors was mostly undertaken in GAS, recent 
studies in SDE and other GCGS species confirmed their contribution for the 
pathogenesis of these microorganisms and, in some instances, revealed unique features 
of the GCGS counterparts. Differences in the presence of particular loci, in the allelic 
sequences of universally distributed genes or differential gene regulation, can all be 
assumed as mechanisms justifying the differences in virulence observed between GCGS 
and GAS. 
Two types of virulence factors have deserved special attention over the years, 
following their recognized importance in GAS pathogenesis: M protein and 
superantigens (streptococcal pyrogenic exotoxins). In the case of the M protein, not only 
is a similar protein encoded in SDE genomes, but a number of M-like proteins (i.e. 
proteins presenting similar structure but that may be encoded in distinct loci)
3
 have been 
detected in other GCGS species (152, 153). Functional characterization conducted in 
those GCGS species pointed for the importance of M and M-like proteins in their 
virulence in distinct hosts. In contrast, limited evidence supports the contribution of 
                                                 
3
 The term “M-like proteins” refers to proteins presenting a similar structure to the archetypal M protein 
encoded by the gene emm in GAS. In GAS, a number of M-like proteins are encoded in distinct loci 
which are referred to as emm-like genes. Similar proteins are also found erratically distributed in GCGS 
species and are often referred to as M-like proteins, although the exact genomic localization of these 
genes has not been determined in many instances. 
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superantigens for SDE virulence in the human host, despite the high number of studies 
looking for GAS genes in this species. 
2.4.1. M and M-like proteins 
The GAS M protein is the archetypal of a group of structurally similar cell-associated 
proteins with antiphagocytic or immunoglobulin binding properties (154). Its fibrillar 
coiled-coil structure is thought to be essential for the multifunctional character which is 
known to effectively contribute to invasiveness by mediating resistance to phagocytosis, 
cell adherence and internalization of GAS strains (137, 154). Following the 
observations that these bacteria resisted to phagocytosis in vitro, reacted with serum 
antibodies raised against the GAS M protein and had fimbriae like structures at the cell 
surface, as shown by electronic microscopy (155, 156), the presence of a protein similar 
to the GAS M protein was confirmed by biochemical and genetic studies (150, 157). 
The M protein is encoded by the emm gene, which is present in virtually all GAS and 
SDE isolates. Thus, the emm genes of these two species are regarded as orthologs (i.e. 
they evolved from a common ancestral gene) and share structural features, such as 
substantial polymorphisms at their 5′ end (157). This portion of the gene determines the 
serological specificity of the M protein and is targeted by the emm typing technique 
widely used in the epidemiologic characterization of both species (158). SDE and GAS 
M proteins have similar structures, both presenting conserved C-terminal and 
hypervariable N-terminal parts (150, 159) (Fig. 1.3a). Two major classes of M proteins, 
I and II, have been proposed in GAS based on the epitopes within the C-repeat region 
located adjacent to the carboxy-terminal side of the pepsin cleavage site (154), and the 
SDE M protein was shown to have high sequence similarity to GAS class I M proteins 
in this region (150). The SDE M protein was shown to bind fibrinogen (via its N-
terminal part), human serum albumin (via the C-repeats), IgG, IgA and plasminogen, 
and to present cross reactivity to keratin and to a joint cartilage protein (160, 161). 
A few detailed studies were conducted in the last years characterizing the biologic 
properties of a SDE M protein  (161, 166–169).4  These studies  proposed the  M protein 
                                                 
4
 The name FOG has been proposed by the authors for the studied protein. Primers used targeted the 
flanking regions of the emm gene described in other studies and, although not clearly stated by the 
authors, there is no evidence that a locus distinct of the emm gene encoding the M protein in the SDE 
genome is being targeted. 






FIGURE 1.3. M protein structure and genomic environment of the emm locus in SDE 
(A) Comparison of SDE and GAS M proteins. The depicted SDE M protein structure is the one reported for protein 
FOG, corresponding to a emm type stG11 isolate (161), and was adapted from this reference. A to D domains are 
indicated in the schematic representation of this M protein. M proteins in SDE isolates containing one to five C-
repeats have been described (162). Numbers refer to amino acid residue positions, where 1 is the first residue of the 
mature molecule. The figure of the GAS M protein was adapted from reference (163). The SDE and GAS M protein 
representations are shown in the corresponding relative positions. 
(B) Genomic location of the emm locus in SDE. Two types of multigene regulator-like regions have been described 
for SDE, which differ by the presence or not of the cpdB gene (164, 165). The following genes are indicated: nrd – 
ribonucleotide reductase, mgc – multigene regulator-like, emm – M protein, cpdB – 2’3’ cyclo-nucleotide 2’-
phosphodiesterase , rel – protein that functions in the synthesis and degradation of guanosine 3’,5’ bipyrophosphate 
(ppGpp),  skc – streptokinase, ABC – ABC transporter, dexB – alpha-glucosidase-like protein, ORF1 and lrp – 
proteins of unknown function. Reproduction from reference (164). 
would mediate survival and multiplication in whole blood, contribute to evasion of the 
immune system by forming complexes with fibrinogen causing neutrophil aggregation 
(161) and to promote adhesion to host tissue by binding to collagen I (168). They also 
showed unique features of the M protein in face of the host innate immune responses 
compared to protein G even if both proteins interact with the same human components 
(166, 169). In a distinct line of investigation, the interaction of the M protein with 
collagen has also been explored to infer the potential of SDE strains to trigger acute 
rheumatic fever due to collagen autoimmunity (139). Taken together, the currently 
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available data on the SDE M protein strongly suggests that it plays an important part in 
the pathogenesis of SDE. 
The genomic context of the emm gene in SDE is distinct of GAS. In the latter 
species, the emm gene is located within a contiguous pathogenicity island referred as the 
mga or vir regulon (170), where other virulence-related genes are encoded, including 
emm-like genes (such as mrp and enn) or the gene encoding the C5a peptidase. All these 
genes are coordinately regulated by a positive multigene regulator encoded by the mga 
gene, located upstream of the emm gene (170). In SDE, an mga-like gene (called mgc in 
SDE) is also found upstream of the emm gene, presenting around 61% sequence 
similarity to GAS mga (164) (Fig. 1.3b). Whether the product of the mgc gene functions 
as a regulator in SDE is unknown. In clear contrast to GAS, neither emm-like genes nor 
the C5a peptidase gene are present in this location, but downstream of the emm gene in 
SDE is the region encoding the streptokinase, another important virulence factor (164). 
Recent genome analysis of GAS, SDE and also S. dysgalactiae subsp. dysgalactiae, 
mapped an ancient pathogenicity island including the emm region and extending for up 
to 47-kb in all GAS genomes (171), whereas in both S. dysgalactiae subspecies most of 
the genes are instead present in subsets dispersed throughout the genome (172). 
A number of M-like proteins have been described from other GCGS species. 
Although in S. dysgalactiae subsp. dysgalactiae emm-like and mga-like genes are found 
physically associated (152), suggesting that the same locus is present in both GAS and 
SDE, no such evidence has been reported for other GCGS. However, these species do 
possess proteins that have functional and structural features of the M protein family. M-
like proteins have been described for the three subspecies of S. equi (85, 153). These 
proteins differ from each other in terms of both sequence and function (153) and have 
higher similarity to M-like proteins which are encoded in loci other than the emm locus 
in GAS genomes. More recently, a M-like protein was also described in S. canis (173), 
which was shown to mediate the binding of human plasminogen and fibrinolytic activity 
(174), and full genome analysis of a representative of this species confirmed the 
presence of several emm-like genes (14). 
2.4.2. Superantigens 
GAS pyrogenic exotoxins act as superantigens and are thought to contribute to STSS 
caused by this species (163). The association of most of these genes with phages in 
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GAS, which could potentiate their horizontal transfer, and the implication of SDE in 
numerous cases of STSS, prompted the idea that such genes could also be present in the 
latter species. However, studies specifically looking for these genetic determinants in 
STSS SDE isolates were unable to detect any other than the speG gene that is not phage 
associated (78, 136). 
Some SDE isolates possess an ortholog of the GAS speG gene in their genome (175) 
and this seems to be almost the only one present in SDE. Studies which looked for the 
speG gene in SDE human isolates in distinct geographic locations detected it in variable 
proportions. For example, speG was detected in 43% of  the isolates causing STSS and 
necrotizing fasciitis in Japan (136) and in 58% of invasive and non-invasive isolates in a 
recent study from Israel (176). Data has been accumulating that speG is not expressed in 
SDE (177), probably due to mutations in the promoter region (178), while another 
superantigen chromosomal gene in GAS, smeZ, appears to have been lost from the SDE 
genome during evolution (178). One study conducted in Norway identified a non-
invasive SDE isolate that carried speC, speG, speH, speI and smeZ (140). These genes 
presented identical or near identical sequences to their GAS counterparts, as well as to 
speH and speI found in S. equi subsp. equi (140), suggesting that this SDE isolate may 
have acquired by horizontal gene transfer those genes which are phage-associated in 
both GAS and S. equi subsp. equi (163, 179). 
Given the currently available data, it is unlikely that superantigens play a significant 
role in the pathogenesis of SDE infection in humans, but the same does not hold true for 
GCGS isolated from animal infections. A study characterizing the allelic variants of the 
SpeG protein among strains of S. dysgalactiae indicated that these may be associated 
with differences in mitogenic activity and that SpeG may be relevant in animal rather 
than human infections (180). This view is also supported by the growing number of 
superantigen genes detected in GCGS species associated with animal infection, 
including those which have counterparts in GAS, as found in S. dysgalactiae subsp. 
dysgalactiae (181) and S. equi subsp. equi (179), or novel superantigen genes, as those 
recently described in the S. equi subsp. zooepidemicus genome (182). By opposition, no 
exotoxin genes were detected in the published S. canis genome (14), although a S. canis 
human isolate carrying a new allele of the smeZ gene was reported in the past (183). A 
bacteriophage-encoded mitogen was also detected in dog isolates of this bacterium, but 
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its genetic determinant was not related to any of the streptococcal pyrogenic exotoxin 
genes (184). 
2.4.3. Other factors 
The number of putative virulence factors detected in SDE has been increasing over 
the years. Many were recognized for a long time and include cell-surface associated 
proteins, such as the C5a peptidase (185), the fibronectin-binding protein Fnb (186) or 
the plasmin(ogen)-binding protein GapC (187), and a number of extracellular proteins, 
including streptokinase (188), streptolysins O and S (24) and streptodornase (189). Well 
known GAS regulatory systems are also present in SDE, as is the case of the two-
component signal transduction systems covRS and fasCAX (190), indicating that 
common mechanisms could mediate the virulence of both species. Regardless of the 
number of virulence factors that SDE shares with GAS, a few that are believed to be 
critical for GAS virulence are not conserved in SDE. In addition to the differences in 
superantigen gene content, as discussed above, SDE lacks the gene encoding the 
cysteine protease SpeB, and some reports have shown that the full hasABC operon 
required for the biosynthesis of the hyaluronic capsule is not conserved among SDE 
strains (15). 
FCT-like regions (for fibronectin-binding, collagen-binding and T antigen) have 
been recently identified in the SDE genome (15). These are known to encode pilus-like 
structures in GAS (191). The SDE FCT-like regions are similar to those previously 
identified in GAS, GBS and S. equi subsp. zooepidemicus, and include transcriptional 
regulators and a number of genes which seem structurally organized in operons (15). 
Together with old observation of the presence of T antigens in SDE isolates (192), these 
data strongly suggests that SDE expresses pilus-like structures, although their 
distribution in the SDE population remains unknown. 
A limited number of potential virulence factors were identified in S. canis prior to the 
whole-genome characterization of an isolate belonging to this species. The presence of 
proteins similar to the streptolysin O and M proteins of GAS in dog isolates was 
suggested in the past (58), but definitive evidence for the presence of M-like proteins in 
S. canis was published only recently (173, 174). The recently available genomic data 
indicates that this species also shares a number of virulence factors with GAS, SDE and 
Chapter 1 – General Introduction 
31 
other streptococcal species (14), including streptolysins O and S. A gene for CAMP 
factor, characteristic of GBS strains, is also found in the S. canis genome (14). 
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3. ANTIMICROBIAL SUSCEPTIBILITY AND TREATMENT 
The antimicrobial susceptibility patterns of GCGS species are similar to those 
reported for the generality of beta-hemolytic streptococcal species. SDE and other 
GCGS remain consistently susceptible to penicillin and other beta-lactam agents, and 
penicillin is a first choice antibiotic for the treatment of infection by these bacteria (3, 
20). The addition of an aminoglycoside to penicillin has long been advocated for the 
treatment of serious GCGS infections, to avoid delayed or poor responses due to 
treatment with penicillin (193). The combination of penicillin with an aminoglycoside 
or a cephalosporin has been frequently used in the treatment of bacteremia by GCGS 
(4). Macrolides and lincosamides are appropriate alternatives to penicillin in the 
treatment of GCGS infections (20, 194), particularly in cases of patients which are 
allergic to the latter agent. In Portugal, where only parenteric penicillin is available, the 
oral route of administration of macrolides and lincosamides is an additional advantage. 
As observed for beta-lactams, GCGS isolates resistant to antimicrobial agents such as 
the glycopeptides, linezolide and quinupristin-dalfopristin have not been recognized 
(195). 
A few reports have described GCGS isolates displaying in vitro antimicrobial 
tolerance to both penicillin (193, 196) and vancomycin (197). This phenomenon was 
defined for isolates presenting low minimum inhibitory concentration but an 
incremented (often by more than 100 times) minimum bactericidal concentration (198). 
More recently, a report studying SDE from both Europe and United States described 
isolates with increased minimum inhibitory concentration to penicillin (up to 0.25 
µg/mL) (199). Although it has been suggested that these observations could be related 
to treatment failures and SDE have been implicated in such cases (200, 201), the 
significance of these observations is unclear and seems to have limited expression. 
The resistance patterns detected so far in GCGS are similar to those reported for 
other beta-hemolytic streptococci. Resistance to tetracyclines (202), followed by 
resistance to macrolides and lincosamides (203), and less frequently to aminoglycosides 
(204) or fluoroquinolones (199), have been described. The available studies 
demonstrated that most of the resistance determinants are shared with other 
streptococci, possible a result of the association of resistance genes to some of these 
antimicrobial classes with mobile genetic elements that can promote their transfer 
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between distinct species. Examples include macrolide (205, 206), tetracycline (207, 
208) and aminoglycoside (204) resistance determinants. Specific gene variants may also 
be present, as observed for macrolide resistant SDE isolates (209, 210). 
The use of macrolides and lincosamides in the treatment of infections caused by 
GCGS and other beta-hemolytic streptococci has been compromised by substantial rates 
of resistance found in the group (211, 212). Members of these two antimicrobial classes 
as well as streptogramin B, have identical mechanisms of action, by inhibiting protein 
synthesis by binding to the 50S ribosomal subunit (205). The overlapping binding sites 
on the ribosome imply that resistance to these antibiotics also arises in a similar way 
(205). Resistance to macrolides and lincosamides in GCGS is conferred essentially by 
identical mechanisms to those found in other beta-hemolytic streptococci. Both erm 
genes, encoding methylases which modify the binding site of these antibiotics in the 
ribosome and confer broad-spectrum resistance to macrolides, lincosamides and 
streptogramin B (MLSB) antibiotics, and mef genes, encoding a pump which promotes 
the active efflux of the antibiotic, were detected in SDE (203, 206, 209, 210, 213). The 
prevailing mechanisms of resistance differed between studies (209, 210) and resistance 
rates to erythromycin in SDE have ranged from values below 10% (203, 209) up to 26% 
(141) in European countries and almost 30% in invasive isolates from the United States 
(17). Such variations are not unexpected, as it is known that the prevalence of the 
distinct macrolide resistance mechanisms can change both geographically and 
temporally within streptococcal species (212). 
High resistance rates to tetracycline (30 to 40% and higher) were previously reported 
in GCGS isolates from several geographic locations (135, 141, 199), in line with the 
wide dissemination of tetracycline resistance determinants in many Gram positive 
bacteria (208). Tetracyclines inhibit protein synthesis by binding reversibly to the 30S 
ribosomal subunit and blocking the binding of the tRNA, and resistance to these agents 
arises upon acquisition of tet genes (208). At least three distinct genes encoding 
ribosomal protection proteins, tet(M), tet(O) and tet(S), and the tet(L) gene encoding an 
efflux pump were previously detected in SDE (141, 202, 207). 
Aminoglycosides are another antimicrobial class interfering with protein synthesis by 
binding to the 30S ribosomal subunit (214). Although streptococci are intrinsically 
resistant to low concentrations of aminoglycosides (214), high-level resistance to these 
antimicrobial agents has been found to be confined to a few GCGS isolates (135). A 
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study by Galimand et al. (204), which characterized the genetic element responsible for 
high-level resistance to aminoglycosides in a group G human isolate, showed that it 
resulted from a recombination event between two widespread transposons found in 
staphylococci carrying the genetic determinants for three distinct aminoglycoside 
modifying enzymes. 
Fluoroquinolones are not first-line options in the treatment of GCGS and other beta-
hemolytic streptococci, but these agents retain excellent activity against these bacteria  
(199). Fluoroquinolones act by inhibiting the bacterial DNA gyrase and DNA 
topoisomerase IV (215). Alteration of the target enzymes is the more widespread 
mechanism of resistance in streptococci and confers high-level resistance to these 
antibiotics (215). Resistance rates not exceeding 1% have been reported in SDE isolates 
from the United States (17, 199) and Japan (122), but the potential emergence of 
resistance to fluoroquinolones in streptococci is a cause of concern. Non-susceptibility 
to this antimicrobial class has been reported to be increasing in GAS isolates from 
Belgium (216) and horizontal transfer events involving S. dysgalactiae have been 
proposed to contribute to the emergence of fluoroquinolone resistant-GAS (217). 
  
Chapter 1 – General Introduction 
35 
4. TYPING METHODOLOGIES 
The use of typing methods to determine the clonal relationships between distinct 
bacterial isolates enables the spread of defined clones and the population dynamics of 
bacteria to be studied. The information generated can therefore be used to derive 
hypothesis related to taxonomy, ecology and the study of pathogenesis (218). A 
practical example of these aspects is obtained by looking at how the distinct typing 
methodologies were used to characterize GCGS strains over the years. Both phenotypic 
and genotypic methods were essential to recognize the several GCGS populations which 
were ultimately allocated to distinct species. 
4.1. Phenotypic methods 
Phenotypic testing, i.e. to discriminate between isolates according to observable 
traits, has long been used to characterize GCGS. In addition to the hallmark of these 
methods, the Lancefield serologic technique (2), the epidemiologic characterization of 
GCGS strains involved biochemical testing (100), antimicrobial typing (197), 
serotyping (192), and also phage and bacteriocin typing (3). Biochemical testing, 
comprising both individual tests and commercially available panels (including 
enzymatic and sugar fermentation tests), was probably the most used (33). 
In the particular case of SDE, the intraspecific characterization of human strains was 
also achieved by employing the serological technique known as T typing, which is 
widely used in GAS epidemiology (137). This method was applied to SDE in the 
studies conducted by Efstratiou et al. in the United Kingdom during the 1980’s (110, 
192, 219). T typing was used to follow healthcare-associated outbreaks by this 
bacterium and it was shown that more than 80% of the SDE isolates could be typed with 
this scheme, with minimal overlap with GAS T types (110). Although a few more 
examples exist in the GCGS literature reporting the use of this technique, its application 
did not stand to the present and is now in disuse. 
Phenotypic typing methods are often insufficient for achieving the desirable degree 
of differentiation between individual isolates. Although a premise for these methods is 
that a phenotype results and accurately reflects a given genotype, this is not always the 
case, and genetic exchange may blur the evolutionary history suggested by a particular 
phenotype (218). These aspects, as well as reproducibility issues, make these methods 
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generally unsuitable for comprehensive studies of bacterial population structure and 
dynamics (218, 220). 
The multilocus enzyme electrophoresis technique constitutes an exception within 
phenotypic methods, as it presents a performance similar to many genotypic methods. It 
measures the different electrophoretic mobility of a set of proteins to indirectly detect 
the allelic variation of the genes that encode those proteins (220), and it can be 
considered the precursor of the multilocus sequence typing (MLST) technique. 
Multilocus enzyme electrophoresis was used in the past as a reference method for 
defining the phylogenetic structure of clonal lineages in bacterial populations (218). In 
the specific case of GCGS, it was useful in characterizing the subspecies level divisions 
recognized nowadays for some of the members of the group (33, 83), including the 
current taxonomic status of SDE. 
4.2. Genotypic methods 
Genotyping allows the variation in the genomes of bacterial isolates to be assessed 
with respect to their composition, overall structure, or specific nucleotide sequences 
(218). Among the genotypic methods used over the years to type GCGS strains are 
included those based on the electrophoretic separation of DNA fragments, as is the case 
of the pulsed-field gel electrophoresis (PFGE) technique (46, 63), and those relying on 
the sequence analysis of one or more genes (97, 157). While the first are more adequate 
for short-term epidemiology, such as the follow-up of the increasing prevalence of a 
strain during an outbreak, some of the latter have the advantage of providing 
information on long-term evolutionary changes (220). 
4.2.1. Pulsed-field gel electrophoresis (PFGE) 
Although several methods of DNA profiling analysis were employed in the past to 
characterize GCGS, PFGE was the most widely used (46, 58, 63, 115, 124). This 
technique has a higher discriminatory power than many other methods (221), and it was 
shown to be more discriminative than other techniques for typing beta-hemolytic 
streptococci, including GCGS (222). Differentiation of human and animal strains of S. 
dysgalactiae is also accomplished by PFGE (46). 
The PFGE technique involves the embedment of bacterial cells in agarose plugs, 
followed by cellular lysis in situ, therefore maintaining DNA integrity. The enzymatic 
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hydrolysis of the total DNA is then carried out with endonucleases that cleave 
infrequently in the genome. The agarose plugs containing the DNA are then inserted 
into the wells of an agarose gel. In contrast to conventional electrophoresis, higher 
voltages and a pattern of electric pulses in which the direction of current is switched are 
applied, allowing the separation of the large DNA fragments. The end result of this 
electrophoresis is the production of a profile pattern for each isolate. The PFGE profiles 
of the isolates are then compared with each other to evaluate their relatedness (221) 
(Fig. 1.4). 
 
                                                           
FIGURE 1.4. Illustration of the PFGE technique 
(A) Schematic representation of the PFGE procedure. (B) PFGE profiles generated after SmaI digestion of total DNA 
from SDE isolates. The first and last lanes correspond to the lambda ladder PFGE marker (New England Biolabs, 
Beverly, MA). 
The methods used to compare the PFGE profiles of each isolate have critical 
importance in the ability of the technique to ascertain relatedness. Guidelines for the 
visual interpretation of DNA patterns were proposed in 1995 by Tenover et al. (223). 
However, these criteria were proposed to be used with a small set of isolates, in the 
context of healthcare-associated outbreaks of limited duration (223). Visual comparison 
is not practical for studies comprising large populations of microorganisms collected 
over extended periods of time. In these cases, computer assisted analysis is useful. 
Embed bacterial cells in 
agarose plug 





PFGE profiles comparison  
A. B. 
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Commercially available software can be used to construct a dendrogram, i.e., a binary 
tree illustrating a cluster analysis performed on a number of isolates for a given typing 
data, based on pairwise comparisons among the isolates and depicting possible 
relationships between them (218). 
The observable changes in PFGE patterns of related strains occur by random genetic 
events, including point mutations, insertions and deletions of DNA (223). PFGE 
analysis is not directed towards a specific region of the genome, but screens multiple 
loci, including uncharacterized regions that might accumulate increased variation in the 
bacterial population. Therefore, this technique allows detecting the microvariation that 
is generated in bacterial populations that circulate in a given geographic area and is 
especially useful in monitoring outbreaks. 
4.2.2. emm typing 
The emm typing technique was developed for the epidemiologic characterization of 
GAS isolates (158), to replace the successful use of the surface exposed M protein for 
serological typing of this species. A portion of the emm gene is sequenced, including the 
5’ region encoding the N-terminus of the mature protein, which determines the 
serological specificity. As observed for GAS, the emm locus is universally present in the 
SDE genome, as an emm gene can be amplified from virtually all SDE isolates analyzed 
(7, 17), and the emm alleles found in SDE also show polymorphisms at their 5’ end 
(157). Thus, emm typing was successfully extended to the latter species. Distinct emm 
types are found in the two species (66, 135), although some common emm types have 
been occasionally detected (162). 
The emm typing technique has become the most widely used typing scheme for the 
characterization of SDE isolates recovered in distinct parts of the world (7, 17, 106, 119, 
140, 165). Characterization of SDE isolates recovered from both invasive and non-
invasive infections showed the presence of multiple emm types (7, 106, 135), allowing 
SDE strains to be differentiated according to this marker. Over seventy distinct emm 
types are currently recognized for GCGS isolates, the vast majority corresponding to 
SDE emm types (http://www.cdc.gov/ncidod/biotech/strep/strepblast.htm). A few emm 
types have been reported from S. canis, but most of the isolates are PCR negative in the 
conventional emm typing scheme, limiting the usefulness of the technique to this 
bacterium. emm typing is not used to type other GCGS species, since no emm gene will 
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be amplified from their genome. In S. equi isolates, distinct M-like proteins were 
proposed as epidemiologic markers (224, 225). 
The utilization of a typing method to compare groups of isolates presenting distinct 
virulence characteristics permits pathogenesis related markers to be identified (218). 
Given that the M protein is likely a major contributor to SDE virulence (as discussed 
above), the information obtained from emm typing may be clinically and 
epidemiologically relevant to ascertain differences in the virulence of SDE isolates, 
allowing particularly virulent strains or emerging clones to be detected. On the other 
hand, this technique might be inappropriate to infer evolutionary information. Since the 
emm gene encodes a surface exposed protein, this locus is likely evolving quickly due to 
the diversifying selection pressure that is exerted by the host immune response. Strains 
sharing a recent common ancestor might not be recognized as such, as the generation of 
variation may exceed the speed of spread (218). Moreover, results suggestive of 
recombination between SDE emm types have been detected (140), which may imply an 
additional loss of phylogenetic signal. 
4.2.3. Multilocus sequence typing (MLST) 
The MLST technique was developed in 1998 by Maiden et al. (226) and consists in 
sequencing internal fragments from a set of housekeeping genes, i.e. genes responsible 
for the maintenance of basic cellular functions. An allele number is arbitrarily assigned 
to the distinct nucleotide sequences obtained from each of the loci analyzed. By 
combining the allele numbers determined for a given isolate, an allelic profile is 
generated for each isolate which is named the MLST sequence type (ST) (Fig. 1.5). 
 
FIGURE 1.5. Illustration of the MLST technique 
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The allelic profile data is also used to establish the relationships between the distinct 
STs by grouping isolates that share the same alleles. By using clustering algorithms, 
such as eBURST (227) or goeBURST (228), isolates that share at least n -1 loci with 
each other are grouped together into clonal complexes (CCs). In the previous example, 
CCs are defined at the single-locus-variant (SLV) level, but analysis can also be 
conducted by considering more distantly related genotypes, such as double- and triple-
locus-variants (DLVs and TLVs, respectively). The putative group founder in these CCs 
is identified as the ST which differs from the highest number of other genotypes in the 
CC at only one locus, i.e., the ST with higher number of SLVs. 
A MLST scheme was initially proposed for SDE in 2003, by adaption from the pre-
existing scheme for GAS. However, this work could not be reproduced by other authors 
(44, 97), leading to the retraction of the original paper (229). Only in 2009 a novel 
MLST scheme for SDE was established (97). In the same work, this scheme was 
applied to the characterization of S. canis, although it was unsuccessful in typing all the 
isolates belonging to this species. A distinct MLST scheme is also available for the 
characterization of S. equi isolates (230). 
One of the advantages of MLST over many other typing methods is the unambiguous 
and portable nature of the generated data, which allows it to be easily transferred and 
compared between laboratories (226). Another major feature of the method is that 
MLST analysis may be more relevant for the study of population genetics and dynamics 
than other methods used for epidemiologic purposes (220). By relying on housekeeping 
genes, MLST targets variation in bacterial genomes which is slowly accumulating in the 
population and that is expected to be selectively neutral (226). MLST sequence data can 
also be used to estimate recombination and mutation rates (231), making it possible to 
infer the importance of each if these forces in the emergence of clonal lineages, and to 
assess how commonly bacterial genomes undergo horizontal gene transfer events. 
Because of the aforementioned aspects, MLST has been extensively applied to many 
different bacterial species, providing vital information concerning their diversification 
and evolution. 
4.2.4. Whole-genome sequencing 
Whole-genome sequence methods offer the opportunity to assess genetic differences 
among members of a bacterial species or between unrelated bacteria with an increased 
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sensitivity in relation to the typing techniques described above. In particular, next 
generation sequencing technologies, which generate complete or nearly complete 
genome sequences of a great number of isolates with decreasing costs and turnaround 
times (232), allow the characterization of nucleotide changes accumulating in the entire 
genome which would be otherwise undetectable. Therefore, these technologies may 
have a strong impact if applied to epidemiological typing (such as surveillance and 
outbreak investigation) and routine genotypic identification and antimicrobial 
susceptibility testing (233), but has also the potential of considerably improving our 
knowledge on the virulence and evolution of bacterial pathogens. 
Five SDE complete genome sequences are now available (January 2014), ranging 
from 2.08 to 2.18 Mb in size, while a single one has been released for S. canis 
(http://www.ncbi.nlm.nih.gov/genome). Among the five SDE genomes, including 
Lancefield group G (n = 3), C and A isolates, there is around a ninety percent overlap in 
sequence and most of the observable diversity within this set is due to the presence of 
prophages (234). 
The first SDE whole-genome analysis, published for a group G isolate recovered 
from a patient with STSS (15), not only showed that it shared many virulence factor 
genes with GAS but also indicated the existence of related prophages in both genomes. 
In addition to the comparative analysis of gene content among these and other 
streptococci (172, 234), later studies have also evaluated the contribution of replacing 
and additive horizontal gene transfer events between the two species (235), the 
distribution of distinct types of mobile genetic elements (14, 15), and reconstructed the 
evolutionary history of specific loci (178). The evolutionary picture arising from the 
growing number of genomes being published for GCGS species reveals that strains 
belonging to the S. dysgalactiae (15, 172) and S. canis (14) taxa are more closely 
related to GAS (based on both genome wide and gene level comparisons, in nucleotide 
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AIMS OF THE THESIS 
The increasing relevance of GCGS as agents of human infection contrasts with the 
limited knowledge on the population biology of these bacteria at the present. A rising 
number of reports are showing that these streptococci have genetic and clinical features 
analogous to some of the main pathogens of the genus, strengthening the view that 
GCGS may have a substantial pathogenic role in the human host. Even so, a limited 
number of studies have comprehensively focused in the epidemiology of human 
infections caused by GCGS, when compared to other species. In Portugal, as in many 
other geographic regions, there is no study assessing the clinical importance of this 
streptococcal group. Thus, the general purpose of this thesis was to obtain new insights 
into distinct aspects of the biology and epidemiology of GCGS infections in the human 
host, with particular emphasis on the characterization of the population clonal structure. 
Given that SDE was the most common GCGS species found causing human infections 
in Portugal, most of the work centered in this bacterium. 
Particular emphasis was put on the following aspects: 
• Evaluate the prevalence of the distinct GCGS species causing human infection in 
Portugal, allowing the comparison with other geographical areas and clarifying 
the significance of each species as human pathogens. 
• Perform the epidemiologic characterization of the isolates using molecular typing 
techniques such as PFGE, emm typing and MLST, in order to determine the 
clonal diversity and structure of GCGS populations. 
• Assess the congruence between the distinct typing techniques used, with the 
purpose of evaluating the ability of each of the methods for delineating GCGS 
lineages. 
• Compare the clonal relationships between invasive (i.e. recovered from normally 
sterile sites) and non-invasive SDE isolates, in order to identify genetic lineages 
with enhanced virulence. 
• Investigate the clonal relationship between SDE strains bearing Lancefield group 
C and G antigens. 
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• Develop a MLST protocol for SDE which allowed the clonal identity of PFGE 
and emm typing defined groups to be confirmed, as well as to produce a global 
view of the population structure of this pathogen. 
• Determine the antimicrobial susceptibility of GCGS isolates to antimicrobial 
agents with potential use in the treatment of GCGS infections, and evaluate the 
implications of the detected resistance to the therapy of GCGS infections. 
• Evaluate the molecular mechanisms of resistance to fluoroquinolones which 
could justify the high resistance rate to these agents identified in the current work 
for SDE isolates recovered in Portugal. 
• Estimate the extension of genetic recombination between SDE and GAS in the 
genes defining fluoroquinolone resistance and the contribution of such events to 
the development of resistance. 
• Extend the analysis of horizontal gene transfer events to the other loci analyzed 
in the current thesis, in order to evaluate how relevant such events could be in the 
evolution of GCGS. 
• Develop a fully applicable MLST scheme for S. canis, allowing the clonal 
structure of the population of this species to be defined. 
• Explore the zoonotic potential of distinct S. canis genetic lineages, by directly 
comparing isolates from different hosts. 
• Establish MLST databases for both SDE and S. canis, providing new tools for the 
molecular typing of these microorganisms and improving our understanding of 
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ABSTRACT 
Lancefield group G and group C streptococci (GGS and GCS, respectively) are 
pathogens responsible for a number of life-threatening infections. A collection of 116 
recent (1998 to 2004) invasive (n = 28) and noninvasive (n = 88) GGS and GCS clinical 
isolates from Portugal were characterized. All isolates were identified as Streptococcus 
dysgalactiae subsp. equisimilis (SDE) and characterized by emm typing and DNA 
macrorestriction profiling using pulsed-field gel electrophoresis (PFGE). emm typing 
revealed the presence of 22 distinct types, including 3 novel types. PFGE identified 14 
clones with more than two isolates, but over half of the isolates were concentrated in 3 
large clones. Individual clones and emm types showed a low level of association, since 
the majority of the clones included more than one emm type and the same emm type was 
found among diverse genetic backgrounds. Two emm types, stG2078 and stG10, were 
significantly more frequent among invasive isolates, and another two, stG6792 and 
stG166b, were present only in noninvasive isolates, suggesting a correlation between 
emm type and invasive disease potential. 
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INTRODUCTION 
Beta-hemolytic, large-colony-forming (diameter, >0.5 mm) Lancefield group G and 
group C streptococci (GGS and GCS, respectively) are increasingly recognized as 
important human pathogens (6, 16, 23), but the study of these infections has been 
hampered by the heterogeneity of the species presenting Lancefield group C and G 
polysaccharides. The taxonomic classification of both GGS and GCS is in a state of 
flux, but at least three species have been found in human infections: Streptococcus 
dysgalactiae subsp. equisimilis (SDE), Streptococcus equi subsp. zooepidemicus, and 
Streptococcus canis (12). Characterization of the isolates recovered from human 
infections to the species level is uncommon, and most of the available data consider 
GGS and GCS independently, with more information available on GGS bacteremia (6, 
27) and much less for GCS (5). Invasive GGS infections were mostly reported to be 
caused by SDE (6, 27). This species may also present group C polysaccharide, and such 
isolates have been recovered from human infections (26). However, few studies present 
species identification of GCS, and a study from Hong Kong reported that most group C 
beta-hemolytic streptococcal bacteremias are caused by S. equi subsp. zooepidemicus 
(28), while the contributions of the different species to GCS infections in other 
geographic locations remain mostly unknown. 
Although both GGS and GCS are part of the normal human microbiota (9), they have 
also been identified as causative agents of infections of the respiratory tract (29), 
infections of the skin and soft tissue, and life threatening infections such as endocarditis, 
bacteremia, and meningitis, frequently with a poor prognosis (3, 9). More recently, an 
increasing number of reports described the association with streptococcal syndromes 
typically caused by Streptococcus pyogenes (Lancefield group A streptococcus [GAS]), 
such as streptococcal toxic shock syndrome (STSS) (16, 19) and acute rheumatic fever 
(15). Despite differences in the disease burden attributable to each of these organisms, 
GGS, GCS, and GAS are closely related genetically and share several virulence factors 
(9, 12). Proteins similar to the M protein (encoded by the emm gene), a key virulence 
factor in GAS, have long been identified in GGS and GCS from human infections, and 
the emm genes of both species share structural features such as substantial 
polymorphisms at the 5′ end (21). The M protein contributes considerably to the 
invasive capacity of GAS by mediating the antiphagocytic, adherence, and 
internalization processes (7). For GAS, different emm genes have been suggested as 
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genotypic markers for tissue site preference (20), and a recent study reevaluated an 
older observation that isolates expressing certain M proteins were more frequently 
associated with invasive disease (11). It is therefore conceivable that the M protein also 
plays an important part in GGS and GCS pathogenesis, although its role remains largely 
unexplored and most of the work has concentrated on the presence of superantigens in 
these bacteria (16, 19). 
The M protein has also been used to differentiate strains, and the sequence-based 
typing scheme developed for GAS, relying on the hypervariable region of the emm 
gene,  was successfully applied to GGS and GCS   (http://www.cdc.gov/ncidod/biotech/ 
strep/strepindex.htm). Other molecular typing techniques, such as macrorestriction 
profiling using pulsed-field gel electrophoresis (PFGE), have also been used 
successfully with pyogenic streptococci, including GGS and GCS (2). 
The higher rate of isolation of these organisms in recent studies may be due to 
improved detection methods, an increase in virulence, or an expanding population of 
compromised hosts. In this study we have used emm typing and PFGE to characterize a 
collection of invasive (i.e., recovered from normally sterile sites) and noninvasive GGS 
and GCS isolated in Portugal during the years 1998 to 2004. The molecular 
characterization of these isolates allowed us to test whether PFGE-defined clones 
associate specifically with certain emm types and if there was a higher invasive disease 
potential of particular emm types and PFGE-defined clones. 
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MATERIALS AND METHODS 
Bacterial isolates 
A total of 116 beta-hemolytic, large-colony-forming (diameter, >0.5 mm) GGS and 
GCS isolates from clinical infections were collected from June 1998 to December 2004. 
The distribution of isolates over the study period was as follows: 5 in 1998, 14 in 1999, 
12 in 2000, 14 in 2001, 14 in 2002, 35 in 2003, and 22 in 2004. The Lancefield groups 
and sources of the isolates are given in Table 2.1. The strains were recovered in nine 
laboratories, located in Portugal, that were asked to submit all nonduplicate GGS and 
GCS isolates associated with human infections. 
TABLE 2.1. GGS and GCS isolates recovered from invasive and noninvasive 
infections during 1998 to 2004 in Portugal 
Source 
No. of isolates in Lancefield group:  Total no.  
of isolates C  G 
Blood  6 16 22 
Other normally sterile fluids
a
  1 5 6 
Pharyngeal exudate  8 18 26 
Sputum  2 9 11 
Skin and soft tissue  9 39 48 
Vaginal exudate  0 2 2 
Urine  0 1 1 
Total  26 90 116 
                        a Articular fluid (n = 2), peritoneal fluid (n = 2), or pleural fluid (n = 2). 
Species identification 
Strains were identified to the genus level by the submitting laboratory. Upon receipt, 
the Lancefield group was confirmed by a commercial latex agglutination technique, the 
Slidex Strepto-Kit (bioMérieux, Marcy-l'Etoile, France). All further studies were carried 
out at the Laboratory of Microbiology of the Lisbon School of Medicine. Beta-
hemolysis and colony size were confirmed in tryptic soy agar (Oxoid, Hampshire, 
England) supplemented with 5% (vol/vol) defibrinated sheep blood, after overnight 
incubation at 37°C. Further identification to the species level was done using the API 20 
Strep system (bioMérieux, Marcy-l'Etoile, France). Additionally, all the invasive 
isolates were subjected to 16S rRNA sequencing. Two generic primers for gram-
positive bacteria (24) were used to amplify and sequence a 1,419-bp fragment of the 
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16S rRNA coding region. Template DNA for the PCR was prepared according to the 
method   recommended for    emm typing       (http://www.cdc.gov/ncidod/biotech/strep/ 
protocols.htm). One microliter of DNA template lysate was added to the PCR mixture 
containing 1× PCR buffer (100 mM Tris-HCl, 500 mM KCl, pH 9, 0.1% gelatin, 1% 
[vol/vol] Triton X-100), 200 μM deoxynucleoside triphosphates (MBI Fermentas, 
Vilnius, Lithuania), 0.5 μM primers, 1.5 mM MgCl2, and 1 U of SUPER Tth DNA 
polymerase (HT Biotech, Cambridge, United Kingdom) in a final volume of 50 μl. PCR 
conditions for amplification were as follows: 35 cycles of 95°C for 1 min, 55°C for 1 
min, and 72°C for 2 min, and a final extension at 72°C for 10 min in a Biometra T 
gradient thermocycler (Goettingen, Germany). Amplification products were purified 
using a High Pure PCR product purification kit (Roche, Mannheim, Germany) and 
sequenced with the primers used for amplification. The sequences were compared to 
those deposited in the Ribosomal Database Project II (http://rdp.cme.msu.edu/) and 
GenBank. 
emm typing 
Isolates were emm typed by following the protocols and recommendations for GAS 
of the Centers for Disease Control and Prevention (CDC) 
(http://www.cdc.gov/ncidod/biotech/strep/protocols.htm). Briefly, emm genes from 
GGS and GCS were amplified with primer 1 and primer 2 and sequenced with 
emmseq2. The first 240 bases of sequence were used to query the CDC streptococcal 
emm sequence database (http://www.cdc.gov/ncidod/biotech/strep/strepindex.htm). 
When a type assignment was not obtained, the full sequence was used to query 
GenBank. An emm type was defined as ≥95% identical over the first 160 bases of 
sequence obtained with primer emmseq2 (1). Sequences that did not show an identity to 
previously described sequences sufficient for emm type assignment were submitted to 
Bernard Beall at the CDC and were assigned an emm type designation. 
PFGE macrorestriction profiling 
Agarose plugs of total DNA were prepared according to methods described 
elsewhere (13), with some modifications. Briefly, cells were embedded in agarose plugs 
and lysed with a solution containing 5 U/ml mutanolysin, 1 mg/ml lysozyme, and 30 
μg/ml RNase A (Sigma-Aldrich, Steinheim, Germany) for 5 h at 37°C and with 0.5 
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mg/ml proteinase K (Roche, Mannheim, Germany) for 17 h at 50°C. After digestion 
with SmaI (Fermentas, Vilnius, Lithuania), the fragments were resolved by PFGE as 
described previously (13). 
PFGE patterns were compared by using Bionumerics software (Applied Maths, Sint-
Martens-Latem, Belgium) to create dendrograms by the unweighted-pair group method 
with arithmetic means (UPGMA). The Dice similarity coefficient was used with 
optimization and position tolerance settings of 1.0 and 1.5, respectively. Clones were 
defined as groups of isolates (n ≥ 2) presenting profiles ≥80% related on the 
dendrogram, as previously described for Streptococcus pneumoniae (22). 
Estimation of the invasiveness of emm types and PFGE-defined clones 
In order to compare the probability of invasive disease due to individual emm types 
and clones, an empirical odds ratio (OR) and 95% confidence intervals (CI) (8) were 
calculated by reference to all other emm types and clones as previously described (4). 
The OR was calculated as (ad)/(bc), where a is the number of invasive A emm types or 
clones, b is the number of noninvasive A emm types or clones, c is the number of non-A 
emm types or clones, and d is the number of noninvasive non-A emm types or clones. It 
follows from the formula presented that it is not possible to calculate an OR when no 
isolates of a given emm type or clone were recovered from invasive infections. 
The choice of using all other emm types and clones to measure the reference OR was 
supported by prior studies (reference 4 and references therein) that also provide a 
discussion of the strong points of this method. The ORs calculated in this way will be 
comparable between studies, although the set of all other strains that is used to measure 
the reference OR will be different. In contrast, the alternative hypotheses, such as 
choosing an arbitrary emm type or clone or using the pooled minor emm types or clones 
as a reference, suffer from more-severe pitfalls. The choice of a particular emm type or 
clone will cause the ORs to change significantly depending on which emm type or clone 
is chosen and will prevent comparison of the ORs between studies when that particular 
emm type or clone is not found. The pooling of minor types suffers from similar 
limitations, and both alternatives reduce statistical efficiency relative to that obtained by 
using all other emm types or clones, justifying the use of all other emm types and clones 
to measure the reference OR. An OR of 1 indicates that the emm type or clone was 
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equally likely to be invasive or noninvasive, whereas an OR of >1 or <1 indicated an 




All 116 isolates were identified with the API 20 Strep system alone or together with 
16S rRNA gene sequencing and were shown to be SDE independently of their 
Lancefield group polysaccharide. All but five strains could be identified to the species 
level by using the API 20 Strep system with a confidence in the identification above 
95%, according to the manufacturer's literature. Each biochemical profile obtained with 
a confidence in the identification below 99% had a matching 16S rRNA gene sequence 
available, confirming the species identification. Only one isolate had an inconclusive 
identification with the API 20 Strep system (a group G blood isolate that fermented 
mannitol and sorbitol); however, the sequence of the 16S rRNA gene clearly identified 
it as SDE. Overall, 16 distinct biochemical profiles were obtained. Almost half of the 
strains (44%) fermented lactose, and 41% hydrolyzed esculin. Other tests for which 
results differed occasionally included pyrrolidone arylamidase and beta-galactosidase 
production. 
The sequence of the 16S rRNA gene was obtained for all 28 invasive isolates; they 
differed at only 1 base in a 1,419-bp fragment of the gene and were all 99.9% identical 
to SDE ATCC 35666 (GenBank accession number AB096755). 
emm type distribution and clonal relationships among isolates 
emm genes were successfully amplified and sequenced for all the 116 SDE isolates 
analyzed in our study. We found 22 distinct emm types (Table 2.2), including 3 with 
novel emm sequences: stGLP1, stGLP2, and stGLP3. Overall, the eight most prevalent 
emm types accounted for approximately 75% of the isolates (Table 2.2). Most emm 
types were found exclusively among either group G or group C isolates. Exceptions 
occurred with stC839 (nine group C isolates and one group G isolate) and stG485 (six 
group C and three group G isolates). 
Analysis of the PFGE patterns generated after digestion with SmaI revealed 14 
clones differing greatly in size (Fig. 2.1). Over half of the isolates were distributed in 
three large clones, D33, J19, and F16 (the subscript number in each clone designation is 
the number of isolates) (Table 2.2).  Clone D33 stands out, because it comprised almost 
one-third of the isolates analyzed. During the study period there were no clear trends 
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regarding the prevalences of the various emm types, and isolates representing the three 
major clones were recovered during all the years of the study and in most laboratories. 

















C G  D33 J19 F16 B7 G7 I6 Other
c
 Total  
stG10 0 16  7/9       7/9  2.9 (1.1-7.6) 
stG6792 0 14    0/9    0/5 0/14  NA 
stG6 0 12  1/0 0/5    0/2 1/3 2/10  NS 
stG480 0 10  0/3   0/3  0/1 1/2 1/9  NS 
stG2078 0 10  3/0 2/2    2/1  7/3  9.4 (2.2-41.2) 
stC839 9 1  0/1  0/2  1/6   1/9  NS 
stG485 6 3   2/4  1/0   1/1 4/5  NS 
stG166b 0 8  0/6      0/2 0/8  NA 
stG62647 4 0   1/2     0/1 1/3  NS 
stG643 0 4   1/0  0/1   1/1 2/2  NS 
stC36 3 0    2/0    0/1 2/1  NS 
stC6979 3 0        0/3 0/3  NA 
stC74a 0 2     0/2    0/2  NA 
stG245 0 2  0/1      1/0 1/1  NS 
stG652 0 2        0/2 0/2  NA 
Other 1 6  0/2  0/3    0/2 0/7  NA 
Total 26 90  11/22 6/13 2/14 1/6 1/6 2/4 5/23 28/88  NA 
a emm types are given in decreasing order of frequency. Other emm types with a single representative isolate included 
emm57, stG4974, stG5420, stCK401, stGLP1, stGLP2, and stGLP3. 
b PFGE clones were designated arbitrarily by capital letters and a subscript number indicating the number of isolates 
included in the clone. 
c PFGE clones with <5 isolates. stG6792 isolates were distributed among four distinct clones, stG480 and stC6979 
isolates among three, stG6, stG485, stG166b, and stG652 isolates among two, and stG643 isolates formed a single 
clone. Five noninvasive isolates (three group G and two group C isolates) had unique PFGE patterns (i.e., shared less 
than 80% similarity with any other isolate in the collection). 
d An OR of >1 indicates increased invasive disease potential. NS, not significant; NA, not applicable. 
Half of the clones included both group G and C isolates; however, the largest clone 
(D33) included no group C isolates, and more than half of GCS (n = 14) were 
concentrated in two clones – G7 and J19 – of which G7 included only GCS isolates. The 
majority of the clones included more than one emm type (Table 2.2). In D33 nine distinct 
emm types were found; however, stG10 (n = 16) and stG166b (n = 6) together 
accounted for two-thirds of the isolates. Only clone G7, already noted for including only 
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GCS isolates, was associated with a single emm type (stC839). Within clones, 
subgroups of the same emm type could be defined; still, there was no similarity cutoff 
that allowed the separation of all isolates presenting distinct emm types. 
 
FIGURE 2.1. PFGE SmaI macrorestriction profile analysis of GGS and GCS isolates 
from invasive and noninvasive infections. 
(A) Dendrogram showing UPGMA cluster analysis of the PFGE profiles of the 116 isolates studied. Dice coefficients 
(percentages) are indicated in the scale above the dendrogram. Each clone (defined as a group of ≥2 isolates with a 
Dice coefficient of ≥80%) is represented by a triangle proportional to the number of isolates included in the clone. 
Clones are designated by capital letters and a subscript number indicating the number of isolates included in the 
clone. (B) PFGE profiles of representatives of each clone. Capital letters above the lanes correspond to clone 
designations; m, lambda ladder PFGE marker (New England Biolabs, Beverly, MA). 
With the exception of stG10, all the emm types had representatives in more than one 
clone, although the majority of the isolates of each emm type were represented in a 
single clone. In contrast, stG480 and stG2078 were highly dispersed among distinct 
genetic backgrounds. 
Invasive isolates 
None of the clones identified was significantly associated with invasive infection. 
However, it is noteworthy that a significant number of invasive isolates (stG10 [n = 6] 
and stG2078 [n = 3]) were tightly clustered within clone D33 at a similarity of 97.5% in 
the dendrogram. 
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ORs calculated to evaluate the invasiveness of the various emm types are presented 
in Table 2.2. The emm types stG10 and stG2078 were significantly more associated 
with invasive disease. While all the stG10 isolates were present in a single clone, D33, 
stG2078 isolates were found to correspond to diverse genetic backgrounds (represented 
in three different clones). The emm types stG6792 (n= 14) and stG166b (n = 8), each 




This study aimed to characterize human infections caused by GGS and GCS. 
Identification to the species level revealed that all isolates were SDE independently of 
their Lancefield polysaccharide group. This finding is not unique, since this species has 
been shown to express both C and G polysaccharides (26) and a recent study of GGS 
and GCS pharyngitis in the United States identified SDE as the sole species (29), but it 
was in sharp contrast with the situation in Hong Kong. In this region, SDE was the only 
species associated with GGS (27) but S. equi subsp. zooepidemicus was the only species 
identified in GCS bacteremia (28). In the latter study, the same strains were found in 
pigs and humans, suggesting a zoonotic origin of the infections. The data presented here 
support a different epidemiology of invasive GCS infections in Portugal, possibly not 
involving animal exposure, similar to that proposed in a report from the United States 
(5). In spite of the high phenotypic heterogeneity observed, resulting in a diversity of 
profiles with the API 20 Strep system, all dubious identifications were confirmed using 
16S rRNA sequencing as the “gold standard,” substantiating previous suggestions of the 
usefulness of this system for species identification of GGS and GCS (26, 27). 
More than 150 emm types are currently recognized for GAS, and a smaller number 
were  found  exclusively  in  GGS  or  GCS    (http://www.cdc.gov/ncidod/biotech/strep/ 
strepindex.htm). We identified 22 distinct emm types, including 3 novel types, among 
the 116 isolates tested; however, none of the emm types identified had also been found 
in GAS, in spite of previous reports documenting the occurrence of typical GAS emm 
types among GGS (21). 
PFGE analysis revealed considerable genetic diversity among SDE isolates, 
indicating that there are several distinct clones causing human infection. Nevertheless, 
the prevalences of the different clones among this streptococcal population differed 
considerably, and three large clones accounted for over half of the isolates. Since none 
of the clones appeared to result from a specific outbreak, it is conceivable that some 
particular characteristics in the genomes of these strains are responsible for their 
predominance. 
Isolates bearing either C or G group antigen were not clearly separated from each 
other by PFGE, which is in agreement with the classification of these isolates into a 
single taxon and confirms previous data based on whole-cell protein profiles (25). An 
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interesting observation was that PFGE-defined clones did not include a single emm type 
but, in contrast to GAS (10), predominantly comprised isolates with distinct emm types. 
Many isolates with diverse emm types clustered with higher Dice coefficients than those 
presenting the same emm type, suggesting that it is unlikely that the observed clustering 
of isolates with distinct emm types is due to a lack of discriminatory power of PFGE. 
This observation supports previous suggestions of higher rates of genetic exchange 
among GGS and GCS than among GAS (18). The only exception to the heterogeneity 
of genetic backgrounds associated with each emm type was the most prevalent type in 
our study, stG10, which was found associated with the largest clone (D33) only. 
Numerous studies have identified a number of host factors, including malignancy, 
predisposing to invasive GGS or GCS infection (6). Studies on bacterial factors 
promoting invasiveness have focused on STSS and its association with the expression 
of superantigens (16, 19). Although none of the isolates in our collection was associated 
with a diagnosis of STSS, 24% (n = 28) of our isolates were from invasive disease. 
These isolates were recovered from normally sterile sites of patients that were 
hospitalized at the time of isolation, attesting to the severity of the infections and the 
aggressiveness of the strains. We investigated if either individual emm types or clones 
were more associated with invasive disease than would be expected by chance by 
calculating ORs comparing the prevalences of individual emm types and clones in 
invasive and noninvasive infections. While no clone was significantly associated with 
invasiveness, two emm types (stG10 and stG2078) had significant ORs. 
The presence of stG10 in a single clone precludes the evaluation of whether the 
overrepresentation among invasive isolates is due to this emm type or to the clonal 
expansion of a specific strain bearing this emm type. However, the nonrandom 
distribution of invasive isolates within this clone points to the existence of a specific 
genetic background responsible for the increased virulence, where factors other than the 
M protein may also play a role. 
In contrast to stG10, stG2078 isolates had a polyclonal origin. Therefore, the 
observed overrepresentation among invasive isolates cannot be attributable to clonal 
expansion of a given strain. In this case, our observations suggest that isolates with 
stG2078 have a higher probability of causing invasive disease independently of their 
genetic background, suggesting a role for the product of the emm gene or that of a 
closely linked gene. Heterogeneity in the genomic region flanking the emm gene has 
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already been described among GGS and GCS (14). Although this variability was not 
correlated with invasiveness, a number of virulence-related genes are known to cluster 
in this region in GAS, and it is conceivable that alterations of the same region in GGS 
and GCS lead to changes in virulence. A further indication that strains with stG2078 
have increased invasive potential is the fact that this emm type was not more frequently 
detected globally than other emm types. Interestingly, stG2078 has previously been 
reported as one of the dominant emm types (present in 3 of 21 isolates) among isolates 
causing invasive disease (17) and was the only emm type expressed by two isolates 
among a collection of GGS and GCS (n= 12) associated with STSS (16). In contrast, a 
study conducted in Israel failed to identify any stG2078 isolate among 94 GGS from 
cases of bacteremia (6). 
Although the potential of isolates with specific M proteins to cause certain disease 
manifestations remains to be established, numerous studies point to a nonrandom M 
type distribution among invasive isolates of GAS (7). Our observations suggest that 
specific emm types are associated with increased invasiveness of GGS and GCS strains. 
Nevertheless, host factors as well as bacterial traits other than the M protein may 
contribute to the frequency of invasive disease. This is supported by the finding of emm 
type variability among invasive isolates (10 emm types among 22 invasive isolates) 
reported in this paper and elsewhere (6, 16). Geographic differences in the prevalences 
of particular clones or emm types may also play an important role, since a study of GGS 
bacteremia in Israel failed to identify any stG2078 isolates and type stG10 was 
represented by a small number of isolates (3 of 94) (6). This study also identified 
stG6792 (n = 3) and stG166b (n = 6) among isolates causing bacteremia, whereas in our 
collection neither of these emm types was identified in invasive isolates. However, the 
Israeli study does not provide information on the frequency of these emm types in 
noninvasive disease, precluding a direct comparison, but these differences highlight the 
importance of conducting studies similar to that presented here in diverse geographic 
locations. 
The data presented highlight the importance of studying both GGS and GCS to fully 
evaluate the prevalence and severity of infections by SDE and suggest an association 
between emm type and invasive disease potential in this bacterium. 
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ABSTRACT 
Streptococcus dysgalactiae subsp. equisimilis (SDE) is an emerging global pathogen 
that can colonize and infect humans. Although most SDE isolates possess the 
Lancefield group G carbohydrate, a significant minority have the group C carbohydrate. 
Isolates are further sub-typed on the basis of differences within the emm gene. To gain a 
better understanding of their molecular epidemiology and evolutionary relationships, 
multilocus sequence typing (MLST) analysis was performed on SDE isolates collected 
from Australia, Europe and North America. The 178 SDE isolates, representing 37 emm 
types, segregate into 80 distinct sequence types (STs) that form 17 clonal complexes 
(CCs). Eight STs recovered from all three continents account for more than 50% of the 
isolates. Thus, a small number of STs are highly prevalent and have a wide geographic 
distribution. Both ST and CC strongly correlate with group carbohydrate. In contrast, 
eleven STs were associated with more than 1 emm type, suggestive of recombinational 
replacements involving the emm gene; furthermore, 35% of the emm types are 
associated with genetically distant STs. Data also reveal a history of extensive inter- and 
intra-species recombination involving the housekeeping genes used for MLST. 
Sequence analysis of single-locus-variants identified through goeBURST indicates that 
genetic change mediated by recombination occurred approximately 4.4 times more 
frequently than by point mutation. A few genetic lineages with an intercontinental 
distribution dominate among SDE causing infections in humans. The distinction 
between group C and G isolates reflects recent evolution, and no long-term genetic 
isolation between them was found. Lateral gene transfer and recombination involving 
housekeeping genes and the emm gene are important mechanisms driving genetic 




Most streptococci displaying beta-hemolysis fall within the pyogenic branch of the 
16S rRNA-based taxonomy, and are pathogens or commensals of mammalian hosts (1, 
2). Two species within the pyogenic branch - Streptococcus dysgalactiae subsp. 
equisimilis (SDE) and Streptococcus pyogenes (group A streptococcus, GAS) - colonize 
and/or infect the respiratory tract and skin of the human host (2). Whereas GAS is an 
important human pathogen, SDE is largely considered to be a commensal organism. 
However, numerous studies report that SDE can cause disease among otherwise healthy 
individuals (2–5). The disease spectrum of SDE infection is similar to that of GAS, and 
includes pharyngitis, post-streptococcal glomerulonephritis, cellulitis, necrotizing 
fasciitis, septicemia, and streptococcal toxic shock syndrome (6–9). Furthermore, in 
some geographic regions where streptococcal diseases are endemic, surveillance studies 
report higher rates of throat colonization by SDE than by GAS (10, 11). 
The surface-exposed Lancefield group carbohydrate is an important cell wall antigen 
that aids in distinguishing between several of the beta-hemolytic streptococcal species. 
S. pyogenes almost exclusively expresses the group A carbohydrate (1). Although the 
vast majority of SDE isolates have group G carbohydrate, and are often referred to as 
group G streptococci, a significant minority of SDE isolates have group C carbohydrate; 
very rarely do SDE harbor the group A or L carbohydrate (1, 12). Among the GAS and 
SDE populations, differences in the sequences of individual emm genes are widely used 
for intra-species strain typing. At present, more than 200 GAS and approximately 50 
SDE emm types are recognized (http://www.cdc.gov/ncidod/biotech/strep/ 
strepblast.htm). Although one report finds SDE isolates expressing emm types stG2078 
or stG10 to have enhanced invasive disease potential (5), most studies have failed to 
uncover disease associations among SDE emm types (13–15). In contrast, associations 
between emm type and specific diseases are well established for GAS (16–19). 
Comparative genome hybridization studies using a microarray containing probes 
corresponding to genes encoding virulence factors and putative surface proteins failed 
to reveal clear cut associations between emm type and gene content among SDE (13). 
Multilocus sequence typing (MLST) is a nucleotide sequence-based method that uses 
core housekeeping genes to characterize genetic relationships between isolates of the 
same species. MLST has been used extensively to study the beta-hemolytic GAS (20–
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22) and S. agalactiae (23–24) populations, and was recently used to investigate genetic 
relationships amongst 61 geographically restricted SDE isolates (25). In the present 
study, an intercontinental collection of SDE isolates is characterized by MLST and emm 
typing, and the geographic distribution of the identified clones and their genetic 
relationships are defined. 
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MATERIALS AND METHODS 
Bacterial Strains 
The 117 SDE isolates analyzed in this study were collected from Australia (n = 55), 
Portugal (n = 36) and the United States (n = 11). Another 15 SDE isolates were obtained 
from other countries or had no associated geographic information (Table S3.1). All 
isolates were classified as SDE on the basis of isolation from a human host, beta-
hemolysis following growth on sheep blood-containing agar, the presence of group C or 
G carbohydrate, and the presence of a recognized emm type. emm type was determined 
by nucleotide sequence typing as described (38), and emm type was assigned using the 
BLASTn-emm server (http://www.cdc.gov/ncidod/biotech/strep/strepblast.htm). Group 
carbohydrate was determined using the latex bead agglutination test. Forty-five isolates 
were obtained from normally sterile tissue or fluid and classified as causing invasive 
disease; 59 isolates were recovered from other non-sterile sites and classified as causing 
noninvasive infections. Information on the 61 invasive isolates recovered from the 
United States, and reported in a previous study (25), was integrated into the current 
analyses to obtain a global overview of the relationships between GGS and GCS 
causing infections in humans. 
MLST 
Seven housekeeping genes are used for MLST of SDE. With the exception of atoB, 
the housekeeping genes used for MLST of SDE are the same as those used in the GAS 
MLST scheme (38). The seventh allele, atoB, (also called yqiZ) has been described 
(25); the allele name has been changed for this report, in order to reduce confusion with 
the GAS MLST gene, yqiL, which occupies a different locus. Primer sequences used for 
PCR amplification are listed in Table S3.2. Although our MLST scheme was developed 
independently from that reported previously (25), the data is directly comparable 
because the same genes, and regions within genes, are targeted for sequencing. All PCR 
products were sequenced in both the forward and reverse directions; newly identified 
alleles and alleles defining new STs were re-sequenced in order to validate the initial 
findings. Unique alleles at each locus were assigned individual allele numbers. The 
combination of the seven allele numbers for each isolate was used to define the 
sequence type (ST). MLST data for SDE is available at http://sdse.mlst.net/. 
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Data analysis 
goeBURST (http://goeburst.phyloviz.net/) (39), which uses the same clustering rules 
as eBURST (40) but provides a global optimal solution, was used to determine the 
relationships between STs. Clonal complexes (CCs) are defined as STs that are linked 
through single-locus-variants (SLVs) and are named on the basis of the predicted 
founder ST, which is the ST having the most SLVs. In cases where a CC contains only 
two STs, the lower numbered ST was used to define the CC. Isolates that share four of 
seven alleles (i.e. triple-locus-variants, TLVs) were used to define larger, more distantly 
related clonal groups. 
The Simpson Index of Diversity (SID) and Wallace coefficients (W) were calculated 
as described previously (41) using www.comparingpartitions.info. A SID value equal to 
one signifies that the typing method distinguishes between all isolates, whereas a SID 
value equal to zero means that all isolates are identical. The W coefficient provides a 
finer comparison between two typing methods, since the value indicates the probability 
that two strains classified as the same type by one method are also classified as the same 
type by the other method. A high value of the W coefficient (values close to 1) indicates 
that partitions defined by a given method could have been predicted from the results of 
another method, suggesting that the use of both methodologies could be redundant. 
Nucleotide diversity (π), nonsynonymous (dn) and synonymous substitution rates (ds) 
were calculated using DnaSP (version 5) (42). 
Phylogenetic analysis 
Phylogenetic relationships amongst individual housekeeping alleles was examined 
using the neighbor joining (NJ) method with Jukes-Cantor substitution algorithm model 
as implemented in MEGA4 (43); bootstrapping (1000 replicates) was used to ascertain 
support for branches. For concatenated housekeeping alleles, evolutionary history was 
inferred using the NJ method or maximum parsimony method (PAUP 4.0). 
Recombination and point mutation 
Empirical estimates of the number of mutation and recombination events 
contributing to the diversification of SLVs were made as previously described (21, 44), 
with additional modifications. The nucleotide sequence differences in the mismatched 
allele among the pair of STs that define an SLV are scored as genetic changes that arise 
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due to either mutation or recombination. Nucleotide differences between the two variant 
alleles at greater than 1 nucleotide site is scored as a probable recombination event. 
Single nucleotide differences between the two variant alleles that do not occur in other 
any other alleles among the SDE set of strains are scored as a change likely due to point 
mutation. If the single nucleotide polymorphism is present in two or more alleles 
assigned to different CCs, the genetic change is scored as likely due to recombination. 
The relative ratio of recombination events versus mutation events was then determined. 
To calculate the per site recombination/mutation (r/m) ratio, the total number of 
nucleotide sites that change due to recombination were divided by the total number of 
nucleotide sites that change due to mutation. 
Recombination among SDE and between the SDE and GAS at each individual gene 
was evaluated using Recombination Detection Program (RDP) (26), which implements 
a large number of methods (RDP, GENECONV, MaxChi, Chimaera, SiScan, 3Seq) for 
detecting intragenic recombination. For these analyses the entire collection of GAS 
alleles was downloaded from the MLST database (http://spyogenes.mlst.net). Since a 
high number of comparisons were performed, the p values reported are corrected for 
multiple tests. SplitsTrees4 was also used to assess intragenic recombination (45), 
excluding parsimony uninformative sites, and using the neighbor net algorithm, 
uncorrected P distance, and the Phi test for recombination (46).  




MLST was used to characterize 117 SDE isolates collected from three continents 
(Table S3.1). Most of the isolates selected for MLST were derived from large 
independent collections and were chosen, in part, based on prior knowledge of their 
emm type and geographic site of isolation, with the goal being the compilation of a 
genetically diverse data set. 
The isolates represent 24 of the approximately 50 known SDE emm types, and 
include strains bearing the group G or group C carbohydrate. A summary of the 
epidemiological features of the isolates is provided in Table 3.1. 
With the inclusion of previously published MLST data on 61 invasive SDE isolates 
obtained from the USA (25), a total of 37 emm types are represented among a larger set 
of 178 isolates, which is used for the analyses in this report. The frequencies of the 
different emm types span a wide range; however, only 38% of the emm types account 
for the majority (74%) of the isolates. 
Among the 178 SDE isolates, the number of alleles identified for each housekeeping 
gene locus ranges from 10 for gtr, murI and mutS, to 22 for xpt (Table 3.2). The gki, 
recP, and xpt loci exhibit the highest level of nucleotide sequence diversity (π). The 
percentage of polymorphic nucleotide sites ranges from 2.7 (n = 12) for murI, to 10.1 (n 
= 50) for gki. A significant portion of the polymorphism observed in gki can be 
attributed to gki12, a highly divergent allele with greater similarity to GAS gki alleles 
than to SDE alleles (Figure S3.1); when the divergent gki12 allele is removed from the 
analysis, the nucleotide diversity of gki falls from 0.021 to 0.012, and the percentage of 
polymorphic sites drops from 10.1 to 5.4 (n = 27). The dn/ds ratio is less than one for 
each of the seven housekeeping genes, consistent with stabilizing selection. 
 Relationships among STs 
The seven housekeeping alleles of each of the 178 isolates yield a total of 80 distinct 
allelic profiles, referred to as sequence types (STs). Of the 80 STs, 37 are newly 
identified in this study and 43 were previously defined by Ahmad et al. (25). A minority 
of STs (10%)  account for a  disproportionate number  (approximately 50%)  of the total 
  





No. off different partitions (SID ± 95% CI)
 a
  




No. of isolates in Lancefield group  No. of invasive/ 
non-invasive 
isolates 




Australia 55 17 (0.926 ± 0.030) 23 (0.937 ± 0.033)  14 47 8  24/25 
Portugal 36 17 (0.951 ± 0.021) 22 (0.956 ± 0.033)  11 28 8  10/26 
USA 72 34 (0.984 ± 0.008) 45 (0.975 ± 0.014)  33 48 23  70/1 
     NYMC 11 8 (0.927 ± 0.094) 10 (0.981 ± 0.045)  5 6 5  9/0 
     CDC     61 33 (0.983 ± 0.005) 37 (0.972 ± 0.016)  28 42 18  61/1 
Other 15 12 (0.971 ± 0.030) 13 (0.981 ± 0.030)  10 7 7  1/6 
Total  178 37 (0.961 ± 0.006) 80 (0.966 ± 0.011)   na 131   46   106/59 
      a SID – Simpsons Index of diversity; CI – Confidence interval 
      b na – not applicable 








No. of variant positions 
  π dn ds dn/ds 
Nucleotide (%) Amino acid 
Glucose kinase (gki) SDEG_1515 498 12 50 (10.1) 7   0.021 0.0035 0.0736 0.047 
Glutamine transport protein (gtr) SDEG_1494 450 10 15 (3.3) 7   0.010 0.0059 0.0248 0.240 
Glutamate racemase (murI) SDEG_0413 438 10 12 (2.7) 1   0.012 0.0068 0.0142 0.479 
DNA mismatch repair protein (mutS) SDEG_2091 405 10 27 (6.7) 7   0.016 0.0062 0.0480 0.129 
Transketolase (recP) SDEG_1735 459 20 37 (8.1) 3   0.034 0.0008 0.1472 0.006 
Xanthine phosphoribosyl transferase (xpt) SDEG_0895 450 22 38 (8.4) 10   0.021 0.0049 0.0736 0.067 
Acetoacetyl-coathioloase (atoB) SDEG_1700 434 12 18 (4.1) 5   0.011 0.0035 0.0330 0.106 
    a Based on ORF number in the GGS_124 genome (GenBank number AP010935) 
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FIGURE 3.1. goeBURST diagram of relationships between 178 global SDE isolates 
The size of each circle is proportional to the number of isolates with that particular ST in a logarithmic 
scale. STs assigned to the same CC are linked by straight lines. Blue circles represent isolates that have 
the group G carbohydrate. Red circles represent isolates expressing the group C carbohydrate. Whenever 
isolates of the same ST have different group carbohydrates, the number of isolates bearing the same 
carbohydrate is proportional to the respective color. The green circle represents the single isolate 
expressing the group L carbohydrate. 
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SDE isolates under evaluation. The vast majority of STs (62, or 77%) are represented by 
only one SDE isolate. The most prevalent ST (ST15) is represented by 20 isolates. Eight 
STs, each represented by eight or more isolates, account for 51% of the 178 SDE 
isolates characterized by MLST. 
The 80 STs can be grouped into 17 clonal complexes (CCs) by goeBURST, whereby 
the connected STs are single-locus-variants (SLVs) of at least one other ST in the 
group, differing at only one housekeeping gene (Figure 3.1). However, only six of the 
17 CCs contain more than two STs. CC8 contains the highest number of STs (n = 9), 
whereas CC15 (n = 26) and CC29 (n = 20) contain the most isolates. 
Twenty-six STs, representing 15% of the 178 isolates, are singletons and differ from 
all other STs by more than two housekeeping alleles. When clusters are constructed 
linking STs that are up to triple-locus-variants (TLVs) of each other, 66 STs are 
grouped into a single major cluster, whereas only three STs remain ungrouped 
singletons (Figure S3.3), indicating that several intermediate genotypes probably exist, 
but have not yet been sampled. 
Relationships between emm type and ST 
The overall correspondence between ST and emm type, as determined by the Wallace 
Coefficient, is low (ST vs emm type W = 0.473, CI95% 0.332–0.542; emm type vs ST W 
= 0.384, CI95% 0.311–0.456) reflecting the fact that most emm types are found in 
multiple STs, and that the same ST can harbor different emm types (Table 3.3 and Table 
3.4). The correspondence between emm type and CC (W = 0.551, CI95% 0.478 to 0.625) 
is also weak. 
STs associated with multiple emm types most likely arose via recombinational 
replacement of the emm gene; they are referred to as emm variable STs. Of the 18 STs 
represented by more than one isolate, 11 STs (61%) are associated with more than one 
emm type (Table 3.3). Five STs are associated with two emm types (ST34, 20, 29, 52, 
63), two STs (ST17, 25) are associated with three emm types, one ST (ST3) is 
associated with four emm types, two STs (ST4, ST8) are associated with five emm types 
and one ST (ST15) is associated with 7 different emm types. 
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TABLE 3.3. Relationship between ST and emm type 
ST No. of isolates Associated emm types No. of emm types 
15 20 stC839, stG10, stG166b, stG2078, stG245, stG6, stG652 7 
8 10 stC839, stG11, stG480, stG643, stG7860 5 
4 10 stC36, stC5344, stG6792, stG97, stG7882 5 
3 10 EMM57, stC1400, stC839, stG653 4 
25 9 stG166b, stG5420, stG6 3 
17 9 stC74a, stG2078, stG485 3 
63 2 stG6, stG652 2 
52 2 stG6, stG643 2 
20 8 stC6979, stG62647 2 
34 3 stC1400, stG5063 2 
29 14 stC74a, stG485 2 













stG6 13 15, 24, 25, 44, 52, 58, 62, 63 8 4 2 2 
stG480 11 7, 8, 38, 39, 40, 41, 67 7 2 2 2 
stC1400 8 3, 28, 34, 46, 64, 66 6 3 1 4 
stG485 8 17, 29, 37, 47, 55, 69 6 3 2 2 
stG643 9 8, 12, 22, 48, 52, 73 6 3 4 5 
stG652 7 15, 32, 59, 61, 63, 71 6 3 2 
 
stC6979 8 9, 19, 20, 54, 80 5 4 4 3 
stC36 6 4, 45, 49, 50, 68 5 2 1 2 
stC74a 15 17, 29, 70, 77 4 2 3 3 
stC839 7 3, 8, 15, 78 4 3 2 3 
stG166b 5 15, 25, 56, 65 4 2 2 2 
stG11 5 6, 8, 42 3 1 1 
 
stG2078 9 15, 17, 72 3 2 2 2 
stG245 3 15, 21, 36 3 2 2 2 
stG4831 3 74, 75, 76 3 1 0 
 
stG62647 9 20, 33, 60 3 1 1 
 
stG6792 6 4, 31, 51 3 1 1 
 
EMM57 3 3, 57 2 1 0 2 
stC5344 3 3, 43 2 1 1 
 
stC6746 2 5, 27 2 1 0 
 
stC9431 2 13, 14 2 1 1 
 
stG5063 2 2, 34 2 1 0 
 
stG840 2 26, 30 2 1 1 
 
stG7882 2 4, 18 2 1 1   
a CCSLV – Clonal complex based on single-locus-variant relationships. 
b CCDLV – Clonal complex based on double-locus-variant relationships. 
c Number of STs sharing the same emm type and differing from all other STs harboring that emm type at greater 
than five housekeeping alleles. 
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The same emm type is often found in association with multiple STs (Table 3.4). The 
association of a given emm type with multiple STs can arise following diversification of 
housekeeping genes, or by horizontal transfer of the emm gene. An estimate of the 
horizontal movement of emm is made by enumerating the number of distant STs 
harboring the same emm type, whereby distant STs are defined as having five or more 
housekeeping allele differences to any other ST that shares the same emm type; for a 
given CC, only one representative ST is counted. 
Thirteen emm types are associated with distant STs: five emm types are associated 
with more than two distant STs and eight emm types are found among a single pair of 
distant STs, whereas five emm types are associated with three or more distant STs 
(Table 3.4). The most promiscuous emm type is stG643, found among five genetically 
distant strains. A total of 21 horizontal transfer events involving emm genes are evident 
in the SDE data set. Taken together, the data provides strong support for the hypothesis 
that emm genes of SDE undergo extensive lateral exchange between strains. 
Relationships between group carbohydrate and ST 
The group specific carbohydrate of the streptococcal cell wall can be used to 
discriminate among β-hemolytic streptococcal species. The majority of SDE isolates 
(74%) in this study express the group G carbohydrate. A sharp distinction between STs 
associated with strains expressing the group G versus C carbohydrate is observed by 
goeBURST (Figure 3.1). Isolates representing 54 STs have group G carbohydrate 
(group G streptococci, GGS), whereas 27 STs are associated with strains expressing 
group C carbohydrate (group C streptococci; GCS). A single isolate has the group L 
carbohydrate. 
Only two STs (ST4 and ST20) have isolates associated with both group C and G 
carbohydrates; for ST4, nine of 10 isolates are GGS and for ST20, seven of eight 
isolates are GCS. Overall, ST and group carbohydrate, whose biosynthesis locus is 
unknown, display very strong linkage (W = 0.970, CI95% 0.939 to 1.000). The 
correspondence between CCs and group carbohydrate is also high, with nine CCs 
containing only GGS isolates and six CCs restricted to GCS isolates (W = 0.979, CI95% 
0.957 to 1.000), indicating that STs belonging to the same genetic lineage almost always 
also share the same group carbohydrate. 
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Percentage of alleles: 
Shared by GCS and GGS Restricted to GCS Restricted to GGS 
murI 30 30 40 
xpt 32 36 32 
gtr
b
 56 33 11 
gki 33 25 43 
atoB 50 33 17 
recP 35 35 30 
mutS 40 30 30 
Total for all alleles 38 36 29 
a Presented in order of the locus position on the genome of strain GGS_124. 
b Excludes gtr06 which is restricted to group L. 
For each of the seven housekeeping loci, the relative distribution of alleles among 
GCS and GGS isolates was evaluated (Table 3.5). Overall, 38% of the housekeeping 
alleles are shared among GCS and GGS isolates. Approximately 36% and 29% of the 
housekeeping alleles are restricted to GCS and GGS isolates, respectively. This finding 
shows that there is a common housekeeping gene pool that is shared among numerous 
GCS and GGS isolates, despite the highly restricted associations that are observed 
between group carbohydrate and ST. 
Relationships between group carbohydrate and emm type 
Unlike ST, which is largely restricted to a single group carbohydrate form, 13 (35%) 
of the 37 emm types are found in association with both GGS and GCS isolates (W = 
0.821, CI95% 0.764 to 0.876). Eight of the variable associations between emm type and 
group carbohydrate likely arose following horizontal transfer of an emm gene to a strain 
having a different group carbohydrate (data not shown). However, it remains possible 
that lateral movement of genes encoding carbohydrate biosynthetic enzymes also 
contributes to the generation of diversity among SDE, although the frequency of this 
event is probably low because carbohydrate-variable STs are rare. 
Geographic distribution of genetically diverse SDE isolates 
To examine the global distribution of SDE clones, the ST and emm type of the 
isolates recovered from Australia, Europe and North America were compared. Clonal 
diversity based on either ST or emm type, as measured by the Simpson Index of 
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Diversity, was high (>0.9) for isolates collected from each of the three primary locations 
(Table 3.1). 
The eight STs that were recovered from all three continents also represent the STs 
with the highest overall prevalence (ST3, 4, 8, 15, 17, 20, 25, 29) (Table S3.1; Figure 
3.2). Furthermore, five of the eight highly prevalent STs are predicted to be founders of 
a CC, wherein the founder ST is defined as that having the highest number of SLVs. 
The data suggest a wide geographical dispersion of founder STs. Of the next 10 most 
highly prevalent STs (each of which is represented by two to four isolates), four were 
associated with isolates from two continents (Table S3.1). Fourteen emm types were 
recovered from each of the three continents; 13 of these are represented by the most 
highly prevalent strains, having greater than 5 SDE isolates per emm type. Together the 
results demonstrate that the most highly prevalent strains of SDE, whereby strain is 
defined by either ST or emm type, are widely disseminated. 
 
FIGURE 3.2. Venn diagram depicting the distribution of ST and emm type  
across three continents 
Unbracketed numbers represent the total number of STs or emm types. The numbers in brackets indicate the 
percentage of total isolates in the entire collection. 
Among the 178 SDE isolates, 107 unique combinations of ST, emm type, and group 
carbohydrate were observed. Isolates corresponding to eight of the 107 unique emm ST-
carbohydrate profiles are widespread and were recovered from all three continents 
(Table 3.6); another seven were isolated from two continents. Three intercontinental 
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clones belong to CC8, two of which likely arose from a common ancestor by either 
genetic diversification at a housekeeping gene locus and/or by horizontal transfer of the 
emm gene. The two intercontinental CC17 clones are SLVs, whereas the CC15 and 
CC25 sets of intercontinental strains arose via lateral exchange of emm type. The 
genetic changes are likely to be ancient events that preceded the intercontinental 
migration of the founders. 
TABLE 3.6. Intercontinental clones of SDE 
CC ST emm type Group carbohydrate Australia Europe North America 
3 3 stC839 C x x x 
4 4 stG6792 G 
 
x x 
8 8 stG480 G x x x 
8 8 stG11 G x 
 
x 
8 38 stG480 G x x x 
15 15 stG10 G x x x 
15 15 stG652 G x 
 
x 
15 15 stG166b G 
 
x x 
17 17 stG2078 G x x x 
17 12 stG643 G x 
 
x 
20 20 stG62647 C x x x 
25 25 stG5420 G x x x 
25 25 stG6 G x x 
 
29 29 stC74a G x x x 
49 49 stC36 C 
 
x x 
Phylogenetic analysis of housekeeping genes 
Clonal relationships established via goeBURST are based on the character state of 
the housekeeping gene allele, and do not take into account the degree of nucleotide 
sequence heterogeneity. In order to further investigate the relatedness of the 
housekeeping gene alleles at each locus, phylogenetic trees for each gene were 
constructed by the neighbor joining method. With the exception of atoB, these trees 
included the alleles from loci of GAS having the highest percentage nucleotide 
sequence identity based on BLASTn. Additionally, the housekeeping genes of GAS and 
SDE share synteny (Table 3.2) (20). In agreement with a previous report (25), several 
SDE alleles are more similar to GAS alleles than to other SDE alleles (Figures S3.1, 
S3.2). Both gki12 and mutS3 form a cluster with GAS alleles, whereas all gtr and murI 
alleles from SDE and GAS segregate into distinct species-specific clusters. The 
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relationship between recP and xpt alleles in the two species is more complex, and the 
phylogenies for the xpt and recP alleles do not resolve into species-specific clusters. 
The seven housekeeping alleles were concatenated (3,134 nucleotide sites) for each 
of the 80 STs of SDE, and the concatenates used to construct a phylogenetic tree by the 
maximum parsimony method (Figure 3.3). The relative distribution of STs along the 
tree branches is highly concordant with the CCs generated via the goeBURST clustering 
algorithm that used allele character states (Figure 3.1). A striking feature of the 
phylogenetic tree is that GCS and GGS taxa are highly interspersed and fail to form 
discrete evolutionary lineages, even in portions of the tree having strong bootstrap 
support. However, the homoplasy index for the phylogenetic tree is high (0.7331, 
excluding uninformative characters) and strong bootstrap support is absent for many of 
the deeper branches. Thus, the phylogeny may be less accurate for long term 
evolutionary events due to a past history of extensive recombination, but nevertheless, it 
appears to recapitulate the short term evolution detected by goeBURST. The analysis 
also provides additional support for the horizontal transfer of housekeeping genes 
between GCS and GGS organisms. 
Phylogenetic trees constructed by the minimum evolution (data not shown) or 
neighbor joining (Figure S3.4) methods also exhibit high concordance with the CCs 
generated via goeBURST. The only exception is CC15, which is divided into two or 
three small subclusters. However, like the maximum parsimony tree (Figure 3.3), there 
is little bootstrap support for deep branches in the neighbor joining tree (Figure S3.4). 
Role of recombination in genetic change in SDE 
An analysis of recombination events between the GAS and SDE housekeeping gene 
alleles, using the RDP suite (26), predicts extensive recombination between GAS and 
SDE in the gki gene. The gki75 and gki102 alleles of GAS were identified as having 
derived from recombination with SDE alleles (p<0.00001 and p = 0.00037, 
respectively), whereas the gki12 and gki4 of SDE appear to result from recombination 
with GAS alleles (both with p<0.00001). These data account for the high nucleotide 
percentage diversity observed in the gki locus. Recombination between GAS and SDE 
could also be identified using RDP in the recP gene. The GAS recP21, recP40, recP54, 
recP71, recP85  are presumed to have resulted from recombination  with SDE alleles  
(p = 0.02469,  p = 0.01073,  p = 0.00050, p = 0.00900 and p = 0.00900, respectively). In  




FIGURE 3.3. Maximum parsimony tree of concatenated housekeeping alleles 
The housekeeping alleles for each of the 80 STs for SDE were concatenated (3,134 nt positions), and a maximum 
parsimony tree was constructed. The radial, unrooted phylogenetic tree is shown. Bootstrap values (500 replicates) 
showing branch support equal or greater than 80% are indicated; bootstrap analysis used a heuristic search and the 
50% majority-rule consensus tree is presented. STs representing GCS and GGS are depicted in red and blue, 
respectively; the single group L isolate (ST1) is depicted in green. CCs having three or more STs are indicated. 
Characters: 2937 are constant, 56 variable characters are parsimony-uninformative, 141 are parsimony-informative. 
Consistency index (CI) = 0.3350; CI excluding uninformative characters = 0.2669; retention index (RI) = 0.7926. 
contrast, SDE alleles recP12 and recP3 seem to result from recombination with GAS 
alleles (p = 0.00262 and p = 0.00231, respectively). No significant recombination events 
between the other GAS and SDE housekeeping alleles (gtr, murI, mutS, xpt) were 
observed using RDP. The SplitsTrees analysis for networked evolution was also used to 
assess intragenic recombination involving the MLST genes within the SDE population. 
Statistically significant evidence for recombination (PHI test) was observed for murI, 
recP, xpt and atoB (p<0.01). 
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It is important to note that the recombination detection algorithms do not detect the 
complete replacement of the analyzed fragment. As pointed out previously, at least one 
instance of recombination involving the entire fragment of mutS analyzed is also 
suggested by phylogenetic analysis (Figure S3.2). Taken together, these data strongly 
suggest that intra- and inter-species recombination has occurred for several 
housekeeping genes. 
The largest CC (CC8) contains 11.3% of the total STs, and is within the range of 
reliable performance of the BURST rules (27). To estimate the relative role of 
recombination versus mutation in the short-term evolution of SDE, the SLVs linked by 
goeBURST were examined for genetic differences between the variant alleles of each 
SLV pair. goeBURST identified 38 primary SLVs. Of these, 31 are predicted to have 
arisen via recombination, and seven SLVs are predicted to arise through point mutation. 
Thus, recombination occurred 4.4 times more often than mutation. The per site 
recombination to mutation (r/m) ratio was 20.7. An additional four SLVs, representing 
alternative ST relationships, are also present in the data set; of these, three SLVs are 
predicted to arise through recombination. The empirical findings on the relative 
contribution of recombination versus mutation to the genetic diversification of 
housekeeping genes are highly consistent with other findings that indicate extensive 
recombination involving SDE. 
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DISCUSSION 
SDE is increasingly recognized as an important human pathogen that causes disease 
in many regions of the world. The findings of this report demonstrate that the major 
genotypes of SDE have an intercontinental distribution. The recovery from all three 
continents of the likely founder ST of at least five CCs supports a model whereby a few 
successful clones have undergone extensive migration, followed by genetic 
diversification. Several of the descendents are also widely disseminated, indicative of 
subsequent waves of clonal migration. 
SDE is largely a commensal species, yet the vast majority of isolates evaluated in 
this study were recovered from cases of human disease. The mode of person-to-person 
transmission of SDE has not been well-characterized, and there may be large 
differences among SDE strains in terms of their virulence properties and ease of 
transmission to new hosts. It stands to reason that the most widely disseminated clones 
are probably among the most readily transmitted. Whether transmission is positively 
linked to virulence is an important question that remains to be established for SDE. 
Molecular typing of SDE, as provided in this report, provides a framework upon which 
the question of whether or not subpopulations of SDE strains have heightened virulence 
can be addressed. 
More than half (60%) of the SDE isolates studied have a unique combination of emm 
type, ST and group carbohydrate, indicative of a very high level of genetic diversity 
within the species. The high level of strain diversity may be a consequence of a high 
rate of genetic change and/or a very large population size. Nonetheless, molecular 
typing using only the emm gene versus MLST, yields stratifications that are highly 
discordant, and neither method by itself is satisfactory for defining strains or clones. 
This finding provides support for a role of extensive horizontal gene transfer and 
recombination in promoting random associations of emm and ST. 
Recombination following horizontal gene transfer in SDE is observed at several 
levels of biological importance, involving core housekeeping genes and the emm gene, 
and perhaps even the genes encoding the group carbohydrate biosynthetic enzymes, 
albeit at a much lower frequency. Inter-specific gene transfer between SDE and GAS is 
likely for several of the housekeeping genes. Interestingly, ST3 and ST78 isolates 
possess the SDE recP6 and xpt2 alleles, which are identical to the GAS derived recP83 
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and xpt4 alleles respectively. Although it is formally possible that the recP and xpt 
alleles were transferred in a single genetic exchange event involving a large genome 
segment, this hypothesis is unlikely because SDE-like gki and gtr alleles are positioned 
in between the xpt and recP loci on the SDE genome. 
Transfer of emm genes between SDE and GAS also seem likely to have occurred, but 
to a much more limited extent, as evidenced only by the prototypical GAS emm types 
emm57 (25) and emm12 (28). In addition to emm and the housekeeping genes, lateral 
exchange between GAS and SDE is documented for several other genes, including 
those encoding a fibronectin-binding protein (29), a DNA gyrase subunit implicated in 
fluoroquinolone resistance (30), a transcriptional regulator of pilus gene expression 
(31), and the plasminogen activator streptokinase (32, 33). Thus, SDE and GAS share 
common gene pools for numerous loci. 
Intra-species genetic exchange among SDE organisms, involving either the core 
housekeeping genes or the emm gene, has been extensive. Data suggest recombination 
to be the predominant mechanism of genetic diversification among SDE, occurring four 
times more often than point mutation in housekeeping loci. The per-site recombination 
to mutation ratio is also greater than 20. More than half of the STs represented by more 
than one isolate are considered to be emm variable STs, and are found in association 
with at least two distinct emm types. ST15 is a particularly successful recipient of emm 
genes originating from multiple SDE donor strains, as evidenced by its recovery in 
association with seven different emm types. Mechanisms that might explain the 
existence of STs having associations with many distinct emm types include possession 
of genetic machinery that increases their probability for recombinational success, 
additional accessory genes which facilitate their transmission to new hosts, a high 
prevalence (eg., ST15 comprises 20 of the 178 isolates) or natural selection favoring the 
emergence of variants harboring unique emm types. 
Numerous emm gene donor-recipient ST pairs are also represented within the SDE 
isolate data set, wherein 13 different emm types are associated with two or more 
genetically distant STs; in total, 21 distinct emm gene horizontal transfer events are 
suggested by the data. One emm type (stG643) is found in association with five distant 
STs or CCs. The emm gene of GAS is part of an ancient pathogenicity island (34). Thus, 
it will be of interest to determine whether the stG643 gene is harbored by a functional 
mobile genetic element. 
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In GAS, the emm gene product (M protein) is a major virulence factor and a primary 
target of protective immunity by the human host. However, to our knowledge, it 
remains to be shown that the M protein of SDE prevents phagocytosis in the absence of 
M type-specific antibody, which is a hallmark feature of GAS. Thus, the relationship 
between gene replacements involving the emm gene, and positive selection arising from 
host immune pressures, remains speculative for SDE. The M proteins of GAS are also 
multifunctional proteins, which as a group, exhibits binding for numerous host proteins 
that include plasminogen, fibrinogen, immunoglobulins and complement regulatory 
proteins, as recently reviewed by Smeesters et al. (35). Like GAS, M proteins of SDE 
that can bind plasminogen have been identified (36). However, the full extent by which 
the M proteins of SDE share functional attributes with the M protein of GAS remains to 
be established. The acquisition of new, M protein-mediated functional activities by a 
recipient SDE strain could conceivably drive selection for the emergence of novel emm-
ST combinations among SDE. 
Group carbohydrate is synthesized by biosynthetic enzymes whose genes have yet to 
be characterized. Among SDE, the association between group C versus G carbohydrate 
and ST approaches 100% concordance. The observed linkage between group 
carbohydrate and ST is probably a large reflection of short term evolution. An 
evolutionary history of housekeeping gene exchange between GCS and GGS is evident 
from the phylogenetic tree of concatenated housekeeping gene sequences. While it is 
likely that GCS and GGS diverged from a common ancestor, subsequent genetic 
exchange masks that history, making it difficult to ascertain the extent to which GCS 
and GGS comprise distinct evolutionary lineages. However, MLST data makes it clear 
that lateral gene transfer leading to a group carbohydrate switch is a rare event. 
The goeBURST population snapshot of SDE (Figure 3.1) differs from that reported 
for GAS (16). For GAS, only 2.8% of the STs are present in the largest CC, as 
compared to 11.2% of the SDE STs (i.e., CC8). Based on simulated bacterial 
populations differing in levels of recombination and diversity generated by mutation 
(27), the population genetic structure of GAS is best explained by high rates of both 
recombination and mutation acting on a diverse set of housekeeping genes. For SDE, 
the recombination rate and housekeeping gene diversity may be similarly high; however 
the mutation rate may be somewhat lower than in GAS. This proposed genetic structure 
for the SDE population is supported by correspondence to simulated populations (27), 
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combined with findings that show a greater than 4-fold excess of recombinational 
events in the diversification of SLVs. 
SDE appears to be among the closest extant relatives of GAS. In general terms, a 
pathogenic species of bacteria can arise from an organism of lower virulence following 
acquisition of virulence genes (eg., pathogenicity islands). However, evolution can also 
flow in the opposite direction, as recently evidenced by the loss of virulence genes and 
descent of the commensal Streptococcus mitis from the pathogen Streptococcus 
pneumoniae (37). Determination of whether the most recent common ancestor of GAS 
and SDE is more closely related to GAS or to SDE, will probably require more 
extensive genomic analyses. The molecular typing and characterization of the 
population biology of SDE in this report provides a foundation for future studies that 
address the evolution and molecular basis for virulence in SDE. 
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TABLE S3.1. Characteristics of SDE isolates in this study 







168554 stG485 G 47 37 Portugal UL 
171712 stG480 G 38 8 Portugal UL 
220269 stG2078 G 15 15 Portugal UL 
223754 stC839 C 3 3 Portugal UL 
230631 stG480 G 8 8 Portugal UL 
231995 stC74a G 29 29 Portugal UL 
241940 stC36 C 50 49 Portugal UL 
273600 stG166b G 65 15 Portugal UL 
299298 stG643 G 8 8 Portugal UL 
313247 stG6 G 25 25 Portugal UL 
363962 stG2078 G 17 17 Portugal UL 
378119 stC839 G 15 15 Portugal UL 
380870 stG480 G 41 8 Portugal UL 
386041 stC839 C 3 3 Portugal UL 
394314 stG2078 G 72 17 Portugal UL 
423738 stG62647 C 20 20 Portugal UL 
450784 stG10 G 15 15 Portugal UL 
460880 stG10 G 15 15 Portugal UL 
493188 stG485 C 69 s Portugal UL 
542567 stG6 G 62 s Portugal UL 
618280 EMM57 G 57 s Portugal UL 
SH0004 stG6792 G 4 31 Portugal UL 
SH0015 stG6 G 25 25 Portugal UL 
SH0032 stG166b G 15 15 Portugal UL 
SH0102 stG2078 G 17 17 Portugal UL 
SH0107 stG643 G 52 52 Portugal UL 
SH0110 stG6 G 25 25 Portugal UL 
SH0113 stG6792 G 4 31 Portugal UL 
SH0124 stG6792 G 4 31 Portugal UL 
SH0218 stG245 G 15 15 Portugal UL 
SH0254 stG485 C 69 s Portugal UL 
SH0257 stC6979 C 80 s Portugal UL 
SH0259 stG652 G 71 17 Portugal UL 
SH0275 stG485 G 55 29 Portugal UL 
SH0330 stC36 C 49 49 Portugal UL 
SH0336 stG5420 G 25 25 Portugal UL 
G121 stC74a G 29 29 Australia QIMR 
G122 stC74a G 29 29 Australia QIMR 
GCS10128 stC1400 C 46 s Australia QIMR 
GCS2816 stG62647 C 20 20 Australia QIMR 
GCS6894 stG62647 C 20 20 Australia QIMR 
GCS6929 stG62647 C 20 20 Australia QIMR 
GGS075 stG166b G 56 25 Australia QIMR 
GGS101 stG643 G 12 17 Australia QIMR 
GGS10b stG6 G 44 44 Australia QIMR 
GGS11172 stC74a G 29 29 Australia QIMR 
GGS11543 stG643 G 12 17 Australia QIMR 
GGS120 stG4831 G 74 74 Australia QIMR 
GGS19 stC1400 G 64 s Australia QIMR 
GGS2 stG10 G 15 15 Australia QIMR 
GGS24 stG6 G 44 44 Australia QIMR 
GGS430 stG643 G 12 17 Australia QIMR 
GGS463 stG10 G 15 15 Australia QIMR 
GGS539813 stC74a G 29 29 Australia QIMR 
GGS540048 stG485 G 29 29 Australia QIMR 
GGS545448 stG10 G 15 15 Australia QIMR 
GGS569 stC6979 G 54 29 Australia QIMR 
GGS592 stG480 G 8 8 Australia QIMR 
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TABLE S3.1. (cont) 




Complex Location Collection 
GGS9225 stC74a G 29 29 Australia QIMR 
GGS985 stC1400 G 66 15 Australia QIMR 
GGSRHD stG480 G 39 8 Australia QIMR 
MD01 stG11 G 8 8 Australia QIMR 
MD02 stG10 G 15 15 Australia QIMR 
MD03 stG2078 G 17 17 Australia QIMR 
MD031 stC74a G 17 17 Australia QIMR 
MD04 stG6 G 25 25 Australia QIMR 
MD05 stG6 G 63 52 Australia QIMR 
MD06 stC74a G 29 29 Australia QIMR 
MD07 stG6 G 58 s Australia QIMR 
MD08 stG2078 G 17 17 Australia QIMR 
MD09 stG10 G 15 15 Australia QIMR 
MD122 stC74a G 29 29 Australia QIMR 
MD136 stG10 G 15 15 Australia QIMR 
MD163 stG652 G 63 52 Australia QIMR 
MD227 stC6979 C 20 20 Australia QIMR 
MD248 stC6979 G 54 29 Australia QIMR 
MD296 stG10 G 15 15 Australia QIMR 
MD411 stC1400 G 66 15 Australia QIMR 
MD499 stC6979 G 54 29 Australia QIMR 
MD504 stC839 C 3 3 Australia QIMR 
MD605 stG62647 C 20 20 Australia QIMR 
MD633 stG643 G 73 17 Australia QIMR 
MD722 stC74a G 29 29 Australia QIMR 
MD805 stG652 G 59 15 Australia QIMR 
MD834 stC36 G 4 31 Australia QIMR 
MD872 stG62647 C 60 s Australia QIMR 
MD921 stC6979 G 54 29 Australia QIMR 
MD934 stG5420 G 25 25 Australia QIMR 
NS1121 stG4831 G 75 74 Australia QIMR 
NS542 stG652 G 15 15 Australia QIMR 
NS752 stG6 G 44 44 Australia QIMR 
GCS01ny stC1400 C 3 3 Other NYMC 
GCS04ny stC5344 C 43 s Other NYMC 
GCS07ny stG6792 C 51 s Other NYMC 
GCS08ny stC5345 C 53 44 Other NYMC 
GCS10ny stC74a C 70 s Other NYMC 
GCS11ny stC839 C 78 3 Other NYMC 
GGS12ny stG11 G 8 8 Other NYMC 
GGS13ny stG480 G 8 8 Other NYMC 
GGS15ny stC74a G 29 29 Other NYMC 
GGS16ny stG485 G 29 29 Other NYMC 
GGS19ny stG11 G 42 8 Other NYMC 
GGS24ny stG4974 G 79 s Other NYMC 
GGS22ny stG4831 G 76 s Other NYMC 
GGS 124 stG480 G 67 15 Other other 
DSM6176 stG652 C 61 s Other other 
GCS02ny stC839 C 3 3 USA NYMC 
GCS03ny stG653 C 3 3 USA NYMC 
GCS05ny stG643 C 48 s USA NYMC 
GCS06ny stC36 C 49 49 USA NYMC 
GCS09ny stC36 C 68 s USA NYMC 
GGS14ny stG10 G 15 15 USA NYMC 
GGS17ny stG480 G 38 8 USA NYMC 
GGS18ny stG480 G 40 8 USA NYMC 
GGS20ny stC36 G 45 s USA NYMC 
GGS21ny stG6 G 52 52 USA NYMC 
GGS23ny stC74a G 77 29 USA NYMC 
            a ‘s’ denotes singleton 
  
TABLE S3.2. PCR primer pairs used for MLST in the study 
Locus Forward primer Forward primer sequence (5' to 3') Reverse primer Reverse primer sequence (5' to 3') 
gki Gkigc-up GGAATTGGTATGGGATCACCAGGAGC Gkigc-dn AATTCTCCTGCTGCTGACAC 
gtr Gtrgc-up GCACAAGTATTATGGGCACA Gtrgc-dn CACGGTCTGCGACTTC 
gtr Gtrgc-up2 AAATATTATGGGCAAAACGAGGTG Gtrgc-dn2 CTTCCACAATAACGCCGCCATCCATA 
murI Murigc-up GACCTGCTGAGCAAATTAGAGAATACACATGGG Murigc-dn CAGGACTTGCCGTTGTGTAAAAATGGTG 
murI Murigc-up2 TGCTGACTCAAAATGTTAAAATGATTG Murigc-dn2 GATGATAATTCACCGTTAATGTCAAAATAG 
mutS MutSgc-up GAAGAGTCATCTAGTTTAGAATACGAT MutSgc-dn AGAGAGTTGTCACTTGCGCGTTTGATTGCT 
recP RecPgc-up GCAAATTCTGGACACCCAGG RecPgc-dn CTTTCACAAGGATATGTTGCC 
xpt Xptgc-up TTACTTGAAGAACGCATCTTA Xptgc-dn ATGAGGTCACTTCAATGCCC 
atoB AtoBgc-up ACGTTGCTCAGAAATATGGCAT AtoBgc-dn AAAGTGTTGCTAGTCCTCTGGTTAC 
TABLE S3.2. (cont) 
Locus Nucleotide location in GGS_124
a
 Primers used by
b
 
gki 1473922-1473425 UL, NYMC, QIMR 
gtr 1450465-1450016 UL, QIMR 
gtr 1450465-1450016 NYMC 
murI 389637-390074 UL, NYMC 
murI 389637-390074 QIMR 
mutS 2031544-2031140 UL, NYMC, QIMR 
recP 1668713-1668255 UL, NYMC, QIMR 
xpt 882848-883297 UL, NYMC, QIMR 
atoB 1634373-1634806 UL, NYMC, QIMR 
a Based on nucleotide position in the GGS_124 genome (GenBank number AP010935) 
b UL, University of Lisbon; NYMC, New York Medical College; QIMR, Queensland Institute of Medical Research.




FIGURE S3.1. Evolutionary history of gki (A), gtr (B), murI (C) and atoB (D) alleles  
from SDE and GAS.  
Evolutionary relationships were inferred using the Neighbour-Joining (NJ) method, and evolutionary distances 
calculated using the Jukes-Cantor method. Branches with bootstrap support (n = 1000) greater than 80% are shown 
next to their respective branches. The tree is drawn to scale, with branch lengths in the same units as those of the 
evolutionary distances used to infer the phylogenetic tree. Only names of the GGS alleles are shown. Phylogenetic 





FIGURE S3.2. Evolutionary history 
of mutS (A), xpt (B) and recP (C) 
alleles from SDE and GAS 
Evolutionary relationships were inferred using 
the Neighbour-Joining (NJ) method, and 
evolutionary distances calculated using the 
Jukes-Cantor method. Branches with bootstrap 
support (n = 1000) greater than 80% are shown 
next to their respective branches. The tree is 
drawn to scale, with branch lengths in the same 
units as those of the evolutionary distances used 
to infer the phylogenetic tree. Only names of the 
GGS alleles are shown. Phylogenetic analyses 
were conducted in MEGA4. 










FIGURE S3.3. goeBURST diagram of the relationships between 178 global SDE 
isolates grouped up to TLV 
The size of each circle is proportional to the number of isolates with that particular ST in a logarithmic scale. STs 
differing up to three alleles (triple-locus-variants - TLVs) are linked by straight lines. Black lines link STs differing at 
a single gene. Intermediate grey lines link STs differing at a two genes. Light grey lines link STs differing at a three 
genes. Blue circles represent isolates that have the group G carbohydrate. Red circles represent isolates expressing the 
group C carbohydrate. Whenever isolates of the same ST have different group carbohydrates, the number of isolates 
bearing the same carbohydrate is proportional to the respective color. The green circle represents the single isolate 
expressing the group L carbohydrate. The proposed founders of particular clusters are indicated by a light green outer 





FIGURE S3.4. Neighbor joining 
tree of concatenated housekeeping 
alleles 
The housekeeping alleles for each of the 80 STs 
for SDE were concatenated (3,134 nucleotide 
positions), and a neighbor joining tree was 
constructed (MEGA4). Bootstrap values (1,000 
replicates) showing branch support equal or 
greater than 80% are indicated. STs representing 
GCS and GGS are depicted in red and blue, 
respectively; the single group L isolate (ST1) is 
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INTRODUCTORY NOTE 
The unusual high resistance rate to levofloxacin (12.1%) in SDE that prompted the 
study described in this chapter was found during a survey of the antimicrobial 
susceptibility of GCGS isolates recovered from human infections in Portugal. The 
initial aims of this broader study were to determine the antimicrobial susceptibility 
patterns and to define whether specific resistance traits were associated with distinct 
clonal lineages present in the population. The main findings of this study are given 
below and contextualize the work on levofloxacin resistance described in the main body 
of this chapter and that resulted in the publication described. 
Antimicrobial susceptibility of SDE isolates from human infections in Portugal 
A collection of 314 SDE isolates recovered from invasive and non-invasive human 
infections were collected from June 1998 to December 2005 from 13 laboratories in 
Portugal (detailed information on the isolates is given in the Materials and Methods 
section of this chapter). 
Susceptibility testing to penicillin, cefotaxime, erythromycin, clindamycin, 
tetracycline, chloramphenicol, levofloxacin, vancomycin, streptomycin, gentamicin, 
quinupristin-dalfopristin and linezolide was performed by disk diffusion according to 
the CLSI guidelines (11). The macrolide, lincosamide and streptogramin B (MLSB) 
resistance phenotypes cMLSB (constitutive), iMLSB (inducible) and M, were also 
detected as described in CLSI guidelines (11). The minimum inhibitory concentration 
(MIC) of penicillin was determined for all isolates, while MIC testing of erythromycin, 
clindamycin, levofloxacin, streptomycin and gentamicin was performed on resistant 
isolates to these antibiotics, using E-test strips (bioMérieux, Marcy-l’Etoile, France) and 
the CLSI interpretative criteria (11). The breakpoints used for both disk diffusion testing 
and MIC determination for gentamicin and streptomycin were those recommended for 
detection of high-level resistance in Enterococcus spp., given that CLSI breakpoints for 
aminoglycosides are not available for streptococci. 
All 314 SDE isolates analyzed in this study were susceptible to penicillin. The MIC 
range was 0.006 µg/mL to 0.047 µg/mL, with MIC50 = 0.012 µg/mL and MIC90 = 0.016 
µg/mL. All isolates were also susceptible to cefotaxime, vancomycin, quinupristin-
dalfopristin and linezolide by the disk diffusion test. 
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Overall, 175 (55.7 %) isolates were resistant to at least one of the antibiotics tested 
(153 Lancefield group G and 22 group C). Tetracycline resistance was expressed by 127 
isolates (40.4%), followed by resistance to MLSB antibiotics (22.0%, n = 69), 
fluoroquinolones (12.1%, n = 38) and aminoglycosides (3.5%, n = 11). A single isolate 
was found to be resistant to chloramphenicol. Table 4.1 summarizes the resistance 
patterns observed. 
TABLE 4.1 Resistance patterns of 314 SDE isolates recovered from human 
infections in Portugal (1998 to 2005) 
Antimicrobial 
agent 
Resistance patterns [no. of isolates (%)]
a
 MIC range of  
resistant strains 
(μg/mL)b 
Resistant Intermediate Susceptible 
Tetracycline 127 (40.4) 29 (9.2) 158 (50.3) nd 
Erythromycin 69 (22.0) 0 (0) 245 (78.0) 4 to >256 μg/mL 
Clindamycin 37 (11.8) 0 (0) 277 (88.2) 1 to >256 µg/mL 
Levofloxacin 38 (12.1) 4 (1.3) 272 (86.6) 6 to >32 μg/mL 
Streptomycin 11 (3.5) na 303 (96.5) >1024 µg/mL 
Gentamicin 2 (0.6) na 312 (99.4) >1024 µg/mL 
Chloramphenicol  1  0 (0)  313  nd 
a na, not applicable. For the antimicrobial classes for which MIC testing was performed the MIC results 
were considered definitive. For aminoglycoside high-level resistance, only the resistant and susceptible 
categories are considered. 
b nd, not determined. 
A total of 127 SDE isolates were resistant to tetracycline, while 29 displayed 
intermediate resistance as determined by the disk diffusion test. Thus, tetracycline 
resistance was the most expressive in our study as it was found in over 40% of the 
isolates. 
Resistance to erythromycin was above 20% in our SDE collection. Among the 69 
isolates that were resistant to erythromycin, the MLSB-phenotype of resistance was the 
most commonly found, being expressed by 64 (92.8%) isolates (MIC range, 4 to >256 
µg/mL). Among these isolates, 37 displayed constitutive clindamycin resistance 
(cMLSB). All cMLSB isolates had a clindamycin MIC >256 µg/mL, except one isolate 
for which the MIC to clindamycin was 1 µg/mL (erythromycin MIC = 8 µg/mL). 27 
isolates showed inducible resistance to clindamycin (MIC range, 0,125 to 0,5 µg/mL). 
Most of MLSB resistant isolates had a MIC to erythromycin >256 µg/mL, but 22 
isolates, comprising both constitutive and inducible phenotypes, presented MICs that 
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ranged from 48 µg/mL to as low as 4µg/mL. The M-phenotype was found to be 
expressed by only 5 isolates (MIC range, 4 to 8
 
µg/mL). 
Twelve isolates had a resistant or inconclusive disk diffusion test result for the 
aminoglycosides as defined in CLSI guidelines for enterococci (11) and resistance was 
confirmed for all but one isolate by MIC testing. Only two isolates had a MIC of 
gentamicin >1024 µg/mL, hence being classified as high-level resistant to this antibiotic 
(11). These two resistant isolates plus nine isolates that were susceptible to gentamicin 
(MIC range, 6 to 64 µg/mL), all showed MICs to streptomycin >1024 µg/mL. 
The results of the molecular characterization of all 314 SDE isolates carried out by 
using PFGE and emm typing are detailed in the main body of the chapter (see Table 
4.2). Briefly, resistant isolates to at least one antimicrobial class were present in each 
PFGE cluster and with the exception of stG62647 (n = 11), all emm types found in more 
than two isolates included resistant isolates. The two biggest PFGE clusters, H88 and J77, 
included mostly susceptible isolates and were not associated with resistance to any 
specific antimicrobial class. On the other hand, tetracycline resistant isolates in PFGE 
cluster C56, mostly of emm types stG10 and stG166b (the last one also associated with 
levofloxacin resistance), and macrolide resistant isolates in cluster B11 (mostly stG2078) 
were the most notoriously resistant clonal lineages. In general, resistant isolates were 
not separated from susceptible isolates presenting the same emm type by PFGE. 
Common to most of the prevalent emm types in our study was their association mostly 
into one PFGE cluster, where the majority of susceptible isolates grouped. Thus, apart 
from the exceptions described above, the observed resistance to the several 
antimicrobial agents tested, had a polyclonal origin and could not be explained by the 
occurrence of resistant clonal lineages with increased prevalence. 
The finding in our work of a high rate of resistance to levofloxacin (12.1%) was 
surprising since it has no parallel in the available GCGS literature. These observations 
prompted the clarification of the resistance mechanisms involved and the detailed study 






Quinolone resistance is an emerging problem in Streptococcus pyogenes (Lancefield 
group A streptococcus [GAS]), and recombination with Streptococcus dysgalactiae 
DNA has been implicated as a frequent mechanism leading to resistance. We have 
characterized a collection of S. dysgalactiae subsp. equisimilis (SDE) isolates 
responsible for infections in humans (n = 314) and found a high proportion of 
levofloxacin-resistant isolates (12%). Resistance was associated with multiple emm 
types and genetic lineages, as determined by pulsed-field gel electrophoretic profiling. 
Since we could not find evidence for a role of efflux pumps in resistance, we sequenced 
the quinolone resistance-determining regions of the gyrA and parC genes of 
representative resistant and susceptible isolates. We found much greater diversity 
among the parC genes (19 alleles) than among the gyrA genes (5 alleles). While single 
mutations in either GyrA or ParC were sufficient to raise the MIC so that the strains 
were classified as intermediately resistant, higher-level resistance was associated with 
mutations in both GyrA and ParC. Evidence for recombination with GAS DNA was 
found in some parC alleles, but this was not exclusively associated with resistance. Our 
data support the existence of a common reservoir of genes conferring quinolone 
resistance shared between SDE and GAS, while no recombination with the animal 
pathogen S. dysgalactiae subsp. dysgalactiae could be found. 
  
Chapter 4 – SDE fluoroquinolone resistance and recombination 
123 
INTRODUCTION 
Streptococcus dysgalactiae subsp. equisimilis (SDE) is a beta-hemolytic, large-
colony-forming species (diameter, >0.5 mm) presenting either the Lancefield group C 
or the Lancefield group G antigen (15). Among the members of this group, this species 
is the one the most commonly reported to be a cause of human infections worldwide 
(27, 33, 41, 45) and was the only one previously detected among Lancefield group C 
streptococci (GCS) and Lancefield group G streptococci (GGS) causing infections in 
humans in Portugal (37). Although SDE may be part of the normal human microbiota 
(8), it has also been identified to be the causative agent of infections of the respiratory 
tract, infections of the skin and soft tissue, as well as life-threatening infections, such as 
endocarditis and bacteremia (37, 41, 45). More recently, an increasing number of 
reports have described the association of these organisms with streptococcal syndromes 
typically caused by Streptococcus pyogenes (a Lancefield group A streptococcus 
[GAS]), such as streptococcal toxic shock syndrome (22) and acute rheumatic fever 
(21). Several studies point to a close relationship between SDE and GAS, with multiple 
common virulence (40) and antibiotic resistance (17) determinants being found in both 
species. 
Fluoroquinolones (FQs) are nowadays valid therapeutic options for the treatment of 
streptococcal infections (24). However, the emergence of resistance to this antimicrobial 
class is a global concern and resistance is increasingly being reported among several 
streptococcal species (13, 26, 30), including SDE (5). FQs act by inhibiting the bacterial 
DNA gyrase and DNA topoisomerase IV (24). Alteration of the target enzymes is the 
more widespread mechanism of resistance in streptococci and the only one that confers 
high-level resistance to FQs (24), but active efflux was also shown to confer low-level 
resistance in Streptococcus pneumoniae (4, 9) and in other viridans group streptococci 
(20), but this mechanism was not detected in GAS (30). 
Both DNA gyrase and topoisomerase IV are tetramers of two different subunits, 
subunits GyrA and GyrB and subunits ParC and ParE, respectively (24). Previous 
studies have shown that FQ resistance arises from amino acid changes in the structurally 
similar proteins GyrA and ParC, while alterations in GyrB and ParE seem to be less 
relevant (4, 24). Mutations in the DNA sequences of gyrA and parC that confer 
resistance to FQs are found in the so-called quinolone resistance-determining regions 
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(QRDRs) of these genes (34). Mutations in the gyrA and parC QRDRs are thought to 
occur spontaneously in bacterial populations, and this is considered the main 
mechanism of the emergence of FQ resistance (2, 24). 
Evidence for the horizontal transfer of the QRDR between streptococci has been 
found, and this mechanism may also play a role in the rise in the incidence of FQ 
resistance (3, 14, 16, 38). One study suggested that S. dysgalactiae could act as the 
donor species in the emergence of FQ-resistant GAS (38), and more recently, a 
considerable proportion of the GAS isolates from Belgium presented characteristics 
suggestive of the acquisition of their QRDR of parC from SDE (14). However, such 
studies have been hampered by the small number of S. dysgalactiae parC and gyrA 
sequences available, which limits the ability to assess the contribution of FQ resistance 
in this species to a putative QRDR gene pool common among beta-hemolytic 
streptococci. 
We characterized the molecular mechanisms of levofloxacin resistance in isolates of 
SDE responsible for infections in humans in Portugal. The clonal structure of the 
isolates was evaluated by using two well-established typing schemes: emm typing and 
SmaI macrorestriction profiling by pulsed-field gel electrophoresis (PFGE) (37). This 
approach allowed the identification of putative susceptible ancestors of resistant isolates 
and evaluation of the diversity of the genetic backgrounds of FQ-resistant isolates. We 
found that FQ resistance emerged by alteration of the target genes in diverse genetic 
lineages of SDE, as previously shown for other streptococci (2), suggesting that 
mutation and selection are the primary drivers of resistance. The analysis of the QRDRs 
of a large number of genetically unrelated isolates allowed us to identify evidence of the 
frequent ongoing horizontal transfer of the QRDR of parC between SDE and GAS, 
indicating the existence of a gene pool common between these streptococcal species. 
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MATERIALS AND METHODS 
Bacterial isolates 
A collection of 314 beta-hemolytic, large-colony-forming (diameter, >0.5 mm) 
isolates of GGS (n = 249) and GCS (n = 65) responsible for infections in humans were 
collected from June 1998 to December 2005. The distribution of isolates over the study 
period was as follows: 11 in 1998, 28 in 1999, 20 in 2000, 28 in 2001, 29 in 2002, 70 in 
2003, 50 in 2004, and 78 in 2005. The sources of the isolates were the following: blood 
(n = 34), other normally sterile sites (n = 11), pharyngeal exudate (n = 67), sputum (n = 
37), skin and soft tissue (n = 155), vaginal exudate (n = 5), and urine (n = 5). The strains 
were recovered in 13 laboratories, located throughout Portugal, that were asked to 
submit all nonduplicate GCS and GGS isolates associated with human infections. 
Partial descriptions of some of these isolates were published previously (37). 
Species identification 
Strains were identified to the genus level by the submitting laboratory. Upon receipt, 
the Lancefield group was confirmed by a commercial latex agglutination technique 
(Slidex Strepto kit; bioMérieux, Marcy l'Etoile, France). All further studies were carried 
out at the Instituto de Microbiologia, Faculdade de Medicina, Universidade de Lisboa. 
Beta-hemolysis and colony size were confirmed after overnight incubation at 37°C in 
tryptic soy agar (Oxoid, Hampshire, England) supplemented with 5% (vol/vol) 
defibrinated sheep blood. Further identification to the species level was done for all 
non-levofloxacin-susceptible isolates (levofloxacin MICs > 2 μg/mL [11]) and selected 
susceptible isolates used for comparative analysis by using the API 20 Strep system 
(bioMérieux). We had previously confirmed the efficacy of this system for the 
identification of SDE strains by using 16S rRNA gene sequencing as the “gold 
standard” (37). 
Molecular typing 
Isolates were characterized by emm typing and SmaI PFGE macrorestriction 
profiling, as described previously (37). The PFGE patterns were compared by using 
Bionumerics software (Applied Maths, Sint-Martens-Latem, Belgium) to create 
dendrograms by the unweighted-pair group method with arithmetic averages 
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(UPGMA). The Dice similarity coefficient was used with optimization and position 
tolerance settings of 1.0 and 1.5, respectively. Clusters were defined as groups of 
isolates (n ≥ 2) presenting profiles with ≥80% similarity in the dendrogram (37). 
Simpson's index of diversity (SID) and 95% confidence intervals (CIs) were 
calculated as described elsewhere (10). 
Antimicrobial susceptibility testing and efflux screening 
Testing for susceptibility to levofloxacin was done for all 314 isolates by disk 
diffusion, according to the guidelines of the CLSI (11). Testing of the levofloxacin MIC 
for nonsusceptible isolates and selected susceptible isolates was performed with Etest 
strips (AB Biodisk, Solna, Sweden) and by use of the interpretative criteria of the CLSI 
(11). Nonsusceptible isolates were also tested for active efflux by the agar dilution 
method on Mueller-Hinton agar (Oxoid, Hampshire, England) supplemented with 5% 
sheep blood in the presence of levofloxacin or ciprofloxacin with or without 10 μg/mL 
of reserpine (Sigma-Aldrich, Steinheim, Germany), as described previously (9). 
Analysis of DNA sequence conferring levofloxacin resistance 
The segments of the gyrA and parC genes containing the QRDRs were amplified and 
sequenced by using the primers previously proposed for use for this purpose (26). The 
nucleotide sequences and the deduced amino acid sequences of the gyrA and parC 
QRDRs were determined for 56 SDE isolates which exhibited different levels of 
resistance to levofloxacin and which represented the main PFGE clusters and emm types 
identified in this work. 
Phylogenetic analysis of gyrA and parC 
Sequence alignments were performed manually. MEGA (version 4) software (42) 
was used to construct phylogenetic trees by using the neighbor-joining algorithm and 
the Kimura two-parameter substitution model. RDP3 software (31) was used to test for 
recombination by the following four methods: an exact nonparametric method (7), sister 
scanning (18), the maximum χ2 method (32), and a likelihood-assisted recombination 
detection method (23). 
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Nucleotide sequence accession numbers 
The sequences of the QRDRs of the isolates studied here were submitted to GenBank 




Characterization of the non-levofloxacin-susceptible population 
Initial screening by disk diffusion identified 47 isolates that were not susceptible to 
levofloxacin (14.9%), and the MICs for these isolates were determined by Etest. The 
MICs determined were not in full agreement with the results of the disk diffusion test. 
Discrepancies were observed for one isolate that was resistant by disk diffusion and that 
had an MIC of 4 μg/mL (intermediate by use of the CLSI criteria) and for an additional 
set of five isolates that were intermediate by the disk diffusion test and that had MICs of 
2 μg/mL (susceptible by use of the CLSI criteria). The results of MIC testing were 
considered definitive for analysis in this work. 
A total of 38 isolates (12.1%) were resistant to levofloxacin (MIC50, >32 μg/mL; 
MIC range, 6 to >32 μg/mL) and 4 isolates (1.3%) expressed intermediate resistance to 
this antibiotic (MIC range, 3 to 4 μg/mL), resulting in a proportion of nonsusceptible 
isolates (MICs > 2 μg/mL) of 13.3%. Among the 30 susceptible isolates chosen for 
sequence analysis, the MIC range was 0.19 to 2 μg/mL. 
Levofloxacin-resistant isolates were recovered from skin and soft tissue infections (n 
= 33), blood (n = 4), and urine (n = 1), while none was found among the 106 isolates 
recovered from the respiratory tract (P < 0.0001, Fisher's exact test). The recovery of 
small numbers of isolates in the first years of the study precluded the calculation of 
annual resistance rates. However, if we consider the data for the time period between 
2003 and 2005, when more than 50 isolates were recovered each year, the rates of 
levofloxacin resistance were 11.4% in 2003 and 8.0% in 2004, and the rate reached its 
highest level (20.2%) in the last year of the study. 
No difference in levofloxacin or ciprofloxacin MICs was observed for the 
nonsusceptible isolates in the presence of reserpine, excluding a role for active efflux in 
resistance in SDE. 
Analysis of the PFGE patterns generated after digestion with SmaI of the 314 isolates 
revealed 12 clusters and 10 unique profiles (SID ± 95% CI, 0.817 ± 0.021). More than 
80% of the isolates were distributed in four large clusters: clusters H88, J77, C56, and E35 
(Table 4.2). Levofloxacin-resistant isolates were present in nine of these PFGE clusters, 
while two isolates had unique profiles (SID ± 95% CI, 0.818 ± 0.101). PFGE cluster I12 
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was the only cluster with more than 10 isolates that did not include any levofloxacin-
resistant isolates. Of the 31 distinct emm types that were found in the overall population 
(SID ± 95% CI, 0.924 ± 0.009), 10 were represented by levofloxacin-resistant isolates 
(SID ± 95% CI, 0.844 ± 0.071) (Table 4.2). stG166b (n = 13) and stG6792 (n = 8) 
accounted for more than half of the nonsusceptible isolates, followed by stG6 (n = 6) 
and stGLP3 (n = 4). stG166b was distributed into two main clusters: one comprised 
only levofloxacin-resistant isolates (grouped in cluster C56 [n = 11]) and the other 
mostly comprised susceptible ones (grouped in cluster J77 [n = 10], which included an 
isolate with intermediate susceptibility to levofloxacin) (Table 4.2). stGLP3 was the 
only emm type exclusively found in nonsusceptible isolates and, together with the 
stG166b resistant isolates, constituted the most significant presence of levofloxacin-
resistant isolates in a single PFGE cluster (PFGE cluster C56; Table 4.2). The other 
resistant isolates were found to be dispersed in the population and were not concentrated 
in a specific PFGE cluster, as illustrated by stG6792 and stG6. 
TABLE 4.2. emm types and distribution of non-levofloxacin-susceptible isolates  
among PFGE clusters 
emm type  
No. of nonsusceptible isolates/no. of susceptible isolates in PFGE cluster
a
:  
C56 H88 J77 B11 F4 E35 K8 L3 D2 Other
b
 Total 
stG166b 11/0 0/1 1
d
/9  




stG6792 0/2 3/28 
  





/2  1/4 2
d
/20  1/1 
 
1/2 





         
4/0 




















0/1 0/2 2/7 












   
0/5 1/9 
stC6979 








 0/30 0/46 0/17 
  
0/8 
   
0/8 0/109 
Total 16/40 4/84 7/70 4/7 3/1 2/33 2/6 1/2 1/1 2/28 42/272 
a PFGE clusters were arbitrarily designated by the use of capital letters and a subscript number, which indicates the 
number of isolates included in the cluster. 
b Other included 3 PFGE clusters that did not contain resistant isolates and 10 unique PFGE profiles (i.e., the sharing 
of less than 80% similarity in the SmaI PFGE profile with that of any other isolate in the collection). This is the case 
for the two resistant isolates listed in this column. 
c Other included 21 emm types that were not found in resistant isolates. Among these, only stC839 (n = 30),   stG10 
(n = 27), and stG62647 (n = 11) comprised more than 10 isolates. 
d One isolate presenting intermediate resistance is included. 
e Two isolates presenting intermediate resistance are included. 
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Phylogenetic analysis of gyrA and parC 
The gyrA and parC QRDR sequences were determined for 56 SDE isolates, 
including 22 isolates that were resistant to levofloxacin (representatives of 10 emm 
types and 11 PFGE clusters), the 4 intermediate isolates, and 30 susceptible isolates, 
including isolates that had the same emm types and that grouped together with resistant 
isolates in the same PFGE clusters. 
The gyrA sequences of the SDE isolates exhibited minimal variation. Only 4 
nucleotide changes were observed across the 399 bp sequenced, resulting in five distinct 
alleles. As these changes occurred at three specific codons and all resulted in amino acid 
replacements, they are all represented in Table 4.3. 
TABLE 4.3. Amino acid substitutions in ParC and GyrA of SDE isolates  












81 85 142 79 83 91 140 166 
gyrA04, parC
c
 S81F   S79F     >32 5 
gyrA04, parC15 S81F   S79F  N91D   >32 5 
gyrA04, parC17 S81F   S79F  N91D P140S  >32 4 
gyrA02, parC17 S81Y   S79F  N91D P140S  >32 1 
gyrA03, parC08  E85K  S79F     >32 1 
gyrA03, parC06  E85K  S79Y     >32 1 
gyrA04, parC09 S81F    D83N    8, 24, >32 3 
gyrA04, parC13 S81F   S79A     12 1 
gyrA03, parC10  E85K   D83G    8 1 
gyrA04, parC14 S81F     N91D   4 1 
gyrA01, parC04    S79F     3 1 
gyrA01, parC17    S79F  N91D P140S  1.5-3 3 
gyrA01, parC19    S79A  N91D P140S  2 1 
gyrA01, parC12        G166E 1 1 
gyrA01, parC03    S79P     0.75 1 
gyrA01, parC
d
      N91D P140S  0.19-0.5 5 
gyrA01, parC14      N91D   0.5-0.75 3 
gyrA05, parC05   D142N      0.38-0.5 4 
gyrA01, parC
e
         0.38-0.75 14 
a A total of 56 isolates with different levels of resistance to levofloxacin were tested.  
b The allele numbers were attributed on the basis of the DNA sequence of the QRDR of each gene. When more than 
one allele that resulted in the same amino acid sequence was found, no number is indicated and the alleles found 
and the number of isolates presenting them are indicated in the subsequent footnotes.  
c For parC04, n = 3; for parC08, n = 2.  
d  For parC16, n = 4; for parC18, n = 1. 
e  For parC01, n = 5; for parC02, n = 3; for parC07, n = 5; for parC11, n = 1. 
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In contrast, multiple point mutations (mostly silent mutations) could be observed in 
the parC sequences of both susceptible and resistant isolates, resulting in 19 distinct 
alleles, which are indicated in Table 4.4. Surprisingly, the parC sequences of the 
majority of the isolates analyzed (33/56, parC01 to parC13 alleles) were more similar 
to the published sequence of S. dysgalactiae subsp. dysgalactiae (GenBank accession 
number AB101472) than to the majority of the SDE parC sequences available to date in 
the GenBank database (GenBank accession numbers AB101473 and EF619597 to 
EF619601) (Fig. 4.1), with the exception of the sequence retrieved from the recently 
released genomic project (GenBank accession number AP010935). 
 
FIGURE 4.1. Neighbor-joining tree for the parC QRDR 
The Streptococcus agalactiae type strain NCTC 8181 parC sequence (GenBank accession number AB101464) was 
used to root the tree. If the percentage of replicate trees in which the associated sequences clustered together in the 
bootstrap test (1,000 replicates) was greater than 75%, the values are shown next to the branches. The tree is drawn to 
scale, with the branch lengths being in the same units as those of the evolutionary distances used to infer the 
phylogenetic tree. The evolutionary distances were computed by the Kimura two-parameter method and are in the 
units of the number of base substitutions per site. Sp, Streptococcus pyogenes; Sde, Streptococcus dysgalactiae subsp. 
equisimilis; Sdd, Streptococcus dysgalactiae subsp. dysgalactiae. Sets of numbers and letters identify the GenBank 
entries whose sequences are identical to the sequences of the alleles found in our collection or the sequences of GAS 
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G A 
parC18 1 C C T T G C A G C G 
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G* G C 
 
G C T* T* G T C C 
  
C G A 
parC19 1 C C T T G C A G C G   C G G*         G* G C   G C T* T* G T C C     C G A 
        a A total of 56 isolates with different levels of resistance to levofloxacin were tested. 
        b Base substitutions that result in amino acid coding changes are indicated by asterisks. Nucleotide and amino acid positions are numbered according to the S. pneumoniae numbering system (36) 
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The parC18 and parC19 alleles were most similar to the parC sequences of GAS 
strains MGAS9429 (GenBank accession number CP000259) and MGAS10270 
(GenBank accession number CP000260). These alleles were found in two Lancefield 
group C isolates of the same emm type (emm type stG62647) and with identical PFGE 
profiles (PFGE cluster J77) and differed only in the Ser-79-Ala (TCC-to-GCC) change 
in parC. The gyrA sequences of both isolates were indistinguishable and represented the 
most frequent gyrA allele (gyrA01) found in the SDE isolates in our collection, in 
agreement with the species identification. 
Phylogenetic trees were built by the neighbor-joining method (Fig. 4.1 and 4.2). The 
tree for parC shows a single branch that gave rise to the majority of SDE parC alleles 
(parC01 to parC13), which were tightly clustered together with a high bootstrap 
support, but also included the more divergent sequence of S. dysgalactiae subsp. 
dysgalactiae (Fig. 4.1). Another branch groups the more diverse GAS alleles, although 
with a lower level of bootstrap support. As expected, the parC18 and parC19 alleles 
(group T3 in Fig. 4.1) of SDE were found within the GAS branch. Two additional 
branches supported by high bootstrap levels were identified (transformant group 1 [T1] 
and T2 in Fig. 4.1, including parC14 to parC17), but they were not clearly grouped with 
either the SDE or the GAS branches. An analysis of the alignment with RDP3 software 
(31) identified two recombination events that could explain the existence of these 
branches. A possible recombination event (T1) between the parC03 and parC18 alleles 
identified by an exact nonparametric method (P = 0.0346) and also supported by the 
sister-scanning method (P = 0.0024) could give rise to both the parC14 and the parC15 
alleles, with the latter allele corresponding to multiple sequences deposited in the 
GenBank database (GenBank accession numbers EF619597 to EF619599). The parC14 
and parC15 alleles differed at a single nucleotide, with one being more prevalent among 
resistant isolates (parC15, S79F amino acid substitution) and the other being more 
prevalent among susceptible isolates (Table 4.4). Another putative recombination event 
(T2) was detected by the maximum χ
2
 method (P = 0.0299) and was confirmed by the 
likelihood-assisted recombination detection method (P = 0.0400) between an GAS 
allele (GenBank accession number CP000260) and parC09. This could explain the 
origins of both parC16 and parC17. Such a recombination event could also explain the 
parC sequences of a number of SDE strains currently deposited in the GenBank 
database (GenBank accession numbers EF619600 to EF619602 and AB101473). 
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Similar to the previously presented putative recombination event, the parC16 allele was 
not found among resistant isolates, while the parC17 allele was found to be associated 
with resistance (S79F amino acid substitution; see below). 
 
FIGURE 4.2. Neighbor-joining tree for the gyrA QRDR 
The Streptococcus agalactiae type strain NCTC 8181 gyrA sequence (GenBank accession number AB101448) was 
used to root the tree. For details on the methods used to construct the tree, see the legend to Fig. 1. Sp, Streptococcus 
pyogenes; Sde, Streptococcus dysgalactiae subsp. equisimilis; Sdd, Streptococcus dysgalactiae subsp. dysgalactiae. 
Sets of numbers and letters identify the GenBank entries whose sequences are identical to the sequences of the alleles 
found in our collection or the sequences of GAS used to construct the tree. 
In the phylogenetic tree for gyrA, all SDE alleles clustered together with high 
bootstrap support (Fig. 4.2). The only gyrA sequence of S. dysgalactiae subsp. 
dysgalactiae available is included in this branch and represents more than 99% 
sequence identity to the SDE alleles. In contrast to the case for parC, the GAS gyrA 
alleles are more distantly related to those of SDE. 
Contribution of mutations to levofloxacin resistance 
Not all the amino acid substitutions observed in the regions of gyrA and parC 
sequenced (4 and 9 amino acid changes, respectively) were exclusively detected in 
resistant isolates, as summarized in Table 4.3. 
All the resistant isolates had amino acid changes within the QRDRs of both gyrA and 
parC compared to the consensus sequence of the susceptible isolates. The Ser-81 
change to Phe (TCT to TTT) in GyrA and the Ser-79 change to Phe (TCC to TTC) in 
ParC were the most common combinations observed in resistant isolates (n = 14). These 
could also be accompanied by other changes in ParC and invariably resulted in an MIC 
of >32 μg/mL. These two amino acid changes were also the most widespread in 
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nonsusceptible isolates, and both appeared in combination with other amino acid 
changes (Table 4.3). Ser-81-Tyr and Glu-85-Lys in GyrA and Ser-79-Tyr, Ser-79-Ala, 
Asp-83-Asn, and Asp-83-Gly in ParC were other amino acid substitutions found among 
resistant isolates and thought to contribute to resistance. The level of levofloxacin 
resistance achieved was dependent on the combination of the GyrA and ParC amino 
acid changes present in each isolate (Table 4.3). A single set of three isolates that shared 
the Ser-81-Phe and Asp-83-Asn substitutions in GyrA and ParC, respectively, displayed 
significantly variable MIC results (range, 8 to >32 μg/mL). 
In contrast to the double mutations described above, a single amino acid change in 
ParC resulted in intermediate resistance to levofloxacin or in slightly increased MICs in 
susceptible strains (0.5 to 3 μg/mL). An intermediately resistant isolate with an MIC of 
4 μg/mL was also the only one to have a mutation in the GyrA QRDR but no mutations 
in ParC. Common to both susceptible and resistant isolates were the Asn-91-Asp (AAT 





A surprising finding in our work was the high overall rate of resistance to 
levofloxacin (12%). The only previous study that specifically addressed this problem 
(5) found that the rate of resistance to levofloxacin was less than 1% among GGS and 
GCS in a collection of isolates recovered in both Europe and North America. Portugal is 
the European country where FQs are more widely used (19), and their sustained use has 
been implicated in selection for resistance (24). Differences in consumption could thus 
be a major factor conditioning geographic differences in FQ resistance. 
Several mechanisms have been implicated in bacterial resistance to quinolones. The 
existence of plasmids carrying specific genes that confer increased resistance to this 
class of antimicrobials was recently described in the Enterobacteriaceae family (39). 
However, this resistance mechanism has thus far not been found in Gram-positive cocci, 
in which the increased expression of multidrug resistance pumps and alterations of the 
fluoroquinolone targets are the major mechanisms of quinolone resistance (24, 30). 
Similar to what was described in other streptococci, in vitro studies with GAS, a closely 
related species, have implicated alterations in the QRDRs of gyrA and parC as the 
primary mechanism of the loss of susceptibility to fluoroquinolones (6). Studies with 
Streptococcus pneumoniae showed that the transformation of a susceptible strain with 
the QRDRs of these genes from a resistant strain was sufficient to confer resistance 
(43). Taken together, these findings indicate that alterations of the QRDRs of gyrA and 
parC are necessary and sufficient for the development of quinolone resistance in 
streptococci. We found no evidence of efflux-mediated resistance to levofloxacin in 
SDE, similar to what was described in GAS (30, 38), indicating that this resistance 
mechanism is not widespread in beta-hemolytic streptococci and leaving the alterations 
in the quinolone targets as the sole and most probable mechanism of resistance. 
The levofloxacin-resistant isolates presented a variety of emm types, comparable to 
that observed for the entire collection, and they were distributed in several PFGE 
clusters, indicating a polyclonal origin of resistance. It is known from epidemiological 
studies of GAS that some resistant lineages predominate, although mutational 
alterations can also be observed in diverse genetic backgrounds (1, 29). For instance, the 
ciprofloxacin-resistant lineage of GAS carrying the emm6 allele is disseminated in 
distinct geographic regions, such as Spain (1), Belgium (29, 30), and the United States 
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(35). In our collection, we could also identify a PFGE cluster (PFGE cluster C56) that 
was significantly associated with resistance to levofloxacin (P = 0.0009, Fisher's exact 
test), and only two of the emm types found in this cluster (emm types stG166b and 
stGLP3) presented resistant isolates. This suggests that stable levofloxacin-resistant 
lineages also exist in SDE. However, the latter did not dominate among the 
levofloxacin-resistant SDE isolates recovered in Portugal. When we tested if the high 
rate of resistance found in the last year of the study could have been caused by an 
outbreak of a single clone, we verified that this was not so, since the isolates recovered 
in 2005 were a heterogeneous population (seven emm types and nine PFGE clusters). 
Among the streptococci, horizontal gene transfer involving the QRDRs of the FQ 
target genes was first described for S. pneumoniae and members of the viridans group 
streptococci (3, 16). More recently, the parC QRDRs of GAS were also shown to 
present sequence polymorphisms (35), and these observations have been the basis for 
the suggestion of the occurrence of horizontal gene transfer events in this species (14, 
38), with S. dysgalactiae acting as the donor. S. dysgalactiae subsp. dysgalactiae was 
suggested to be the most likely source of DNA by Duesberg et al.. (14). However, such 
conclusions have been hampered by the lack of SDE parC sequences, as only one parC 
sequence of an SDE isolate was publicly available and was found in the GenBank 
database (GenBank accession number AB101473) at the time of these studies. S. 
dysgalactiae subsp. dysgalactiae is mainly a pathogen of animals and, contrary to the 
case for SDE, does not usually infect humans (8, 15). No other reservoir for GAS 
besides the human host is known, making it unlikely that situations favoring gene 
exchange with S. dysgalactiae subsp. dysgalactiae would arise. Thus, SDE would seem 
to be a more suitable candidate that engages in genetic exchange with GAS, as they can 
share ecological niches in the human host. Previous studies have documented the 
existence of bacteriophages capable of the in vitro transduction of chromosomal 
markers from GAS to GCS (12), as well as from GCS to GAS (44), providing a 
mechanism that could mediate genetic exchange between these two species. In 
agreement with the findings of previous studies, our results support the acquisition of 
GAS DNA by SDE (25). The SDE parC18 and parC19 alleles cluster within the GAS 
branch, but the gyrA alleles of the isolates in which the parC alleles were found were 
characteristic of those of SDE. Taken together, these data strongly suggest that 
substitution of the entire QRDR of parC occurred in these isolates, through 
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recombination with GAS DNA. The parC14 to parC17 alleles resulted from 
recombination within the QRDR with GAS alleles, with DNA stretches characteristic of 
both species being retained (Fig. 4.3). Interestingly, the QRDR of the parC sequence 
first available in the GenBank database for SDE seems to have also resulted from 
recombination, a fact that may have confounded previous analyses that led to the 
suggestion that S. dysgalactiae subsp. dysgalactiae could have been the donor species 
for recombination with GAS. Our data support the ecologically more plausible 
hypothesis that gene exchange between SDE and GAS is more frequent than that 
between S. dysgalactiae subsp. dysgalactiae and GAS. Horizontal transfer within SDE 
may also be ongoing, since the same QRDR polymorphisms were found among distinct 
lineages, i.e., isolates belonging to different PFGE clusters and with distinct emm types 
(data not shown). No recombination events between SDE and GAS were detected in the 
gyrA QRDR. A greater divergence between these species at this locus could explain this 
observation, since sequence divergence is a major barrier to gene exchange (28). 
 
FIGURE 4.3. Diagram of the QRDRs of gyrA and parC in isolates 
showing recombination events 
The box on the left represents the gyrA QRDR, while that on the right represents the parC QRDR. White boxes 
represent regions that are characteristic of SDE, while black boxes represent regions characteristic of GAS. Each 
allele combination represents the sequences resulting from the putative recombination events indicated in Fig. 4.1 (T1 
to T3). Recombination breakpoints were determined by the maximum χ
2 method implemented in RDP3 software, 
refined by visual inspection of the sequences (Table 4.4). 
All recombination events detected included both susceptible and resistant 
recombinants, indicating that there was not a strict relationship between recombination 
with foreign DNA and resistance and raising the possibility that the mutations 
conferring levofloxacin resistance occurred subsequent to DNA acquisition. In fact, the 
quinolone resistance-defining mutations have probably arisen independently in multiple 
strains sharing the same mosaic parC genes. If this scenario proves to be true, the 
expansion of levofloxacin resistance among SDE isolates occurs mostly through vertical 
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transmission and not through horizontal dissemination. Still, although our study was not 
designed to evaluate the frequency of recombination, we did identify a high proportion 
of recombinant QRDRs (n = 23/56 [41%] isolates), suggesting that recombination is 
frequent and ongoing. 
Among our collection we could identify several pairs of levofloxacin-resistant and -
susceptible isolates that shared the same emm type or SmaI profile, allowing us to 
investigate more closely the origin of levofloxacin resistance in these isolates. Only 
when mutations were concomitantly present in gyrA and parC were the isolates 
levofloxacin resistant. Changes to phenylalanine in Ser-81 in GyrA and Ser-79 in ParC 
were the most important in the acquisition of levofloxacin resistance in terms of both 
the frequency of occurrence and the level of resistance achieved, while mutations of 
only one of these amino acids predominated in isolates with reduced susceptibility. Our 
data support the hypothesis that the target for first-step mutations in SDE is mainly 
ParC, as previously observed in other streptococci (34). A few groups of isolates with 
the same QRDR alleles showed some MIC variations, but most values were within a 1-
dilution interval. 
Isolates presenting high-level resistance to fluoroquinolones were described among 
different species of beta-hemolytic streptococci, but only one previous work described 
the mutations present in SDE leading to fluoroquinolone resistance (5). The amino acid 
substitutions found to be present in the FQ-resistant isolates among our isolates 
recovered in Portugal resulted from changes in the same relative positions in GyrA (Ser-
81, Glu-85) and ParC (Ser-79, Asp-83), as was the case with the changes described in 
other beta-hemolytic streptococcal species (5, 26). The Ser-79-Ala, Ser-79-Tyr, Asp-83-
Gly, and Asp-83-Asn modifications, all in ParC, were not previously described in SDE. 
Quinolone resistance in SDE was mediated by alterations in ParC and GyrA and not 
by efflux, similar to the situation in GAS. Sequence polymorphisms not related to FQ 
resistance are common in the parC QRDR of S. dysgalactiae subsp. equisimilis; in 
contrast, the QRDR sequence of gyrA is highly conserved. Our data question the 
previously proposed role of S. dysgalactiae subsp. dysgalactiae as a donor for the 
mosaic structures found in GAS (14) and support the more plausible explanation that 
the exchanges occur with SDE isolates that share ecological niches with GAS. A close 
proximity between strains of the two species would afford bacteriophages the 
opportunity to transduce the genetic information between them. The high proportion of 
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recombinant sequences identified supports the occurrence of frequent genetic exchanges 
between the two species that do not seem to be driven exclusively by antimicrobial 
usage. 
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ABSTRACT 
Streptococcus canis is an animal pathogen that occasionally causes human infections. 
Isolates recovered from infections of animals (n = 78, recovered from 2000 to 2010 in 
three European countries, mainly from house pets) and humans (n = 7, recovered from 
2006 to 2010 in Portugal) were identified by phenotypic and genotypic methods and 
characterized by antimicrobial susceptibility testing, multilocus sequence typing 
(MLST), pulsed-field gel electrophoresis (PFGE), and emm typing. S. canis isolates 
presented considerable variability in biochemical profiles and 16S rRNA. Resistance to 
antimicrobial agents was low, with the most significant being tet(M)- and tet(O)-
mediated tetracycline resistance. MLST analysis revealed a polyclonal structure of the 
S. canis population causing infections, where the same genetic lineages were found 
infecting house pets and humans and were disseminated in distinct geographic 
locations. Phylogenetic analysis indicated that S. canis was a divergent taxon of the 
sister species Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis 
(SDE) and found evidence of acquisition of genetic material by S. canis from SDE. 
PFGE confirmed the MLST findings, further strengthening the similarity between 
animal and human isolates. The presence of emm-like genes was restricted to a few 
isolates and correlated with some MLST-based genetic lineages, but none of the human 
isolates could be emm typed. Our data show that S. canis isolates recovered from house 
pets and humans constitute a single population and demonstrate that isolates belonging 
to the main genetic lineages identified have the ability to infect the human host, 




Streptococcus canis is a Lancefield group G beta-hemolytic streptococcal species 
which is mainly found as an animal colonizer and pathogen. This member of the large-
colony-forming Lancefield group C and G streptococcus (GCGS) group (1) was 
officially established as a distinct taxon in 1986 (2), following previous studies which 
showed that the Lancefield group G streptococci isolated from animals and humans 
were biochemically divergent and could represent distinct species (3). Although S. canis 
can be part of the female reproductive tract and the tonsillar and ear microbiota of cats 
and dogs (4–7), it is also an important pathogen for these two species and infects a wide 
range of other domestic and wild animals (2, 8–10). S. canis is the most common 
streptococcal species found in dog infections (11), being identified in cases of 
dermatitis, otitis externa, pneumonia, infective endocarditis, and adult septicemia (6, 11, 
12). This species has also been implicated in fetal or neonatal septicemia, leading to 
abortion or neonatal death, respectively (2, 11), and in both canine and feline 
necrotizing fasciitis and streptococcal toxic shock syndrome (13, 14). S. canis may be 
transmitted between different animal species living in proximity (15) and has been 
responsible for outbreaks of clinical and subclinical mastitis with bacterial shedding in 
milk in cattle herds (16, 17) and in pets living in shelters (14). However, little is known 
about the genetic diversity of S. canis, namely, if there are clones particularly adapted to 
the different animal species. 
The prevalence of S. canis in human infections remains unclear. The first confirmed 
report of human infection was published in 1997 and consisted of a case of septicemia 
in a 77-year-old man (18). In the last few years, a better awareness of S. canis has led to 
an increasing number of reports in the literature (19–23). S. canis has mainly been 
isolated from cases of bacteremia (18, 19, 23) and skin and soft tissue infections (20, 
21). Some of these studies indicated that contact of pets with patients' wounds and 
ulcers would be the most likely portal of entry (18, 21), and one report identified the 
same S. canis strain in a dog and its owner's blood cultures following a bite (22). These 
observations, together with its wide occurrence in animal hosts, led to the perception 
that S. canis is an occasional zoonotic agent, while the majority of Lancefield group G 
streptococcal infections in humans are due to Streptococcus dysgalactiae subsp. 
equisimilis (SDE). 
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S. canis isolates can be distinguished from group G SDE by biochemical and 
molecular tests (23–25). The analysis of 16S and 23S rRNA sequences and that of other 
housekeeping genes also allows the distinction between these two taxa (17, 23) and 
shows a close genetic relationship of both to another beta-hemolytic streptococcal 
species, namely, Streptococcus pyogenes (Lancefield group A streptococcus [GAS]) 
(26). Inter- and intraspecies differentiation of S. canis isolates may also be achieved by 
using various typing methods. Macrorestriction profiling using pulsed-field gel 
electrophoresis (PFGE) has been extensively used to characterize animal and human 
streptococci, including S. canis (13, 22, 27). emm typing, a technique relying on 
sequence analysis of the M-protein gene developed for GAS and also applicable to SDE 
(http://www.cdc.gov/ncidod/biotech/strep/M-ProteinGene_typing.htm), has also been 
employed (19, 23). More recently, a multilocus sequence typing (MLST) scheme has 
been proposed to characterize both SDE and S. canis, but it was unsuccessful in typing 
all S. canis isolates (26). 
The aim of the current work was to characterize a collection of S. canis isolates 
recovered from animals (mainly house pets) and humans. The molecular typing of these 
isolates allowed us to define the clonal structure of the S. canis population and to 
directly compare isolates from different hosts. The current study describes the first 
MLST analysis of S. canis from nonhuman sources and expands considerably the 
known diversity of MLST alleles and sequence types (STs) for this species. 
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MATERIALS AND METHODS 
Bacterial isolates 
A total of 85 S. canis clinical isolates which were recovered from house pets (n = 
77), humans (n = 7), and a horse (n = 1) were studied (Table 5.1). Animal isolates were 
recovered at the Faculty of Veterinary Medicine of the Technical University of Lisbon, 
Lisbon, Portugal (n = 48, isolated between 2001 and 2007), the Institute of 
Microbiology and Epizootics, Veterinary Faculty, Freie Universität Berlin, Berlin, 
Germany (n = 29, isolated between 2000 and 2010), and the University of Camerino, 
Matelica, Italy (n = 1, isolated in 2007). Companion animals were individually owned, 
and no epidemiologic relationship was evident upon admission to the collecting 
laboratory. The seven human isolates were collected during an ongoing nationwide 
study of human large-colony-forming GCGS infections in Portugal between 2006 and 
2010 in six distinct hospital laboratories. No information on patient contact with 
animals was recorded. The S. canis type strain DSM 20715, isolated from a case of 
bovine mastitis (2), was also analyzed by MLST, PFGE, and emm typing for 
comparison purposes. 
TABLE 5.1. Distribution of the 85 S. canis clinical isolates studied 
by source, origin, and geographic location 
Source 
No. of isolates by origin and geographic location
a









P G I   P G I   P G I   P G I   
Ear exudate 27 1 
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29 
Skin and soft tissue exudate 5 4 
  
1 6 
      
1 
   
17 
Urine 14 










          
4 
   
6 
Respiratory tract secretions 
 
2 
          
2 










             
2 
Gastrointestinal sample 
         
1 





              
1 
Total 46 22 1   2 6       1     7       85 
 
a P, Portugal; G, Germany; I, Italy. 
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Species identification 
The Lancefield group was confirmed by a commercial latex agglutination technique 
(Slidex Strepto kit; bioMérieux, Marcy l'Etoile, France). Beta-hemolysis and colony 
size were confirmed in tryptic soy agar (Oxoid, Hampshire, England) supplemented 
with 5% (vol/vol) defibrinated sheep blood, after overnight incubation at 37°C. 
Species identification was obtained by biochemical and genotypic methods. All 
isolates were identified by using the API 20 Strep system (bioMérieux, Marcy l'Etoile, 
France) and by applying a PCR targeting 23S rRNA to differentiate S. canis from SDE 
(25), which can also present the Lancefield group G antigen. Briefly, primers dysF (5′-
GCGACATGGGACTTTAAAAGG-3′) and canR (5′-
CTCCTACCATTACCTCTTAAGGTA-3′) were used to amplify a 924-bp fragment of 
the S. canis 23S rRNA gene. PCR conditions were identical to those previously 
described (25). 
The 16S rRNA of over one-third of the S. canis isolates in our collection was 
amplified and sequenced with previously described primers and conditions (28). The 
group selected included isolates for which the API profiles presented a confidence of 
identification below 99% (according to the manufacturer's literature) and isolates 
representing different MLST groups. 
Antimicrobial susceptibility testing and genotype determination 
Testing for susceptibility to penicillin, cefotaxime, erythromycin, clindamycin, 
tetracycline, chloramphenicol, levofloxacin, vancomycin, quinupristin-dalfopristin, and 
linezolid was performed by disk diffusion according to CLSI guidelines for beta-
hemolytic streptococci (29). High-level resistance to gentamicin and streptomycin was 
screened by using the CLSI recommendations for Enterococcus spp. (29). MICs for 
macrolide- and aminoglycoside-resistant isolates were determined using Etest strips 
(bioMérieux, Marcy l'Etoile, France) according to the manufacturer's instructions and 
CLSI interpretative criteria (29). A multiplex PCR scheme was used for the 
amplification of erm(A) [subclass erm(TR)], erm(B), and mef(A/B), conferring 
resistance to macrolides (30). The tetracycline resistance determinants tet(M), tet(O), 
tet(L), and tet(K) were detected using a multiplex PCR scheme (31). Primers for the 
tet(S) gene (32) were also included. The aadA and aadE genes, conferring resistance to 
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streptomycin but not to gentamicin, were amplified using the primers described by 
Clark et al. (33). 
MLST 
S. canis isolates were tested with a set of seven primer pairs previously described for 
the MLST characterization of this species and SDE (26). We found that most S. canis 
isolates failed to yield a PCR product for the xpt gene using these primers, in 
accordance with the previous observation that an xpt gene could not be amplified from 
all S. canis isolates (26). Primers Xptgc-up (5′-TTACTTGAAGAACGCATCTTA-3′) 
and Xptgc-dn (5′-ATGAGGTCACTTCAATGCCC-3′), designed for SDE in a distinct 
study (34), were used instead for amplification and sequencing of this locus. The 
sequences obtained were trimmed to cover the same region of the xpt gene reported 
previously (26), and alleles identical to those described earlier were determined for 
some isolates, indicating that the same locus is targeted by using both primer sets, as 
observed for SDE (34). 
Unique sequences at each locus were assigned allele numbers. The combination of 
the seven allele numbers for each isolate was used to define the ST. ST assignment was 
done following the numbering started by Ahmad et al.. for human invasive isolates 
recovered in the United States (26). Data for three of these isolates were included in the 
analysis (corresponding to ST2 to ST4). The ST1 isolate in the North American study 
failed to yield a PCR product for the xpt gene, so it was excluded from the current 
analysis. ST1 in our study was assigned to the ST that shared all other six alleles with 
that isolate. The MLST data for S. canis strain FSL Z3-227 were extracted from the 
genome shotgun sequence assemblies obtained from GenBank (accession numbers 
AIDX01000001 to AIDX01000003) (35) and also included in the analysis. Strain FSL 
Z3-227 was isolated in an outbreak of bovine subclinical mastitis in the United States 
(15). The goeBURST algorithm (36) implemented in PHYLOViZ software (37) was 
used to establish relationships between STs. Clonal complexes (CCs) were defined at 
the single-locus-variant (SLV) and double-locus-variant (DLV) levels. 
Phylogenetic analysis of the 16S rRNA and MLST loci 
Sequence alignments were performed manually. The MEGA (version 5) program 
(38) was used to construct trees by using the neighbor-joining algorithm and the Kimura 
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two-parameter substitution model. Branch support was tested by 1,000 replicate 
bootstrap tests in each analysis. The 16S rRNA gene sequences of the type strains S. 
canis DSM 20715 (GenBank accession number DQ303184), SDE CIP105120 
(GenBank accession number DQ232540), S. dysgalactiae subsp. dysgalactiae ATCC 
43078 (GenBank accession number AB002485), S. agalactiae ATCC 13813 (GenBank 
accession number DQ303183), and S. suis ATCC 43765 (GenBank accession number 
DQ303193) were used for comparison. The closest match to the 16S rRNA gene of the 
GAS type strain allowing comparison to the 1,435 bp analyzed was selected for 
construction of the tree (GenBank accession number CP003068). MLST sequence data 
from GAS and SDE used for the phylogenetic comparison with S. canis loci were 
obtained from the respective MLST databases (http://www.mlst.net/). The yqiZ (also 
called atoB) (34) gene used in the SDE MLST scheme and the yqiL gene used for GAS 
are distinct loci and were excluded when concatenating the internal fragments of the 
genes used in MLST. 
PFGE and emm typing 
Isolates were characterized by PFGE macrorestriction profiling and by emm typing 
as previously described (28). Briefly, PFGE patterns generated after SmaI (Fermentas, 
Vilnius, Lithuania) digestion were compared by using Bionumerics software (Applied 
Maths, Sint-Martens-Latem, Belgium) to create dendrograms by the unweighted-pair 
group method with arithmetic means (UPGMA). The Dice similarity coefficient was 
used with optimization and position tolerance settings of 1.0 and 1.5, respectively. 
Clusters were defined as groups of isolates (n ≥ 2) presenting profiles ≥80% related on 
the dendrogram (28). Characterization by emm typing was carried out with the primers 
and conditions available at http://www.cdc.gov/ncidod/biotech/strep/protocol_emm-
type.htm. 
Statistical analysis 
The diversity of the classifications and the congruence of the results obtained by 
PFGE and MLST were quantitatively evaluated by calculating Simpson's index of 
diversity (SID) (39) and the adjusted Wallace (AW) coefficient (40) with 95% 
confidence intervals (CIs). All calculations were done using the Comparing Partitions 
website (http://darwin.phyloviz.net/ComparingPartitions/). 
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Nucleotide sequence accession numbers 
The sequences of the 16S rRNA and MLST alleles found in the isolates studied here 
were submitted to GenBank under accession numbers JX876612 to JX876641. The 
sequence of the novel emm type stG1451 was submitted to GenBank (accession number 
KC291148) and to the CDC database (http://www.cdc.gov/ncidod/biotech/strep/M-
ProteinGene_typing.htm). An online database using the BIGSdb platform (40a) and 
containing the data reported in this paper is available at http://pubmlst.org/scanis/. 
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RESULTS 
Phenotypic and genotypic identification of S. canis isolates 
All isolates were beta-hemolytic and carried the Lancefield group G polysaccharide. 
The API 20 Strep system identified all but one isolate as S. canis. Among the 26 distinct 
biochemical profiles that were found with this system, 21 (n = 81 isolates, including the 
type strain DSM 20715) corresponded to S. canis with a confidence of ≥99% according 
to the manufacturer's literature, while for 4 isolates it ranged from 87.6% to 97.6%. 
Only one isolate had a profile not consentaneous with S. canis, being identified as group 
L streptococcus with 86.0% confidence (API 20 Strep profile 2673415). 
All isolates yielded a PCR product of the expected size for S. canis in the 23S rRNA 
PCR assay, while an SDE control isolate was negative (data not shown). Sequence 
analysis of the 16S rRNA gene revealed the presence of nine distinct 16S rRNA alleles 
among the 30 isolates chosen for analysis, with differences being observed in 8 
positions across the 1,435 bp examined. A tree built using the neighbor-joining method 
for the 16S rRNA gene (Fig. 5.1) showed a single branch that gave rise to all the S. 
canis alleles (SC1 to SC9). The S. canis type strain DSM 20715 16S rRNA sequence 
(GenBank accession number DQ303184) (41) is identical to the sequence of the SC5 
allele found in the isolates characterized in this work. The closest relative in the tree to 
the S. canis alleles was the GAS sequence used for comparison, which differed by 28 bp 
(98% identity) from the sequences of the SC2 and SC3 alleles. The single isolate 
identified as group L streptococcus by the API 20 Strep system had the SC6 allele, 
together with another five isolates belonging to the same genetic lineage (see below). 
The GenBank accession numbers of the 16S rRNA gene sequences determined in the 
current study are given in Table S5.1 in the supplemental material. 
Antimicrobial susceptibility 
All isolates were susceptible to penicillin, cefotaxime, chloramphenicol, 
levofloxacin, vancomycin, quinupristin-dalfopristin, linezolid, and gentamicin. 
Tetracycline resistance was expressed by 23 isolates (27%) and 5 showed intermediate 
resistance, as determined by disk diffusion. Two tetracycline-resistant isolates were also 
resistant to macrolides and streptomycin (but not to gentamicin). Both isolates presented 
a macrolide, lincosamide, and streptogramin B (MLSB) constitutive resistance 
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phenotype with MICs to erythromycin and clindamycin of >256 μg/ml, and they had 
MICs to streptomycin and gentamicin of >1,024 μg/ml and 3 μg/ml, respectively. 
 
FIGURE 5.1. Neighbor-joining tree of the 16S rRNA 
The Streptococcus suis type strain ATCC 43765 16S rRNA sequence (GenBank accession number DQ303193) was 
used to root the tree. Branches clustering sequences with greater that 75% bootstrap support (1,000 replicates) are 
indicated. The tree is drawn to scale, with branch lengths corresponding to the number of base substitutions per site. 
S. canis alleles determined in this work are named SC1 to SC9. GenBank entries whose sequences were used to 
construct the tree are indicated in parentheses. The number of S. canis isolates presenting a given allele is indicated in 
brackets. SC, S. canis; SDD, S. dysgalactiae subsp. dysgalactiae; SDE, S. dysgalactiae subsp. equisimilis; SA, S. 
agalactiae; GAS, S. pyogenes. 
The tet(M) and tet(O) genes were the sole determinants carried by 11 and 8 
tetracycline-resistant isolates, respectively. One isolate simultaneously carried the 
tet(M) and tet(L) genes, and another one was positive for the tet(L) and tet(S) genes. 
Two resistant isolates were negative for all genes tested in this work, as were all the five 
isolates with intermediate resistance. The two isolates that were simultaneously resistant 
to tetracycline, macrolides, and streptomycin were tet(O) positive and carried the 
erm(B) and aadA genes. These isolates were recovered in 2004 and 2005 from dogs in 
Portugal, and they were clonally related, belonging to ST9 and being found in PFGE 
cluster B20 (see below). The remaining tetracycline-resistant isolates were found to be 
associated with various STs and PFGE clusters, including the main genetic lineages 
found among susceptible isolates. 
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S. canis clonal relationships inferred by MLST 
The novel MLST scheme proposed here enabled us to successfully characterize all S. 
canis isolates. Twenty-four STs (SID ± 95% CI, 0.887 ± 0.044) were found among the 
86 isolates characterized in our study, from which 22 were novel STs (ST1 and ST5 to 
ST25). The number of alleles ranged from 5 (for murI, mutS, and yqiZ) to 9 (for gki and 
xpt). All alleles previously described in isolates recovered from human infections in the 
United States (26) were also present in isolates from house pets characterized in the 
current study, except for the recP3 allele (GenBank accession number FJ238476), 
which was found solely in ST4. The numbering of the S. canis alleles found at the 
different loci and respective GenBank accession numbers are given in Table S5.1 in the 
supplemental material. The MLST data used in the current work are given in Table S5.2 
in the supplemental material. 
The goeBURST analysis of all 90 isolates that have been characterized by MLST to 
date (including the three isolates characterized previously and the S. canis FSL Z3-227 
isolate for which MLST data were obtained from the genome sequence project) revealed 
that 17 STs were grouped into 5 CCs defined at the SLV level, while 8 STs were 
singletons (i.e., had no SLVs in the data set) (SID ± 95% CI, 0.804 ± 0.053) (Fig. 5.2). 
At the DLV level, 5 CCs and 3 singletons could be identified (SID ± 95% CI, 0.752 ± 
0.054). All STs had at least one triple-locus-variant (TLV) in the data set, except for 
ST25, which shared no more than one allele with any other ST. The isolate having ST25 
had unique gki, gtr, mutS, recP, and yqiZ alleles. This isolate also had a unique 16S 
rRNA sequence (allele SC9 in Fig. 5.1) and was recovered from a cat in Germany. ST9 
(n = 24), ST13 (n = 13), and ST1 (n = 11) were the most frequent STs in isolates from 
both Portugal and Germany and together accounted for more than half of the isolates. 
These STs were identified as the putative founders of the CCs in which they were 
included (Fig. 5.2). ST9 included the S. canis type strain DSM 20715 and the FSL Z3-
227 isolate (both recovered from bovine mastitis), as well as five of the seven human 
isolates recovered in Portugal, and was the most frequent ST recovered from house pets 
in both geographic locations, including six of the eight cat isolates analyzed (Table 5.2). 
The single horse isolate analyzed presented ST10, a SLV of ST9. ST9 is also a SLV 
from ST3 detected in invasive infections in United States (26). Two additional human 
isolates characterized in this study represented ST12 and ST14. These STs did not share 
any allele with ST9 and were each other's SLVs, as well as the SLV of ST4, exclusively 
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recovered from a human infection in the North American study (26). With the exception 
of ST4, all S. canis STs found in human isolates were also found among isolates from 
house pets (Fig. 5.2A). 
 
 
FIGURE 5.2. goeBURST diagram of the relationships between 90 S. canis isolates 
recovered from animal and human infections in distinct geographic locations 
The size of each circle is proportional to the number of isolates with that particular ST on a logarithmic scale. STs 
assigned to the same CC at the SLV level are linked by straight lines. Whenever isolates of the same ST were 
recovered from different hosts (A) or from more than one location (B), the number of isolates with the same 
characteristic is proportional to the respective color. Putative CC founders are identified by a light green line. 
ST9, ST2, and ST3 found in human isolates were also detected in house pets in both 
Portugal and Germany (Fig. 5.2B). The CCs formed included isolates from both 
Portugal and Germany, and only CC11, which included the smaller number of isolates 
(n = 3), was an exception. Three of the singletons were also found in the two countries. 
The isolates previously reported from the United States, as well as the single isolate 
recovered from Italy and the S. canis type strain, were distributed into the main CCs. No 
geographic segregation was evident from the goeBURST analysis. 
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TABLE 5.2. Distribution of PFGE clusters, emm types, and isolate origin  
among MLST STs and CCs 
ST  
(no. of isolates) 
CC
a









(no. of isolates) SLV DLV 




10 (1) 9 9 B20 (1) NT (1) Horse (1) 
3 (3) 9 9 C10 (3) NT (3) Dog (3) 
23 (2) 9 9 C10 (2) NT (2) Dog (2) 
16 (3) S 9 C10 (2), B20 (1) NT (3) Dog (2), cat (1) 
22 (1) S 9 G2 (1) NT (1) Dog (1) 
13 (13) 13 13 H25 (13) NT (13) Dog (13) 
14 (4) 13 13 H25 (4) NT (4) Dog (3), human (1) 
12 (2) 13 13 H25 (2) NT (2) Dog (1), human (1) 
17 (2) 13 13 H25 (2) NT (2) Dog (2) 
11 (2) 11 13 H25 (2) NT (2) Dog (2) 
8 (1) 11 13 H25 (1) NT (1) Dog (1) 
2 (3) 2 2 J6 (2), I2 (1) NT (3) Dog (3) 
6 (1) 2 2 J6 (1) NT (1) Dog (1) 
7 (1) 2 2 J6 (1) NT (1) Dog (1) 
18 (2) 2 2 J6 (2) NT (2) Dog (2) 
1 (11) 1 1 A5 (5), E2 (2), F2 (2),  
B20 (1), up (1) 
stG1389 (11) Dog (11) 
24 (1) 1 1 up (1) stG1389 (1) Dog (1) 
21 (4) S 21 L3 (3), G2 (1) NT (3), stG1451 (1) Dog (4) 
15 (1) S 21 H25 (1) NT (1) Dog (1) 
20 (1) S 21 I2 (1) stG1451 (1) Dog (1) 
19 (2) S S D5 (2) NT (2) Dog (2) 
5 (1) S S K2 (1) stG663 (1) Dog (1) 
25 (1) S S K2 (1) NT (1) Cat (1) 
    a CCs are identified by the identified putative founder. S, singleton.  
    b PFGE clusters are designated as indicated in the legend to Fig. 5.5A. up, unique profile.  
    c NT, nontypeable.  
    d S. canis type strain DSM 20715. 
Phylogenetic analysis of S. canis 
A tree was built by the neighbor-joining method for six concatenated loci and for the 
individual loci with the common data available for S. canis, SDE, and GAS. The 
concatenated sequences from each of the three species were clearly separated in 
branches with high bootstrap support (Fig. 5.3). In contrast to the 16S rRNA analysis 
(Fig. 5.1), this analysis identifies S. canis as a more divergent clade and SDE and GAS 
as more closely related. The majority of S. canis sequences were grouped together in a 
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branch with 99% support from which two branches diverged, one containing STs 20 
and 21 and another with the more divergent ST25 (noted before for having unique 
alleles at five loci).  
 
FIGURE 5.3. Neighbor-joining unrooted tree of concatenated sequences of the six 
common genes used in S. canis, SDE, and GAS MLST schemes 
The tree was built with the methods indicated in Materials and Methods. S. canis STs are indicated ST1 to ST25. The 
concatenated STs from the two comparator species were obtained from the respective databases 
(http://www.mlst.net/) and consisted of 80 STs for S. dysgalactiae subsp. equisimilis and 27 STs for GAS (the group 
founders of CCs with at least five STs). A total of 2,700 bp for each sequence type was used in constructing the tree. 
Trees were also built for the individual loci. A single branch with high bootstrap 
support (≥99%) containing only S. canis alleles was observed in the trees for all loci, 
independent of the overall tree topology, which was variable and showed S. canis alleles 
to be either more closely related to the alleles of GAS than to those of SDE (gki, gtr, 
and murI) or an outgroup of these two species (mutS, recP, and xpt). The gki and recP 
trees are shown as an example in Fig. 5.4 (see Fig. S5.1 in the supplemental material for 
the remaining trees). No S. canis alleles were shared with SDE or GAS, but two alleles, 
gki7 and recP7, were divergent from all other S. canis alleles and were more similar to 
SDE alleles. The gki7 allele had a 16-bp difference of the SDE gki10 allele (97% 
identity), while sharing no more than 91% identity to any of the other S. canis alleles 
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(Fig. 5.4A). This allele was found in isolates of ST20 (n = 1) and ST21 (n = 4) noted 
above for their presence in a divergent branch. The recP7 allele was also divergent from 
S. canis alleles, being almost identical to SDE recP alleles 12 (2-bp difference) and 13 
(3-bp difference) across the 459-bp fragment of the recP gene used for analysis (Fig. 
5.4B). S. canis recP7 was exclusively found in the isolate of ST25. 
 
FIGURE 5.4. Neighbor-joining unrooted trees of gki (A) and recP alleles (B)  
of S. canis, SDE and GAS 
The trees were built with the methods indicated in Materials and Methods. gki alleles are indicated SC gki1 to SC 
gki9, and recP alleles are indicated SC recP1 to SC recP7. The gki and recP sequences from the two comparator 
species were obtained from the respective databases (http://www.mlst.net/). The divergent S. canis gki7 and recP7 
alleles are highlighted in the respective trees. 
Diversity among S. canis isolates 
Analysis of the PFGE patterns generated after digestion with SmaI revealed the 
presence of 12 clusters and two isolates with unique profiles (SID ± 95% CI, 0.842 ± 
0.047) (Fig. 5.5A). The two larger PFGE clusters identified, H25 and B20, correlated 
with the two most frequent STs, as they grouped mainly ST13 (n = 13) and ST9 (n = 17) 
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isolates.  Table 5.2 shows the distribution of STs in the various PFGE clusters. Most 
PFGE clusters included more than one ST, and in some cases, the same ST was found 
among diverse PFGE clusters, resulting in an overall low level of association between 
the two typing techniques, as given by an AW coefficient between PFGE clusters and 
STs (AWPFGE→ST) of 0.364 (95% CI, 0.224 to 0.505) and an AWST→PFGE of 0.537 (95% 
CI, 0.368 to 0.706). The overall correspondence between PFGE cluster and CCs was 
significantly higher when CCs were formed at the DLV level [AWPFGE→CC(DLV) = 0.880 
(95% CI, 0.754 to 1)],   reflecting the fact that that a significant fraction of STs included  
 
FIGURE 5.5. PFGE SmaI macrorestriction profile analysis of S. canis isolates from 
animal and human infections 
 (A) Dendrogram showing UPGMA cluster analysis of the PFGE profiles of the 86 S. canis isolates studied. Dice 
coefficients (percentages) are indicated on the scale above the dendrogram. Each PFGE cluster (defined as a group of 
≥2 isolates with a Dice coefficient of ≥80%) is represented by a triangle proportional to the number of isolates 
included in the cluster. PFGE clusters are designated by capital letters and a subscript number indicating the number 
of isolates included in the cluster. 
 (B) PFGE profiles of representatives of S. canis clusters defined. Capital letters above the lanes correspond to cluster 
designations; pairs of isolates recovered from humans (indicated by an asterisk) and house pets belonging to the same 
PFGE cluster and with identical STs are underlined and include two ST9/B20 isolates, two ST9/C10 isolates, and two 
ST13/H25 isolates; lane m, bacteriophage lambda ladder PFGE marker (New England BioLabs, Beverly, MA). 
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in the same PFGE cluster belonged to the same CC (Table 5.2). An example is the 
inclusion of STs 13, 8, 11, 12, 14, and 17, belonging to CC13 defined at the DLV level, 
in the larger PFGE clone, H25 (Table 5.2). 
Isolates recovered from humans and house pets were grouped together in the major 
PFGE clusters, similarly to what was noted above for MSLT-defined groups. Figure 
5.5B shows three examples of paired PFGE profiles of human and house pet isolates 
belonging to the same PFGE cluster. 
An emm gene could be amplified from 15 isolates (17%). None of the human isolates 
yielded a product when tested for the presence of the emm-like gene. All the emm-like 
positive isolates were recovered from dogs. Twelve isolates were stG1389, two had a 
novel emm type (stG1451), and one was stG663. The stG1389 type was found in all 
isolates belonging to STs 1 (n = 11) and 24 (n = 1), both belonging to CC1. The novel 
emm type, stG1451, was found in one ST20 isolate and one ST21 isolate, both 
singletons at the SLV level that were double-locus-variants of each other. The other 
three ST21 isolates did not amplify the emm-like gene. stG663 was found in an ST5 
isolate (also a singleton). emm-positive isolates were found scattered in the PFGE 
dendrogram, including stG1389 isolates which, despite belonging to a single MLST CC, 




S. canis, a widely distributed house pet colonizer and pathogen, is increasingly being 
reported in human infection (20, 21, 23). In industrialized countries, a trend toward 
closer contact and increased cohabitation in households with traditional pets such as 
dogs and cats has been noted (42, 43), making transmission of microorganisms between 
house pets and humans more likely to occur. These observations show that the zoonotic 
potential of S. canis should not be dismissed and prompted us to explore if S. canis 
isolates found in house pets and humans form a single population. 
Many previous epidemiologic studies of human infection by GCGS failed to detect S. 
canis (28, 44, 45). In Portugal, an ongoing survey of human infections by large-colony-
forming GCGS did not detect any S. canis isolates prior to 2005, while over 300 SDE 
isolates were recovered in the same period (46). The seven S. canis isolates recovered 
from both invasive and non-invasive human infections in Portugal between 2006 and 
2010 described herein represent approximately 1.2% of all large-colony-forming GCGS 
isolates recovered during this time period and 3.2% of the large-colony-forming GCGS 
invasive isolates (unpublished data). This is a prevalence similar to the one reported for 
invasive isolates in the United States (19). In sharp contrast to our findings, a 
retrospective study carried out in a French hospital was unique, in that the number of 
infections caused by S. canis exceeded the number of infections caused by SDE and S. 
canis accounted for 1% of all isolated streptococci (20). That report also identified an 
unusually high number of S. canis isolates from nonsterile sites, with many being 
recovered together with other bacteria and some being recovered from patients with no 
signs of infection (20). In our study, three of the seven human isolates were recovered 
from nonsterile sites, including two from the respiratory tract (Table 5.1). The patients 
did present signs of respiratory infection, but we cannot definitively establish a 
pathogenic role for these isolates. These observations raise the possibility of S. canis 
colonization in humans, but such a role remains controversial. 
All the group G isolates described in the current work were identified as S. canis by 
combining phenotypic and genotypic tests. The analysis of the 23S rRNA and 16S 
rRNA showed that we were able to correctly identify more than 99% of the isolates by 
using the API 20 Strep system alone. The high number of distinct API profiles obtained 
is in agreement with previous observations of considerable biochemical variation 
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among S. canis isolates (21), but all profiles were identical to the S. canis profiles 
obtained by the same method and reported elsewhere (18, 21). Taken together, our 
results support the usefulness of the API 20 Strep system for S. canis identification. 
The phylogenetic tree built for the 16S rRNA gene showed that all S. canis alleles 
formed a single branch well resolved from the other beta-hemolytic streptococcal 
species included. S. canis alleles were more closely related to those of GAS, concordant 
with the most frequent tree topology observed in 16S rRNA analysis of streptococci (1). 
The genotypic analysis also showed that the group L streptococcus identification 
obtained for a single isolate by the API 20 Strep system was erroneous. Among 
Streptococcus species, the group L carbohydrate is found only among isolates in the S. 
dysgalactiae taxon, and all S. canis isolates identified to date present Lancefield group 
G antigen (1), as did this isolate. In addition, this isolate yielded a product specific for S. 
canis in the 23S rRNA PCR assay and had a 16S rRNA allele characteristic of S. canis. 
The results of molecular typing also showed that it was part of a well-defined S. canis 
genetic lineage, namely, the ST1, emm type stG1389 present in PFGE cluster A5 (Table 
5.2). Taken together, these results unambiguously identify this isolate as S. canis. 
Like other beta-hemolytic species, S. canis isolates are usually susceptible to 
antimicrobial agents, but occasional resistance to tetracycline, fluoroquinolones, 
macrolides and lincosamides, gentamicin, and chloramphenicol has been reported (6, 
21, 23, 47). The rate of tetracycline resistance (27%) for house pet isolates found in our 
study is similar to the one reported from dog isolates in Denmark (48) and cat isolates in 
Belgium (49). Resistance to tetracycline was significantly disseminated in S. canis, as 
confirmed by the polyclonal origin of the isolates expressing it. On the contrary, 
resistance to erythromycin, clindamycin, and streptomycin was minimal, being 
restricted to two genetically related isolates. Erythromycin and clindamycin resistance 
rates above 10% have been reported for S. canis (6, 48, 49) and for group G isolates 
recovered from human infections (50, 51). Also in contrast to our observations, 
resistance to gentamicin but not to streptomycin has frequently been detected in S. canis 
(6, 21, 23, 48). We could not detect resistance to levofloxacin in S. canis, in sharp 
contrast to our own observations on SDE isolates recovered from human infections in 
Portugal, for which a resistance rate of 12% was found (46). 
Information on the genetic determinants of resistance carried by S. canis is lacking in 
the literature. Tetracycline resistance in our isolates was conferred mainly by tet(M) and 
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tet(O), which are also the genes found the most frequently in other beta-hemolytic 
streptococci of human and animal origin (32, 52). The presence of the tet(L) and tet(S) 
genes has also been noted, but at lower frequencies (32, 53, 54). The detection of two 
tetracycline-resistant isolates negative for the presence of the genes tested in this work 
may indicate that other determinants could be carried by S. canis isolates, which is not 
surprising, given the known diversity of tet genes (55). The erm(B) gene conferring 
constitutive MLSB resistance in our isolates has also been detected in SDE (51). Our 
isolates were resistant to streptomycin while maintaining gentamicin susceptibility; 
accordingly, these isolates were shown to carry the aadA gene, previously detected in 
Gram-negative bacteria and Enterococcus faecalis (33). 
Several typing techniques have been employed in the past to characterize S. canis, 
but most studies relied on a limited number of isolates. We propose a new S. canis 
MLST scheme and demonstrated its effectiveness by typing a larger collection of 
isolates. The goeBURST analysis showed that most STs were grouped into 5 CCs, 
accounting for more than 80% of the isolates and including the unrelated STs described 
in the North American study (26). Moreover, the putative founders of the main CCs 
defined by MLST were identified in Portugal and Germany, where most S. canis 
isolates were recovered, and some of the singletons also included isolates recovered in 
both countries. Taken together, the goeBURST analysis showed that the observed 
structure of the S. canis population is not limited to a single geographic location and 
that S. canis clones are geographically disseminated, as previously observed for human 
SDE (34). 
The sequence data generated by MLST were also used to make a comparative 
phylogenetic analysis of S. canis with SDE and GAS. The tree topologies that we found 
for the different loci are in accordance with what has been reported (26), with S. canis 
or SDE alleles being more closely related to GAS, depending on the similarity observed 
between the last two species, which changes the tree topology (26, 34). Although a 
previous study based on multilocus sequence analysis of these three species showed a 
close genetic relationship and likely recent descent from a common ancestor (56), 
enough sequence divergence has accumulated so that the S. canis alleles and STs form 
discrete branches that are well separated from those of the other two species (26, 56). In 
view of this, the detection of one gki allele and one recP allele of S. canis more similar 
to SDE alleles than to any other S. canis allele can be most parsimoniously explained by 
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their acquisition through recombination. The occurrence of DNA exchange involving 
SDE and GAS housekeeping genes is documented (26, 34, 57). Genomic analysis has 
recently shown significant lateral gene transfer from GAS to Streptococcus equi subsp. 
equi (35), while the data presented here support the hypothesis that SDE may be the 
major donor in the events involving S. canis. The detection in the present study of these 
events was probably made possible due to the increase in the number of isolates 
analyzed. Future studies which enlarge the known diversity of MLST alleles and STs of 
S. canis will provide further insights into the frequency of these events, allowing us to 
better evaluate their potential importance in the evolution of these species. 
The results obtained by MLST were supported by characterizing the same isolates by 
PFGE. Although previous studies that characterized S. canis isolates from house pets 
also using PFGE SmaI profiles found a diverse population (13, 27), the presence of 
well-defined clones by both PFGE and MLST in the current study points to the 
existence of stable genetic lineages in the S. canis population which can be detected by 
both typing techniques. The overall agreement between PFGE and MLST was weak, as 
denoted by the low values obtained for the adjusted Wallace coefficient between PFGE 
clusters and STs or CCs, and only the analysis at the DLV level significantly maximized 
the association of genetically related STs with PFGE clusters (Table 5.2). This 
observation is not unique to S. canis, as poor concordance between typing methods has 
also been noted in the past for SDE, namely, in studies that compared emm typing 
results with either PFGE (28) or MLST (26, 34) typing results. The reasons for these 
observations are not clear, but unlike MLST, PFGE targets the entire genome and 
measures variation that could be accumulating more rapidly (58). 
Although a zoonotic origin of S. canis has been assumed since the first reports of 
human infection (18, 21), most papers have reported the independent and exclusive 
characterization of either human or animal isolates. The MLST characterization 
performed in the current study showed that all the S. canis isolates from human 
infections (from the United States and Portugal) characterized by this technique to date 
have identical alleles and belong to the most prevalent STs/CCs present among house 
pet isolates, a strong indication that S. canis isolates are not segregated by host. 
Furthermore, the inclusion of epidemiologically unrelated human and house pet isolates 
in common PFGE clusters further supported the MLST findings. Taken together, these 
observations lead us to conclude that S. canis from house pets and humans form a single 
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population. The two S. canis isolates from bovine mastitis and the horse isolate had STs 
identical or related to isolates of house pets and humans, indicating that this observation 
may be extended to S. canis isolates found in other animal species. As both MLST and 
PFGE analysis showed that human isolates do not represent separate lineages or unusual 
clones, one can infer that the ability to infect the human host is not restricted to a few S. 
canis strains but, rather, that several genetic lineages have that pathogenic potential. 
The major role played by the M protein in GAS pathogenesis and the virtually 
ubiquitous presence of emm-like genes among SDE isolates infecting humans raised the 
possibility that at least the S. canis isolates causing infections in humans would carry 
emm-like genes. However, only a small proportion of S. canis isolates were successfully 
emm typed, and in none of the human isolates was this gene successfully amplified. 
Despite the successful application of the currently used emm typing protocol for both 
GAS and SDE, many previous studies failed to amplify an emm-like gene from most S. 
canis isolates (19, 23), in agreement with our observations. Information accessible at the 
CDC emm typing database shows that both the stG1389 and stG663 emm types were 
previously   identified  in  S.  canis   (http://www.cdc.gov/ncidod/biotech/strep/types_ 
emm103-124.htm), while stG1451 is a novel emm type. None of these emm types have 
been observed among SDE isolates from Portugal (46) or elsewhere. 
The data from the current study provide new insights into the clonal relationships 
between S. canis isolates infecting distinct hosts. Our report shows for the first time that 
several prominent S. canis lineages found among house pets also have the potential to 
cause invasive infections in humans. By demonstrating that the same MLST- and 
PFGE-based genetic lineages infect both house pets and humans, we provide decisive 
evidence for the zoonotic origin of S. canis. 
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TABLE S5.1. GenBank accession numbers of 16S rRNA gene, MLST 
and novel emm type alleles 
Gene Allele GenBank acession number Reference 
16S rRNA 1 JX876612 This study 
16S rRNA 2 JX876613 This study 
16S rRNA 3 JX876614 This study 
16S rRNA 4 JX876615 This study 
16S rRNA 5 DQ303184 41 
16S rRNA 6 JX876616 This study 
16S rRNA 7 JX876617 This study 
16S rRNA 8 JX876618 This study 
16S rRNA 9 JX876619 This study 
gki 1 EU768807 26 
gki 2 EU768805 26 
gki 3 EU768804 26 
gki 4 FJ238467 26 
gki 5 JX876620 This study 
gki 6 JX876621 This study 
gki 7 JX876622 This study 
gki 8 JX876623 This study 
gki 9 JX876624 This study 
gtr 1 FJ238468 26 
gtr 2 EU768802 26 
gtr 3 EU999155 26 
gtr 4 JX876625 This study 
gtr 5 JX876626 This study 
gtr 6 JX876627 This study 
gtr 7 JX876628 This study 
murI 1 EU999157 26 
murI 2 FJ151278 26 
murI 3 FJ238469 26 
murI 4 FJ151277 26 
murI 5 JX876629 This study 
mutS 1 FJ238471 26 
mutS 2 AJ413210 23 
mutS 3 AJ413208 23 
mutS 4 AJ413209 23 
mutS 5 JX876630 This study 
recP 1 EU283342 26 
recP 2 FJ238477 26 
recP 3 FJ238476 26 
recP 4 JX876631 This study 
recP 5 JX876632 This study 
recP 6 JX876633 This study 
recP 7 JX876634 This study 
xpt 1 FJ238483 26 
xpt 2 FJ238486 26 
xpt 3 FJ238482 26 
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TABLE S5.1. (cont) 
Gene Allele GenBank acession number Reference 
xpt 4 JX876635 This study 
xpt 5 JX876636 This study 
xpt 6 JX876637 This study 
xpt 7 JX876638 This study 
xpt 8 JX876639 This study 
xpt 9 JX876640 This study 
yqiZ 1 FJ263616 26 
yqiZ 2 FJ268647 26 
yqiZ 3 FJ268654 26 
yqiZ 4 FJ263615 26 
yqiZ 5 JX876641 This study 
emm stG1451 KC291148 This study 
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TABLE S5.2. MLST data for 90 S. canis animal and human isolates  
from different geographic locations 
Strain ST gki gtr murI mutS recP xpt yqiZ Origin 
Geographic 
Location 
FMV1315.02 1 1 1 1 1 1 6 1 Dog Portugal 
FMV1425.02 1 1 1 1 1 1 6 1 Dog Portugal 
FMV2238.02 1 1 1 1 1 1 6 1 Dog Portugal 
FMV2322.02 1 1 1 1 1 1 6 1 Dog Portugal 
FMV334.03 1 1 1 1 1 1 6 1 Dog Portugal 
FMV3639.06 1 1 1 1 1 1 6 1 Dog Portugal 
FMV5002.06 1 1 1 1 1 1 6 1 Dog Portugal 
FMVES5.02 1 1 1 1 1 1 6 1 Dog Portugal 
FUB9212 1 1 1 1 1 1 6 1 Dog Germany 
FUB9324 1 1 1 1 1 1 6 1 Dog Germany 
FUB9383 1 1 1 1 1 1 6 1 Dog Germany 
FMV5857.06 2 2 2 2 2 2 1 2 Dog Portugal 
FUB23896 2 2 2 2 2 2 1 2 Dog Germany 
FUB24014 2 2 2 2 2 2 1 2 Dog Germany 
FMV565.02 3 3 3 3 3 1 2 3 Dog Portugal 
FUB24004 3 3 3 3 3 1 2 3 Dog Germany 
FUB24007 3 3 3 3 3 1 2 3 Dog Germany 
FMV3662.06 5 1 2 4 3 1 8 1 Dog Portugal 
FMV6216.05 6 2 2 2 2 2 4 2 Dog Portugal 
FUB23887 7 2 2 2 2 4 1 2 Dog Germany 
FUB6286 8 2 2 4 4 2 3 2 Dog Germany 
DSM20715
T
 9 3 5 3 3 1 2 3 Cow Reference Strain 
FMV1434.06 9 3 5 3 3 1 2 3 Cat Portugal 
FMV2274.05 9 3 5 3 3 1 2 3 Dog Portugal 
FMV261.04 9 3 5 3 3 1 2 3 Cat Portugal 
FMV2797.03 9 3 5 3 3 1 2 3 Dog Portugal 
FMV2861.06 9 3 5 3 3 1 2 3 Dog Portugal 
FMV370.06 9 3 5 3 3 1 2 3 Dog Portugal 
FMV382.04 9 3 5 3 3 1 2 3 Dog Portugal 
FMV4037.03 9 3 5 3 3 1 2 3 Dog Portugal 
FMV5369.04 9 3 5 3 3 1 2 3 Dog Portugal 
FMV7307.07 9 3 5 3 3 1 2 3 Dog Portugal 
FUB11660 9 3 5 3 3 1 2 3 Cat Germany 
FUB11826 9 3 5 3 3 1 2 3 Cat Germany 
FUB12082 9 3 5 3 3 1 2 3 Cat Germany 
FUB12111 9 3 5 3 3 1 2 3 Cat Germany 
FUB23835 9 3 5 3 3 1 2 3 Dog Germany 
FUB24001 9 3 5 3 3 1 2 3 Dog Germany 
FUB5449 9 3 5 3 3 1 2 3 Dog Germany 
SH2062 9 3 5 3 3 1 2 3 Human Portugal 
SH2929 9 3 5 3 3 1 2 3 Human Portugal 
SH5085 9 3 5 3 3 1 2 3 Human Portugal 
SH5107 9 3 5 3 3 1 2 3 Human Portugal 
SH5276 9 3 5 3 3 1 2 3 Human Portugal 
FUB23886 10 3 5 3 3 1 9 3 Horse Germany 
FUB6202 11 4 2 4 4 2 3 2 Dog Germany 
FUB6204 11 4 2 4 4 2 3 2 Dog Germany 
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TABLE S5.2. (cont) 
Strain ST gki gtr murI mutS recP xpt yqiZ Origin 
Geographic 
Location 
FMV5687.03 12 4 2 4 4 4 3 4 Dog Portugal 
SH5565 12 4 2 4 4 4 3 4 Human Portugal 
FMV1129.05 13 4 2 4 4 5 3 4 Dog Portugal 
FMV1565.02 13 4 2 4 4 5 3 4 Dog Portugal 
FMV183.06 13 4 2 4 4 5 3 4 Dog Portugal 
FMV1940.04 13 4 2 4 4 5 3 4 Dog Portugal 
FMV2014.02 13 4 2 4 4 5 3 4 Dog Portugal 
FMV2686.01 13 4 2 4 4 5 3 4 Dog Portugal 
FMV2863.03 13 4 2 4 4 5 3 4 Dog Portugal 
FMV2880.03 13 4 2 4 4 5 3 4 Dog Portugal 
FMV551.02 13 4 2 4 4 5 3 4 Dog Portugal 
FMV5829.03 13 4 2 4 4 5 3 4 Dog Portugal 
FUB6343 13 4 2 4 4 5 3 4 Dog Germany 
FUB9195 13 4 2 4 4 5 3 4 Dog Germany 
UNICAM15 13 4 2 4 4 5 3 4 Dog Italy 
FMV3142.03 14 4 2 4 4 6 3 4 Dog Portugal 
FMV3257.04 14 4 2 4 4 6 3 4 Dog Portugal 
FMV3818.05 14 4 2 4 4 6 3 4 Dog Portugal 
SH3379 14 4 2 4 4 6 3 4 Human Portugal 
FUB23675 15 4 4 5 4 4 7 1 Dog Germany 
FMV2460.07 16 4 5 3 4 1 2 3 Dog Portugal 
FMV596.02 16 4 5 3 4 1 2 3 Dog Portugal 
FUB11801 16 4 5 3 4 1 2 3 Cat Germany 
FUB23673 17 4 6 4 4 5 3 4 Dog Germany 
FUB23883 17 4 6 4 4 5 3 4 Dog Germany 
FMV1757.03 18 5 2 2 2 2 1 2 Dog Portugal 
FMV55.06 18 5 2 2 2 2 1 2 Dog Portugal 
FMV74.05 19 6 2 4 3 4 5 1 Dog Portugal 
FUB23971 19 6 2 4 3 4 5 1 Dog Germany 
FMV1451.06 20 7 4 5 3 1 7 3 Dog Portugal 
FMV4399.06 21 7 4 5 3 4 7 1 Dog Portugal 
FMV4489.05 21 7 4 5 3 4 7 1 Dog Portugal 
FMV6425.07 21 7 4 5 3 4 7 1 Dog Portugal 
FUB23999 21 7 4 5 3 4 7 1 Dog Germany 
FMV1916.05 22 8 2 3 3 1 2 4 Dog Portugal 
FMV3689.07 23 8 5 3 3 1 2 3 Dog Portugal 
FMV3835.03 23 8 5 3 3 1 2 3 Dog Portugal 
FUB23676 24 1 1 1 1 4 6 1 Dog Germany 
FUB12146 25 9 7 3 5 7 7 5 Cat Germany 
Sc2 2 2 2 2 2 2 1 2 Human USA 
Sc3 3 3 3 3 3 1 2 3 Human USA 
Sc4 4 4 2 4 4 3 3 4 Human USA 







FIGURE S5.1. Neighbor-joining unrooted trees of gtr (A), murI (B), mutS (C) and    
xpt (D) alleles of S. canis, SDE and GAS 
The trees were built with the methods indicated in materials and methods and in the legend of Fig. 1. gtr 
alleles are indicated as SC gtr1 to SC gtr7, murI alleles as SC murI1 to SC murI5, mutS alleles as SC 
mutS1 to SC mutS5 and xpt alleles as SC xpt1 to SC xpt9. The sequences from the two comparator species 
were obtained from the respective databases (http://www.mlst.net/). 
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6. GENERAL DISCUSSION 
The last decades witnessed an increased recognition of GCGS as human pathogens. 
This increment is particularly significant for SDE, given that a growing number of 
reports describing infections by this species are being published, many from cases of 
severe infection (1–3). Moreover, in some instances, SDE presents a disease burden 
which is close or even exceeds that attributable to GAS and GBS (4). Whether this is a 
true increase in the incidence of SDE infections or merely reflects a better awareness of 
its pathogenic role in the human host is a question not entirely solved, mainly because 
of the taxonomic issues that hampered many of the published GCGS literature and limit 
the assessment of the individual species contribution to the overall numbers reported. 
Nevertheless, a number of studies from distinct locations in the world showed increased 
incidence of GCGS infections over time (4–6), favoring the first scenario. Currently, 
SDE is no longer regarded simply as a member of the human microbiota showing low 
virulence to humans but as an emerging streptococcal pathogen (1, 7, 8). 
 A central question remaining to be answered is whether the increased detection of 
SDE has been driven by the emergence of more virulent strains of this species. Many 
authors speculated on the molecular events that could increase SDE virulence and 
searched for the genetic determinants that could mediate it. A common path was to look 
for genes known to encode proteins important for the pathogenesis of the closely related 
GAS (which is much better characterized), resulting in the description of a number of 
shared loci between the two species. In many instances such findings were interpreted 
as likely indication of the acquisition of genetic material through horizontal gene 
transfer events. The pathogenesis of SDE diseases is likely dependent on the action of 
many virulence factors present in the bacteria but host factors may also play a key role 
given the noted association of SDE disease with elderly patients and with pre-existing 
co-morbidities. However, in addition to studying the distribution of virulence genes 
throughout the SDE population, typing methods that allow an improved delineation of 
bacterial clones for this species are crucial in order to allow the identification of 
potentially more virulent strains that could have arisen during evolution. 
Prior to the studies described in this thesis there was no information available on the 
epidemiology of GCGS infections in Portugal and molecular typing data from other 
geographic locations was also limited. This lack of both background information and 
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typing methods allowing the identification of GCGS clonal lineages prompted the 
development of the MLST schemes for SDE and S. canis described in this thesis. The 
data generated brought new insights into the population structure of these two species 
and also into the evolutionary dynamics which may contribute to part of their apparent 
increased success as human pathogens. The characterization undertaken also allowed 
some aspects related to virulence and antimicrobial resistance to be explored. 
6.1. Issues relating to the identification of GCGS species 
The importance of conducting species level identification of GCGS is today 
increasingly recognized and seen as critical to fully evaluate the prevalence, 
epidemiology and the pathogenic characteristics of each of the bacterial species 
included in the group. The identification procedures described in the current work 
showed that the identification of either SDE (chapter 2) or S. canis (chapter 5) do not 
pose critical difficulties. Both phenotypic methods, such as API 20 Strep used in this 
work or other biochemical tests, and genotypic methods (9, 10) allow the distinction 
between the two. The application of MLST, which generates sequence information for 
multiple loci, also allows unambiguous distinction of these species, since the vast 
majority of the alleles are species specific and the issues related to single locus based 
identification, such as low discriminatory separation or the sharing of alleles by distinct 
species, are overcome. 
The current work showed the dominant role of SDE among GCGS species causing 
human infections in Portugal, as seen in many other geographical regions (2, 5). SDE 
was the only species isolated in the first years of the study and only when the collection 
was expanded by enrolling a growing number of laboratories were S. canis isolates 
recovered. Thus, it is conceivable that in the beginning of the study the sample size was 
not large enough to allow detection of S. canis, given the low prevalence of this species 
compared to SDE. Studies conducted elsewhere involving a low number of isolates may 
have also a limited ability to detect the presence of S. canis or other GCGS species 
which behave as infrequent human pathogens. 
The characterization of SDE isolates conducted in chapters 2 and 4 showed that 
isolates of this species bearing either the Lancefield group C or group G antigens were 
not clearly separated from each other. Not only did these serological distinct isolates 
have common 16S rRNA alleles and biochemical profiles, but they were also not 
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separated by PFGE and shared some emm types, a finding reported elsewhere (11). 
Such observations were in agreement with previous studies that supported their 
inclusion under a common epithet (9, 12). The application of MLST described in 
chapter 3 further shows that Lancefield group carbohydrates are associated with distinct 
SDE lineages, given that a good correlation was found between both MLST STs and 
CCs with Lancefield classification, although no long-term genetic isolation between 
them could be found. Thus, the data generated in this thesis highlight the absence of 
genetic evidence for the separation of SDE commonly found in human infections 
bearing these groups and reinforces the importance of studying strains bearing both 
groups together to fully evaluate the significance of SDE as an agent of human 
infection. Studies that characterize exclusively Lancefield group C or G strains, a 
concept still in use in the study of GCGS infections, may suffer from a double 
drawback: not only some GCGS species may be missed, but also, in the particular case 
of SDE, they have the bias of selecting distinct clones, resulting in an inadequate picture 
of the SDE population structure. 
6.2. The emm gene: epidemiologic and virulence considerations 
The emm typing technique has gained acceptance in SDE epidemiology during the 
last two decades and has now become the most widely used typing technique for this 
species. Previous studies have described the emm type distribution among isolates 
recovered mostly from invasive infections (13), but the work described in Chapter 2 
was the first trying to correlate emm types with virulence in SDE, i.e., to look for emm 
type differences in SDE isolated from invasive and non-invasive infections. This 
approach allowed the identification of two emm types, stG2078 and stG10, both 
statistically overrepresented among invasive isolates in the sampled population, 
suggesting an association between emm type and invasive disease potential. The 
complementary PFGE analysis showed the polyclonal origin of stG2078 isolates 
(further suggesting the importance of this particular emm type or of a closely linked 
determinant for virulence), while the nonrandom clustering of stG10 isolates in a single 
clone suggested the contribution of a common genetic background. 
emm types stG2078 and stG10 are well represented among studies characterizing 
SDE invasive isolates published in the last years (Fig. 6.1), although this observation 
cannot be generalized to all geographic locations (1, 14). Interestingly, both were found 
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among a group of uncommon emm types associated with more severe disease and 
increased mortality rates in patients with SDE bacteremia in Finland (1).  A study from 
Japan also characterizing SDE isolates from both invasive and non-invasive infections 
found stG485, stG6792 and stG2078 significantly associated with invasive disease (15), 
supporting our own findings on the increased virulence of strains presenting this last 
emm type. Nonrandom distributions of emm types have occasionally been noted in other 
studies, as was the case of stC36 and stC839 detected only in throat isolates and stG480 
and stG6 only in blood isolates in a Danish hospital (16). All these observations support 
a different virulence of SDE strains of distinct emm types, although it is not clear 
whether such differences are driven by the direct action of the product of the emm gene, 
a closely linked gene or other factors in the genome of a genetic lineage exhibiting a 
given emm type. 
 
FIGURE 6.1. emm types distribution among SDE invasive isolates in selected studies 
from distinct geographic locations 
emm types are given by decreasing order of frequency as they were found in 164 isolates recovered in Portugal from 
1998 to 2010 [work not published in scientific paper (17)]. Isolates used for comparison include 212 isolates 
recovered in USA from 2002 to 2004 (2), 231 isolates recovered in Japan from 2006 to 2007 (4) and 48 isolates 
recovered in Norway from 2006 to 2009 (18). The “other” emm types column includes more than 15 different emm 
types, none including more than 10 isolates. 
The several studies on SDE emm type distribution that are now available from 
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geographically. Taking as example the studies referenced in Fig. 6.1, it can be seen that 
although a common group of emm types account for the majority of SDE infections 
independently of the geographic region considered, the individual emm type most 
prevalent at each geographic location changes. In some instances, emm types highly 
prevalent in a given geographic location are absent from another, as is the case of 
stG62647 which was the most frequent in Portugal (when all isolates recovered from 
1998 to 2010 are considered) (17) but not found in Japan (4) and with low prevalence in 
other locations. On the other hand, a number of studies have confirmed the importance 
of SDE isolates bearing emm type stG6792 in Japan. In this country, stG6792 isolates 
were shown to have a nationwide distribution (4), were associated with invasive disease 
(15) and poor outcome (4), and often identified among SDE isolates causing STSS (19). 
This emm type has much less expression among invasive infections in Portugal and was 
exclusively found among non-invasive isolates prior to 2006 (chapter 2). 
 There is still no study covering a sufficiently wide time range to provide evidence of 
emm type temporal variation. However, it has been observed that the emm types 
associated with SDE isolates causing STSS and necrotizing fasciitis in Japan have 
changed during time (3). Both geographic and temporal variations make it difficult to 
evaluate the association of individual emm types to virulence. It also implies that emm 
type differences observed on selected geographic locations and over restricted time 
periods should be interpreted with caution and that local dynamics should be taken into 
consideration. 
A few aspects should be considered which point towards the importance of the 
genetic background of SDE isolates in virulence rather than the emm gene itself: (i) the 
emm type variability observed among invasive SDE isolates (2, 4, 13), an indication that 
multiple variants of this protein can be responsible for invasive infections; (ii) emm 
types commonly found among invasive isolates, even those for which occasional 
statistic association with invasive disease has been obtained, are not uncommon among 
non-invasive isolates, as is the case of the emm types referred above; (iii) the geographic 
differences found in the prevalence of different emm types among invasive and non-
invasive isolates which may imply the presence of distinct clonal lineages associated 
with the same emm type. The application of complementary typing methods should help 
to clarify these issues. 
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 Expanding the analysis beyond the emm locus should prove useful in defining which 
other factors contribute to the increased virulence of particular strains. Characterizing 
the region surrounding the emm gene in SDE might clarify if there are closely located 
gene(s) that could potentially influence virulence. As the emm gene is located in a 
distinct genomic environment in SDE and GAS (20), the importance of this region to 
virulence in SDE cannot be inferred from the previous observations in GAS. Not only is 
evidence lacking that the emm gene is regulated in a similar manner in both species, but 
a recent study showed that the two types of multigene regulator like regions found in 
SDE are correlated with emm types but not with the site of infection, whereas in GAS 
the presence of emm-like genes in this region was associated with tissue tropism and 
disease presentation (14).  
The contribution of other factors present across SDE genomes should also be 
clarified. In some cases, there is the need to elucidate how a given protein functions in 
SDE, since the knowledge on the mode of action for many of the presumed virulence 
factors comes from studies on GAS and the SDE counterpart may present unique 
features. On the other hand, studies exploring a more global view of the bacterial gene 
content should elucidate how different loci contribute to the overall virulence of this 
species and how they are controlled and interact with each other. The distribution of 
such factors in SDE population should be determined, as their presence/absence may 
explain the differences observed between strains. For example, a recent study detected a 
streptococcal inhibitor of complement-mediated cell lysis (SIC)-like gene in stG2078 
isolates (21), which has restricted distribution in both SDE and GAS. 
6.3. Improving GCGS typing by applying MLST 
Although emm typing is the only technique employed to type GCGS isolates in many 
studies, it is now becoming apparent that it is insufficient to ascertain the genetic 
relatedness between these strains. As shown by the simultaneous use of distinct typing 
techniques, not only does emm typing produces stratifications which are discordant with 
those produced by either PFGE or MLST for SDE, it is also unsuitable for this purpose 
in other GCGS species, as is the case of S. canis, since only a few strains will amplify a 
PCR product by the technique usually employed. Studies that complement the data 
obtained by emm typing are still scarce, and further work that does not rely solely on 
this technique should prove useful in defining the population dynamics of GCGS 
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species, its temporal evolution, and in providing a framework upon which the question 
of whether subpopulations of SDE strains have enhanced virulence can be addressed. 
Given the established usefulness of the MLST technique for molecular typing of 
many bacterial species, new MLST schemes for SDE and S. canis were developed in 
collaboration with other groups. The work reported in this thesis occurred 
simultaneously and was preceded by the study published by Ahmad and colleagues in 
2009 (11), which characterized isolates from both species recovered from invasive 
infections in the United States. In the case of SDE, we developed an independent MLST 
scheme with alternative primer pairs but targeting the same regions of the genome. We 
provided a large new dataset covering isolates from distinct geographic locations 
recovered from invasive and non-invasive infections, which improved our 
understanding on SDE population structure and highlighted the broad geographic 
distribution of STs. For S. canis, the proposed modifications resulted in a fully 
applicable MLST scheme allowing the characterization of a large number of S. canis 
isolates from human and animal sources. This work also aimed at establishing a 
publicly accessible MLST database for each of these two species (http://sdse.mlst.net/ 
for SDE and http://pubmlst.org/scanis/ for S. canis), with the goal of improving the 
utility of MLST by allowing the information obtained by distinct laboratories to be 
easily shared. 
A high level of genotypic diversity was found among SDE isolates analyzed from 
Portugal, supported by the variety of emm types, PFGE clusters and MLST defined STs 
that were found. Similarly, the analysis of S. canis isolates also pointed to an 
heterogeneous population in which, despite their low number, human isolates had STs 
which were representative of the several lineages found in animal infections. The 
polyclonal nature of both SDE and S. canis shows that the ability to cause disease in 
humans is not a particular characteristic of a few GCGS genetic lineages. While this is 
not surprising for SDE, since it is well known to be colonizing the human host, the 
diversity of S. canis isolates causing human infection suggest that factors distributed in 
the genome of numerous genetic lineages of this species allow them to infect humans 
once there is an opportunity of transmission. Whether those factors also allow S. canis 
to persist or colonize the human host remains to be demonstrated, but these observations 
suggest a scenario in which these GCGS species have vertically inherited characteristics 
that allow them to infect the human host. As shown by the recently published genomes 
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of both SDE and S. canis strains (22, 23), multiple factors are present in both these 
species that are shared with the human pathogen GAS, which may contribute to their 
virulence in the human host. 
The work conducted in this thesis also provided evidence for the clonal expansion of 
some specific genetic lineages. In the case of SDE, this was supported by the increased 
prevalence of some emm types and PFGE clones when these two typing techniques 
were employed (e.g. the stG10 invasive isolates in chapter 2 and the stG166b 
levofloxacin resistant isolates in chapter 4). The MLST analysis of isolates recovered in 
distinct geographic locations was instrumental in showing the predominance of a few 
SDE clones among the global SDE population (Fig 3.1, chapter 3) and a similar 
situation could be observed with the predominance of ST9 among S. canis isolates from 
different countries (chapter 5). Despite the clonal diversity observed at regional level, 
the demonstration that a small number of STs are highly prevalent and have a wide 
geographic distribution shows the presence of successful genetic lineages which may 
differ from the remaining population in terms of increased fitness, virulence properties 
or transmission capacity. Further characterization should unveil whether this is the case 
and if these properties are linked. 
The SDE MLST analysis performed in chapter 3 included isolates derived from large 
independent collections, with the aim of compiling a genetically diverse dataset to allow 
picturing the global population structure of this bacterium. The sampling strategy 
employed is limited in the sense that isolates were chosen based on prior knowledge of 
their emm type and geographic site of isolation. Thus, it does not necessarily reflect 
clonal abundance nor the clonal structure of the population at each of the geographic 
locations included in the study. MLST application to SDE populations isolated from 
specific geographic locations should clarify the most important genetic lineages 
circulating in that area and allow the regional population structure of SDE to be better 
clarified. 
The application of MLST to SDE population isolated in Portugal is still partial, as 
only 36 isolates were included in the analysis conducted in chapter 3. Since this work, 
further characterization on SDE invasive isolates recovered in Portugal was conducted 
(17) (emm type distribution is shown in Fig. 6.1) and a subsequent study typed a 
collection of SDE isolates mainly recovered from the pharynx of Indian children (24), 
reporting for the first time the MLST characterization of asymptomatic carriage isolates. 
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By including this data, Fig. 6.2 shows all the isolates characterized to date by this 
MLST scheme and intends to illustrate what MLST has brought to the current 
knowledge on the population structure of SDE. The presence of dominating SDE 
genetic lineages with a worldwide distribution as described in chapter 3, can be 
visualized in the CCs represented in Fig. 6.2, most of them including isolates recovered 
from invasive and non-invasive infections and colonization, recovered in distinct 
locations. The same holds true for the putative founders of these CCs. However, this set 
of SDE isolates, enriched in invasive isolates from Portugal and non-
invasive/colonizing isolates from India, also shows the presence of STs or CCs which 
are exclusively found in these regions, likely representing lineages that are particularly 
prevalent in these geographic locations. The importance of local dynamics is also 
exemplified by the findings on levofloxacin resistance reported in this thesis. High rates 
of resistance to levofloxacin are still observable in Portugal at present (unpublished 
data), whereas resistance to this agent has not been found in studies conducted 
worldwide (25), indicating that local factors can be contributing to the spread of 
particular resistance determinants. 
The study on the MLST characterization of other important GCGS species in human 
infections, S. canis, directly compared isolates from human and animal infections at the 
population level. Not only was the ability of several S. canis lineages to infect humans 
established but it was also shown that all S. canis human isolates characterized to date 
by MLST belong to the most prevailing lineages found in house pets. It is conceivable 
that being more frequent in the animal population, these lineages may have more chance 
to pass to humans. A recent study by Richards et al (23) applied a MLST scheme using 
a distinct set of housekeeping genes to type bovine and house pet isolates recovered in 
United States and Europe. The genome sequenced S. canis strain was found to have the 
predominant ST in that study, which occurred in different hosts and geographic 
locations, an observation identical to the one reported in this thesis. Although not 
directly comparable, this is a strong indication that the results of both studies are 
identical, and confirm that the same S. canis lineages are found in bovine, house pet, 
and human hosts. 
  
 
  colonization       non-invasive infection (Portugal)       non-invasive infection (other locations) 
  invasive infection (Portugal)       invasive infection (other locations)       not determined 
FIGURE 6.2. goeBURST diagram of relationships between 513 SDE isolates 
The size of each circle is proportional to the number of isolates with that particular ST on a logarithmic scale. STs assigned to the same CC at the SLV level are linked by straight lines. 
Putative CC founders are identified by a light green line.MLST data used to construct the diagram include the reported in chapter 3, complemented with all invasive isolates recovered in 
Portugal until 2010 [work not published in scientific paper (17)] and from an Indian study including non-invasive and carrier isolates (24).
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6.4. The relevance of horizontal gene transfer events in GCGS evolution 
A noteworthy aspect of the work presented in this thesis was the evidence obtained 
for the occurrence of horizontal gene transfer events involving SDE and, to a lesser 
extent, S. canis. Several examples suggestive of recombination were found in genes 
encoding essential functions in the bacterial cell, including the DNA topoisomerase IV 
parC gene and the housekeeping genes included in the MLST schemes. Although this 
was not the primary goal and the approach used targeted the sequence of DNA regions 
accounting for an extremely small portion of the bacterial genome, the detection of such 
events indicates these must be a frequent phenomenon with a potentially crucial role in 
GCGS biology and evolution. 
The importance of these events for GCGS has deserved special attention because of 
the possible acquisition of virulence genes from more pathogenic species, resulting in 
either an enhancement of the invasive capacity of GCGS species towards humans, such 
as SDE, or enabling the occupation of novel niches by zoonotic pathogens. This idea is 
implicit for many of the GAS virulence genes which have been detected in SDE, and is 
supported in some cases by their observed association with mobile genetic elements. 
Most lines of evidence point towards the occurrence of genetic changes between SDE 
and GAS. Examples involving the two species are countless and include genes encoding 
the M protein (26), a fibronectin-binding protein (27), or the streptokinase gene (28). 
The MLST data presented in this thesis showing horizontal gene transfer involving the 
housekeeping alleles of these two species is in accordance with contemporary or 
subsequent studies employing this technique (11, 24). Moreover, the recently available 
full genome sequence data for SDE showed abundant horizontal gene transfer between 
the core genomes of the two species with more evidence for gene flow in the GAS to 
SDE direction (29). 
The relevance of such events is also exemplified in the case of the emm gene, which 
assumes importance by its potential direct impact in the virulence. The transfer of emm 
genes has been assumed for years (26) and emm types initially found in GAS, such as 
emm57 and emm12, have long been detected in SDE (30).  SDE alleles were also 
occasionally found in GAS, as was the case of stG1750 detected in invasive GAS 
isolates from Portugal (31) and stCK401 in GAS from Australia (32). However, such 
examples seem to be exceptions, as alleles found in each species are almost exclusive as 
is shown by the emm type analysis described in this thesis and supported by the vast 
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majority of studies performing emm typing in SDE (33, 34). The existence of 
intraspecific transfers in SDE is supported by the MLST analysis performed here and by 
others (11), which found the same emm type in distantly related STs and also distinct 
emm types in a single ST. One of the likely explanations for this lack of congruence 
between emm type and SDE clonal lineages, also observed in PFGE (chapter 2), is the 
existence of recombinational replacements involving the emm gene.  Evidence for the 
occurrence of such events was produced by a Norwegian study (34) which demonstrated 
some SDE isolates possessed emm genes composed of segments derived from distinct 
SDE associated emm types. New genomic information which identifies the emm gene as 
part of an ancient pathogenicity island shared with GAS but disaggregated in SDE (35, 
36) reinforces the role that horizontal gene transfer and recombination may have had in 
the evolution of this major virulence factor. 
Despite the significance of the exchanges between SDE and GAS, the horizontal 
genetic transfer events occurring including GCGS have much of partners. SDE gene 
transfer with GBS has been documented (37–39) and includes examples such as the C5a 
peptidase or the surface protein Lmb, whose encoding genes are found in a putative 
composite transposon flanked by insertion sequences in both species (39). SDE 
transfers with other GCGS species have also been reported, as was the case of the 
detected divergent MLST alleles for S. canis which indicated a gene flow in the 
direction SDE to S. canis. Such events were recently detected in the published genome 
of S. canis, involving S. agalactiae and S. dysgalactiae subsp. dysgalactiae (23). GAS 
has also been implicated in the occurrence of horizontal gene transfer with other GCGS 
species. An example is the presence of similar exotoxin genes in GAS and GCGS 
species which do not infect humans such as S. dysgalactiae subsp. dysgalactiae (40) or 
S. equi subsp. equi (41), in spite of the fact that each of these species behave as host 
specific pathogens and are not recognized to share the same host. Thus, a growing body 
of evidence is being generated for the existence of a common gene pool between GCGS 
species and other beta-hemolytic species, in which in addition to the common 
evolutionary history of these bacteria, horizontal gene transfer events are likely to 
contribute significantly to the genetic diversification of individual strains. 
The last years have also been fruitful in clarifying the possible mechanisms of 
horizontal gene transfer occurring in GCGS. Several mobile genetic elements are now 
known to be present in the genomes of these species which could mediate such events, 
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and include bacteriophages, plasmids or integrative conjugative elements (22, 23). It has 
long been known that some bacteriophages could propagate, lyse and lysogenize both 
GCGS and GAS (42) and to transduce streptomycin resistance markers from group A to 
group G streptococci (43). More recently, prophages significantly similar to GAS 
prophages were identified in SDE (22, 44), S. equi subsp. equi (45) and S. dysgalactiae 
subsp. dysgalactiae (36). A rising number of integrative conjugative elements has been 
described in SDE that were shown to carry genes presumably involved in virulence and 
resistance to metals (46) or to encode putative secreted extracellular proteins (38). 
Suzuki and colleagues (36), in their whole-genome comparison of S. dysgalactiae 
subspecies and GAS, identified a predominance of transposons and transposase genes 
which ranked them among the top of streptococcal genomes in terms of transposase 
abundance. A putative integrative plasmid was also recently identified in the S. canis 
genome that was shared with GBS (23). Distinct elements may mediate transfer 
between distinct species, and one study indicated that SDE bacteriophages might play a 
major role in transfers between SDE and GAS while SDE exchanges with GBS would 
be predominantly mediated by transposons (37). The chimeric nature evidenced by 
many of these elements (22, 44, 47–49) also highlights the role of recombination in 
their assembly and gene content. 
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7. CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
The work reported in this thesis provides novel insights into the biology of GCGS in 
relation to the human host, with special focus on aspects related to population dynamics, 
virulence and antimicrobial resistance. The molecular epidemiology and evolutionary 
relationships among members of the two GCGS species studied, SDE and S. canis, were 
scrutinized at both regional and global levels. The clonal relationships among strains 
were elucidated and a polyclonal nature of SDE and S. canis populations revealed, 
supported by the identification of a great diversity of genetic lineages shown by 
different typing methods. The pathogenic potential of multiple members of these two 
species was substantiated by the observed ability of several strains to cause disease in 
the human host. 
The use of the emm gene as an epidemiologic marker was shown to be 
complemented by applying other techniques, as emm typing produced stratifications that 
were not in agreement with either PFGE or MLST. The establishment of MLST 
schemes for SDE and S. canis provides new tools for future studies on their population 
dynamics. Relevant findings in our work also included the statistic association of certain 
emm types with invasive SDE isolates, suggesting a role for the M protein in SDE 
virulence. The data also produced evidence for recombinational replacements between 
SDE and GAS in several loci and, to a smaller extent, between SDE and S. canis, 
indicating that horizontal gene transfer events are important mechanisms driving genetic 
variability in GCGS populations, which may impact key bacterial functions such as 
virulence and antimicrobial resistance.  
The novel data available, mainly from whole-genome sequencing projects, has 
confirmed that these bacteria have the gene repertoire consistent with their pathogenic 
role and potential to infect the human host. Thus, continuous surveillance that will 
contribute to elucidating their pathogenic potential and identifying the factors 
contributing to their virulence and dissemination, both at the strain and population 
levels, are needed. 
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In view of the work presented in this thesis and the current knowledge on GCGS 
pathogenesis in the human host, key issues remain to be elucidated.  Thus, among the 
possible aspects which may be assessed in future work, the following can be 
enumerated: 
• Monitor the GCGS species causing infections in humans in Portugal. The 
continuous characterization of these isolates will allow determining whether there is 
an increase in the incidence in human infection of any of the GCGS species and if 
the epidemiology reported in this thesis is maintained. 
• Continue the molecular characterization of GCGS isolates, in order to obtain a better 
recognition of the most significant genetic lineages causing human infections. 
Detailed typing characterization covering a longer time span may provide additional 
information on epidemiologic temporal trends and help to understand the population 
dynamics of these pathogens. 
• Determine the most suitable typing method(s) to be used for the characterization of 
GCGS species. The quantitative assessment of the congruence obtained by 
employing distinct typing methods to these bacteria has been limited. An approach 
centering on evaluating the discriminatory ability of each typing method, together 
with the analysis of the correlation of the different techniques, may help improving 
the delineation of GCGS clonal lineages.  
• Expand the observation of an association between emm type and virulence in SDE 
by exploring features of either the emm gene or of the genomic environment 
surrounding this locus that may impact on the virulence of the bacteria. The study of 
isolates with emm types associated with invasive disease may be of particular 
interest. 
- Explore intrinsic features of the emm gene: the emm type is defined by the 
analysis of a small proportion of the emm gene. Differences in the biological 
properties of M proteins exhibited by SDE isolates may be encoded in 
regions located outside the region analyzed by the emm typing technique. 
Sequence analysis of the entire length of the emm gene in SDE will allow the 
comparison of the composition of the distinct proteins encoded and may 
reveal differences within the same emm type. 
 204 
- Explore differences in the genomic environment surrounding the emm locus: 
the availability of SDE genomes allows the genomic context to be elucidated 
to a greater extent. Given that the origin of the emm locus in SDE may be 
related to an ancient pathogenicity island shared with GAS, specific studies 
can test the possibility of some emm regions of SDE having an organization 
similar to that of GAS. Whether specific emm genes may be transferred 
between SDE strains as part of one element of this kind may also be 
questioned.  
• Characterize the locus of the emm types detected among the S. canis isolates 
analyzed in this thesis. Although in the S. canis published genome a few emm-like 
genes were present (23), none was identical to the emm types previously described. 
Thus, it would be of interest to define the exact locus from which emm-like genes 
are being amplified in S. canis isolates positive in the emm typing scheme, since 
these could represent loci that are more related to both SDE and GAS loci. 
• Determine the distribution of genes encoding putative virulence factors which are 
differentially distributed throughout the GCGS populations and may account for 
differences in strain invasiveness.  
- Investigate the presence of genes encoding pilus-like structures in the FCT-
like regions detected in SDE. Given the major contribution that pili are 
thought to have to the ability of bacteria colonizing and infecting their hosts, 
including the beta-hemolytic GAS and GBS, these factors are likely to have 
an important role in GCGS as well. 
- Search for the presence of superantigen genes in GCGS. Despite the lack of 
evidence for the expression of the speG gene in SDE, and the absence of 
other superantigen genes in most of the SDE isolates analyzed to date, 
distinct approaches may still be considered. For example: the design of new 
primers which take into account the allelic variation observed in some of 
these genes (including the allelic variants observed in other GCGS species); 
screening for the genes recently described in S. equi subsp. zooepidemicus 
(50); or extend the analysis to other GCGS species (where the products of 
these genes may have increased relevance). Studies that involve these 
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approaches complemented with expression analysis may generate important 
new information. 
• Define the taxonomic status of SDE from animal origin, namely the beta-hemolytic 
Lancefield group C and L strains commonly isolated from house pets, cattle and 
other animals. As it is still a matter of debate the classification of these strains as 
subspecies equisimilis or dysgalactiae (16), work should be done to clarify their 
taxonomy and their relative clinical importance to the various hosts from which they 
have been isolated. 
• Clarify the occurrence of SDE strains from animal origin in humans. The 
comparison of beta-hemolytic SDE from human and non-human sources should 
elucidate the origin of group L strains detected in both animals and humans. For 
example, application of the MLST technique to characterize animal isolates of SDE 
(as illustrated by the work on S. canis reported in chapter 5 of this thesis), may 
allow the identification of SDE strains isolated from human infection that are of 
zoonotic origin, determine how frequently they occur, and improve their detection. 
• Conduct studies on carriage of GCGS. Most of the available studies were conducted 
prior to the current species delineation implying that speciation was not performed 
or is incomplete. New carriage studies may:  
- Offer new insights into the frequency of SDE in colonization. 
- Allow the comparison to isolates causing infection. Characterizing the strains 
that are found in the same time frame in colonization and infection in a given 
geographic region, may be particularly useful in further defining if there are 
clonal lineages more prone to cause disease. 
- Test for the occurrence of colonization by other GCGS species. 
• Perform whole-genome analysis of SDE and S. canis isolates. Given the impact that 
this technology is having in elucidating the molecular mechanisms driving GCGS 
evolution and virulence, it would be of interest to extend the number of isolates 
analyzed. In particular, new data could be obtained by: 
- Analyzing SDE isolates of the emm types that were associated with 
invasiveness. 
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- Sequencing SDE isolates from animal origin, in order to determine how 
genetically and pathogenically distinct are these strains from human SDE. At 
the current time, SDE isolates of human origin have been compared to a S. 
dysgalactiae subsp. dysgalactiae isolate for which genome information is 
also available (36). To extend this analysis to SDE isolates from distinct 
hosts may help bring novel insights into the mechanisms associated with 
niche separation and those important for pathogenesis in the human host.  
- Characterizing additional S. canis isolates. A single S. canis genome has been 
published (23), corresponding to an isolate from bovine mastitis. By 
sequencing other isolates, the virulence factors present in this species could 
be explored, and the inclusion of human isolates could further test whether 
the presence in the human host is associated with any specific traits in 
individual strains. 
• Define the resistance mechanisms to different antimicrobial classes in SDE. 
Monitoring resistance to agents which are treatment options for the management of 
GCGS infections is critical as significant resistance rates have been documented 
among streptococci and common resistance gene pools are present. The follow up of 
the high resistance rate to fluoroquinolones detected should also be maintained, as 
the observations reported for SDE isolated from human infections in Portugal 
remain unique at the present time. 
The work presented in this thesis provided novel insights into the population 
structure of both SDE and S. canis. Integrated typing information together with new 
genomic data from genome sequencing projects should prove instrumental in 
elucidating the pathogenic potential of these GCGS. The availability of new GCGS 
genomes will allow to move into the field of comparative genomics that may allow the 
identification of the core and accessory genomes, and to infer more accurately the 
impact of intra- and inter-species transfer of genetic material in GCGS biology and 
evolution. 
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